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As the sentinel of immune system, macrophages are the first to encounter 
pathogen invasion. Macrophages sense pathogens through pattern recognition 
receptors, of which Toll-like receptors (TLR) are the most well characterized ones. 
Pathogens usually display multiple TLR ligands, which activate a collective of TLRs. 
Activation of some combination of TLRs could induce synergistic production of 
cytokines. The level of cytokine expressed is finely tuned and closely related to 
disease pathology. Insufficient cytokine expression might fail to mount effective 
immune responses, but overwhelming cytokine expression could also cause damage 
to the host itself, such as acute and chronic inflammatory diseases. Thus, it is 
important to understand the molecular basis of cytokine expression, especially 
cytokine synergy, induced by combinatorial TLR activation. Although it is known 
that activation of both TLR adaptor MyD88 and TRIF pathways are needed for 
cytokine synergy, indicating crosstalk between MyD88 and TRIF pathway, the 
detailed mechanism is not known. 
This thesis aimed to unravel the cryptic mechanism of cytokine synergy 
induced by combinatorial TLR activation. We stimulated mouse macrophages with 
poly (I:C) and R848, which are ligands, respectively for TLR3 (mediated through 
TRIF adaptor) and TLR7 (mediated through MyD88 adaptor). We found that synergy 
in cytokine expression was especially profound for secondary response pro-
inflammatory cytokines, IL6 and IL12p40. The time interval and the sequence 
between poly (I:C) and R848 treatments could affect the magnitude of synergy. To 
investigate the mechanism of cytokine synergy, and how TLR3-TRIF and TLR7-





With systems approach, we built the first calibrated ordinary differential 
equations (ODE) based kinetic model for TLR-3 and 7 pathways and their crosstalk. 
The model provided good descriptive and predictive properties. It identified MAPK 
and type I IFN-JAK-STAT pathways to be critical signaling pathways for cytokine 
synergy, which was verified by empirical data. 
With conventional biology methods, we found TLR3-TRIF and TLR7-MyD88 
to directly collaborate at the transcriptional level to synergize cytokine expression. 
Through proteomic analysis and cytokine Il6 and Il12b promoter affinity assay, we 
identified three indispensible transcription factors, IRF1, JunB and C/EBP!, for 
cytokine synergy. We showed that TLR3-TRIF pathway activates IRF1, while TLR7-
MyD88 contributes to the activation of JunB and C/EBP!. All the three transcription 
factors are necessary for optimal transcription of Il6 and Il12b, and combinatorial 
activation of TLR3-TRIF and TLR7-MyD88 pathway synchronize and sustained the 
activation of IRF1, JunB and C/EBP!, leading to the synergistic production of 
cytokine IL6 and IL12p40. Notably, TLR7-MyD88 pathway has an inhibitory effect 
on IRF1, which controls the timing and magnitude of cytokine expression and 
prevents immune over-reaction. 
Next, through MAPK and JAK inhibitor study, we found that JunB is 
upregulated by MAPK JNK, ERK and p38, and C/EBP! is upregulated by ERK and 
p38. Interestingly, ERK and p38 inhibit IRF1 expression under R848 stimulation, 
which might explain the inhibitory effect of TLR7-MyD88 pathway on IRF1. In 
addition, JAK-STAT upregulates IRF1 under poly (I:C) stimulation. The inhibitor 
study linked the signaling pathway predicted by computational modeling with the 




Our results explained how TLR3-TRIF pathway collaborates with TLR7-
MyD88 pathway by activating JAK-STAT pathway, which activates IRF1, and 
MAPK pathway, which in turn induces JunB and C/EBP!, respectively. Together, 
they synchronized transcription factors necessary for cytokine expression and 
facilitate synergy. These results shed light on the crosstalk mechanisms of TLRs with 
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CHAPTER I.  INTRODUCTION 
 
1.1 Innate immunity and macrophages 
Innate immune system is an evolutionarily ancient arm of the host 
defense mechanism and the molecular players are well-conserved in both 
plants and animals. While innate immunity is solely responsible for pathogen 
surveillance and antimicrobial defense in plants and invertebrates, it makes the 
front line of host defense in vertebrates [1]. During an infection, pathogenic 
microorganisms are first encountered by innate immune cells, such as 
macrophages that reside in the tissue. This is followed by recruitment of 
neutrophils to the infection site. Both macrophages and neutrophils are known 
as phagocytes, which could kill pathogens through a process called 
phagocytosis by producing toxic products such as nitric oxide and 
antimicrobial peptides. In addition, activated phagocytes, especially 
macrophages, release small proteins called cytokines and chemokines, which 
attract and activate more macrophages and neutrophils. More importantly, 
these cytokines and chemokines could activate co-stimulatory molecules on 
the macrophages and dendritic cells (DC), another type of phagocyte that 
reside in the tissue, enabling these antigen-presenting cells to initiate the 
adaptive immune system [2]. Figure 1.1 illustrates the innate and adaptive 





Figure 1.1. Activation of innate and adaptive immune system by 
pathogens. Upon pathogen infection, innate immune system is first activated. 
Tissue resident macrophages are the first to sense invading microbes. They 
produce cytokines and chemokines which recuit neutrophils and monocytes to 
fight against pathogens. If innate immune system fails to contain a pathogen, 
adaptive immune system kicks in. The antigen presenting innate immune cells, 
such as macrophages and dendritic cells, could activate adaptive immune 
cells, mounting a later but highly targeted attack against the specific invader. 
 
As the sentinel of innate immune system, macrophages mature from 
monocytes from the circulation system and migrate into the tissues throughout 
the host. According to their different localization in the body, they are given 
different names, for examples, microglial cells in neural tissue and Kupffer 
cells in liver. Macrophages are found in especially large numbers in 
connective tissues, lung, submucosal layer of gastrointestinal tract and spleen. 
Not only can they kill pathogens, but also remove senescent cells and maintain 
homeostasis. They are the first to encounter invading pathogens, making them 




For the past few decades, the innate immune system was considered to 
be non-specific in microbial recognition until the discovery of Pattern 
Recognition Receptors (PRRs) in the mid-1990. With PRRs, macrophages, as 
well as other innate immune cells, could specifically recognize pathogens and 
discriminate ‘infectious non-self’ from ‘non-infectious self’, and initiate 
downstream signaling and immune responses.  
 
1.2 Pattern recognition receptors 
Germline-encoded PRRs recognize evolutionarily conserved structures 
on microbes, which are known as pathogen-associated molecular patterns 
(PAMPs) [3].  Recently, PRRs were also found to recognize endogenous 
molecules released from damaged cells, which are known as danger-
associated molecular patterns (DAMPs). Among PRRs, Toll-like Receptors 
(TLRs) are the first to be discovered and also the most well-studied [4]. 
Besides TLRs, three other classes of PRRs have been identified so far, 
including transmembrane C-type lectin receptors (CLRs), as well as 
cytoplasmic receptors such as the Retinoic acid-inducible gene (RIG)-I-like 
receptors (RLRs) and NOD-like receptors (NLRs) [3,5] (Figure 1.2). CLRs 
are transmembrane proteins with carbohydrate-binding domain and can 
recognize carbohydrates from virus, bacteria and fungi. RLRs are comprised 
of RIG-1, MDA5 and LGP5, which recognize cytoplasmic viral RNAs. NLRs 
consist of more than 20 members, which recognize PAMPs, non-PAMP 
particles and cellular stress effectors, to induce pro-inflammatory responses, 
particularly inflammasome formation. Expression of these PRRs is not limited 




Thus non-TLR PRRs might work in concert with TLRs in innate and adaptive 
immunity and in maintaining homeostasis. Although this thesis mainly focuses 
on the crosstalk between TLRs, we should also bear in mind the possible 
interplay of other PRRs with TLRs under pathogen infection, which warrants 
future study.  
 
 
Figure 1.2. Schematic representation of the structure, cellular localization 
and major components of the PRR families. Four classes of PRRs have 
been identified so far, including membrane binding recoptors TLRs, CLRs, as 
well as cytoplasmic receptors such as the RLRs and NLRs. All TLRs use 
MyD88 as their adaptor, except TLR3, which uses TRIF as its adaptor. TLR4 
needs both MyD88 and TRIF to induce downstream signaling. MyD88 
pathways mainly induce pro-inflammatory cytokines through activating NF-
kB family members, while TRIF pathways mainly induce type I IFN through 
activating IRF3. The figure is from Giorgio et al [6] with copyright permission 








1.2.1 Toll-like receptors (TLRs) 
Among all the PRRs, the TLRs are the first to be identified and the 
most well characterized pathogen receptors. Toll was first discovered in 
drosophila in 1985 by Nüsslein-Volhard [7]; it controls early embryogenesis. 
A decade later, Jules Hoffmann’s lab found its role in the drosophila immune 
defense [8]. In 1997, Ruslan Medzhitov and Charles Janeway found the toll 
equivalent in human, which is now known as TLR4 [9]. So far, 10 and 12 
functional TLRs have been identified in human and mouse, respectively, with 
TLR1-9 conserved in both mice and human. Mouse TLR10 is hitherto not 
known to be functional and TLRs11-13 are missing during the evolution in 
human.  
TLRs are type I transmembrane proteins with ectodomains containing 
leucine-rich repeats which is required for PAMP recognition, transmembrane 
domain and intracellular Toll–interleukin 1 (IL-1) receptor (TIR) domains 
mediating downstream signaling pathways. TLRs are expressed on various 
immune cells including macrophages, DCs, B cells and even on some atypical 
cells such as fibroblasts and epithelial cells. TLRs recognize a vast range of 
PAMPs including proteins, lipids, lipoproteins, nucleic acids from viruses, 
bacteria, parasites and fungi [10] (Figure 1.2). Some TLRs (TLR1, 2, 4, 5, 6) 
are expressed on the cell surfaces and they recognize mainly microbial 
membrane components. For example, subfamily of TLR1, 2 and 6 recognize 
lipids, TLR5 recognizes flagellin, and TLR4 recognizes lipopolysaccharide 
(LPS). While certain others (TLRs 3, 7, 8, 9) are expressed exclusively in 
intracellular vesicles such as endosome, lysosome and endo-lysosomes, where 




internalized into endosomes before signaling occurs [10]. The cellular 
localization of TLRs is important for the accessibility of their ligands and the 
maintenance of tolerance to self molecules such as nucleic acid.  
 
1.2.2 TLR-induced signaling pathways 
After sensing PAMPs, individual TLRs trigger a distinct response, 
which is mainly determined by the adaptors with which each of them 
collaborate (Figure 1.2). The TIR domains of the receptors recruit the TIR 
domain-containing adaptor proteins to initiate downstream signaling 
pathways. These TIR domain-containing adaptor proteins include Myeloid 
differentiation primary response gene (88) (MyD88), TIR-domain-containing 
adapter-inducing interferon-" (TRIF), TIR-associated protein (TIRAP), TRIF-
related adaptor molecule (TRAM) and Sterile-alpha and Armadillo motif 
containing protein (SARM). The adaptor MyD88, used by all TLRs except 
TLR3, mainly triggers the activation of NF-"B, a core transcription factor 
(TF) for pro-inflammatory cytokines and mitogen-activated protein kinase 
(MAPK). In contrast, the adaptor TRIF used by TLR3 and TLR4 [11], mainly 
activates interferon regulatory factor 3 (IRF3), a master transcription 
controller of antiviral responses, as well as NF-"B and MAPK pathways [12]. 
TRAM and TIRAP function as sorting adaptors that recruit TRIF to TLR4 and 
MyD88 to TLR2 and TLR4, respectively. SARM, on the contrary, is reported 
to be a negative regulator of TLR signaling [13]. Thus, TLR signaling 
pathways can be generally subgrouped into either MyD88-dependent 
pathways, which drive the induction of inflammatory cytokines, or TRIF-




interferon as well as inflammatory cytokines. Notably, TLR4 is the only TLR 
that uses both MyD88 and TRIF for its downstream signaling. 
 
1.3 TLR crosstalk and cytokine synergy 
During an infection, each pathogen usually carries with it multiple 
PAMPs which are likely to interact with multiple TLRs (Table 1.1). However, 
the consequences of combinatorial TLR-activation vary a lot depending on 
different combinations of TLRs which are activated. For example, the 
combined activation of TLRs can lead to complementary, synergistic and 
antagonistic cytokine production, indicating crosstalk amongst the TLRs.  
 
1.3.1 Collaboration and antagonism of TLRs  
Initial studies on the collaborations between TLRs expressed by mouse 
macrophages showed that TLR3 and TLR9 ligands could induce more than 
additive production of TNF, IL6 and IL12p40 [14], which confirmed that 
crosstalk between TLRs does exist. Subsequent studies showed both gene 
expression and protein production of TNF, IL1!, IL10, IL6, IL12 and IL23 
which are several fold higher in DCs simulated with combinatorial TLR 
ligands than single stimulations [15,16]. Some in vivo experiments also 
support the notion that TLRs collaborate. For example, Tlr2-/- or Tlr9-/- mice 
are more susceptible to a high dose of M. tuberculosis challenge than their 
wild-type counterparts [17]. In addition, both Tlr3-/- or Tlr9-/- mice have 
reduced resistance to murine cytomegalovirus (MCMV) and this decreased 
resistance is associated with reduced type I IFN and IL12 synthesis [18], 




Table 1.1. Examples of pathogens expressing multiple TLR ligands.  
 
Pathogen TLR TLR ligand 
TLR2 Lipoarabinomannan 




TLR2 Bacterial lipoprotein 
TLR4 Lipopolysaccharide Salmonella typhimurium 
TLR5 Flagellin 
TLR2 Porin 
TLR4 Lipopolysaccharide Neisseria meningitidis 
TLR9 DNA 
TLR2 Lipoprotein Haemophilus influenzae TLR4 Lipopolysaccharide 
TLR2 Phospholipomannan 
TLR4 Mannan Candida albicans 
TLR9 DNA 
TLR2 Viral protein 
TLR3 Double-stranded RNA Murine cytomegalovirus 
TLR9 DNA 
TLR2 Viral protein 
TLR3 Double-stranded RNA Herpes simplex virus 
TLR9 DNA 
TLR7,  8 Single-stranded RNA 
TLR3 Double-stranded RNA Influenza virus 
TLR5 Not determined 
TLR3 Double-stranded RNA Respiratory syncytial virus TLR4 Envelope F protein 




TLR2 Glycosylphosphatidylinositol anchor? Toxoplasma gondii 
TLR11 Profilin 
 









On the other hand, cytokine production could also be antagonized by 
certain combinations of TLRs. IL10 produced by TLR2 ligands was shown to 
inhibit IL12p35 and IP10 induced by TLR3/4 ligands in human DCs [19]. In 
addition, TLR9-mediated type I interferon production was shown to be 
negatively regulated by TLR2 and TLR7 ligands in mouse and human DCs, 
respectively [20,21].  
The positive and negative regulatory role of TLR crosstalk is selective 
and mainly affects genes, such as cytokine genes, that are important for 
immune responses to pathogens.  
 
1.3.2 Cytokines and immune-homeostasis 
The production of cytokines and chemokines is one of the major 
events after TLR signaling is activated. Cytokines constitute the central 
“language” of immune cell communication, interaction and coordination with 
one another. There are more than 150 “words” in this language system 
characterized in humans, each with a specific meaning (function). For 
example, activated macrophages produce chemokines to recruit T-cells and 
phagocytes to the site of infection, and activate them by producing pro-
inflammatory cytokines (e.g. TNF# and IL12). Stimulated phagocytes become 
phagocytic, and produce more cytokines while stimulated T-cells are involved 
in the development of antibody-based acquired immunity with memory. 
TNF#, IL1, IL6, IL10 and IL12 secreted by activated macrophages are key 
immunomodulators [22,23]. While TNF#, IL1, IL6 and IL12 are pro-
inflammatory cytokines, the IL10 is an anti-inflammatory cytokine. Under 




cells usually depends on the coordinated sum of the signals induced by 
multiple TLRs and this determines the quality and magnitude of subsequent 
immune response. Effective and coordinated cytokine production results in 
efficient elimination of infectious agents and tissue repair without 
compromising homeostasis. However, any imbalance or imprecision in 
cytokine production could result in either unsuccessful clearance of pathogens 
or a fatal cytokine storm and chronic inflammatory diseases [24-26].  
 
1.3.3 Physiological significance of cytokine synergy 
This thesis focused on studying cytokine synergy induced by TLR 
collaboration. Cytokine synergy plays a critical role in immune response and 
understanding of the mechanism underlying cytokine synergy will enlighten 
us on its close association with immune-related diseases and how to intervene 
immune over- or under- activation.  
On one hand, insufficient cytokine production may hamper immune 
responses to pathogen infection. This is especially profound in age-dependent 
dysregulation of immune system. One of the first studies of age-dependent 
immune deficiency in mouse showed a generalized decrease in Tlr gene (Tlr1-
9) expression and TLR-induced TNF and IL6 production by splenic and 
peritoneal macrophages from aged mice [27]. An age-dependent impairment 
of TLR2-induced cytokine expression and signaling was also reported in 
alveolar macrophages from a S. pneumoniae infection of a Balb/c mouse 
model and a Porphyromonas gingivalis infection of a C57BL/6 mouse model 
[28,29]. In human, decreased TLR-induced cytokine production was also 




On the other hand, uncontrolled cytokine synergy can be lethal and is 
associated with various diseases. Septic shock is one example that 
uncontrolled production of pro-inflammatory cytokine in response to pathogen 
infection may cause dysfunction of organs and lead to death [36]. Cytokine 
synergy is also involved in chronic inflammatory and autoimmune diseases 
such as Systemic Lupus Erythematosus (SLE). Elevated levels of IL6, 
IL12p40 and IL12p19 were observed in SLE patients as well as mouse models 
[37-41]. MyD88 deficient mouse produces less IFN#, IL6 and IL12, and 
delays the mortality of SLE and prevents nephritis and immunologic 
aberrations than wild type mouse [42]. Thus understanding how cytokine 
synergy occurs during TLR crosstalk will not only contribute to basic research 
on the understanding of how TLR signaling network is shaped, but also sheds 
light on disease pathology which may be translated into potential therapeutics. 
 
1.4 Gap of knowledge in cytokine synergy mechanisms 
Considering the physiological significance of cytokine synergy 
induced by combinatorial TLR activation, it is important to unravel the 
molecular mechanism underlying it. This may help us understand the disease 
etiology and harness strategies relevant to cytokines production. Although 
some researches have been carried out to characterize the synergy mechanism 
from different levels, molecular details are still unclear. The subsections 
below summarize the known mechanisms and why they are insufficient, 






1.4.1. TLRs synergize cytokine production through crosstalk between 
MyD88 and TRIF pathways. 
 
Studies have been carried out to systematically examine the pairwise 
combinations of TLR activation in both macrophages and DCs [16,43-45], and 
the results showed that two TLR ligands could induce synergistic cytokine 
production if the stimuli collectively activated both MyD88 and TRIF 
pathways. Neither MyD88-/- nor TRIF-/- bone marrow derived DCs (BMDC) 
releases synergetic level of cytokines after combinatorial stimulation [45,46]. 
These results suggest that TLR synergy might be mediated through certain 
crosstalks between MyD88 and TRIF pathways. However, the molecular 
mechanism underlying the MyD88-TRIF crosstalk is still poorly defined.   
 
1.4.2. Role of the autocrine-paracrine loop in synergy is controversial. 
Based on the notion that a TRIF-dependent TLR is essential for 
synergy, one postulation was raised that IFN" produced by the TRIF pathway 
might selectively enhance the cytokine production since TRIF pathway is 
more specialized in type I interferon production than MyD88 pathway. 
However, controversial views on the involvement of the autocrine-paracrine 
loop in DC emerged from different research groups. Bagchi and coworkers as 
well as Napolitani et al [16,43] believed it unlikely because the addition of 
exogenous IFN" did not further enhance the cytokine production. On the 
contrary, Gautier et al [15] found that knockout of IFN" receptor abolished 
synergism in cytokine production completely or partially in BMDC). This 
controversy might be a result of different cell culture conditions and 
experimental methods. However, it could also imply that endogenous IFN" 




sensing IFN" in DC. In macrophages, the evidence is consistent among 
different studies, in that the addition of type I interferon and knockout of 
IFNAR do not affect the synergistic production of cytokines [15,47]. 
 
1.4.3. Multiple signaling pathways might be responsible for synergy 
The cytokine production induced by TLR activation is primarily 
mediated by NF$B and MAPK signaling, thus many research groups have 
focused their attention on the signaling mechanisms to investigate synergy. 
However, most of the studies of this kind are in DCs and their results showed 
association of NF$B, JNK, p38, cJun and ERK signaling [16,45,48,49] with 
synergy. In macrophages, which are frontline innate immune cells, only 
sustained ERK phosphorylation has thus far been reported to be concordant 
with synergy [44]. However, none of the research provided in-depth 
understanding on the mechanisms on how MyD88 and TRIF might crosstalk 
to enhance signaling pathways as well as how these signaling pathways 
synergize in cytokine production. 
 
1.4.4. Transcription regulation of cytokine synergy 
Synergistic cytokine production occurs at both the protein and mRNA 
levels [16,44], suggesting the involvement of transcriptional regulation. Sanna 
and co-workers [49] studied transcription factor-binding ability to IL12p35 
promoter under single- or combinatorial- PAMP stimulation of DCs, and 
showed that a combinatorial treatment with TLR3+TLR8 agonists accelerated 
the binding of IRF1 and IRF8 to the IL12p35 gene Interferon-Responsive 




et al [50] found the involvement of another IRF family member, IRF5, in 
synergy, because synergistic production of cytokines (IL12p40, IL12p19 and 
IL6) was impaired in IRF5 knockout mouse peritoneal macrophages. These 
results provided hints that the IRF family members might play a critical role in 
cytokine synergy. However, the role of different transcription factors on 
synergy seems to be gene- and/or cell- type specific [49], for example 
IL12p35 is synergistically regulated by IRF1 and IRF8 in DCs but the 
expression of IL12p35 is very low in macrophage even under combinatorial 
TLR activation. Thus, findings of transcriptional regulation in DC are not 
sufficient to explain the synergy phenomenon in macrophages 
 
1.4.5 Limited information is available on TLR signaling network from a 
global perspective 
 
The study of complex signaling network such as TLR signaling needs 
more than just searching for specific genes and proteins critical for synergy. It 
is also necessary to understand the whole TLR signaling crosstalk from a 
systems perspective. A system, such as TLR signaling network, is not just an 
assembly of genes and proteins, its properties cannot be fully understood 
merely by drawing static diagrams. Although such a pathway diagram 
represents an important first step, what we really seek to know are the 
dynamics and patterns, why a certain profile emerges, and how we can control 
them. Lack of a general knowledge of the system may mislead us in 
interpreting experimental results.  This is especially important in drug design. 
Many drugs are proven to have side effects in clinical trials, although most of 




of the whole system with computational biology approach might help us gain 
a more comprehensive overview of the system. 
Over the past two decades, intensive research has identified and 
characterized hundreds of components and interactions involved in TLR 
signaling, constituting a first step towards understanding TLR signaling on the 
whole. Systems biology approaches were then extensively applied to enhance 
our understanding of TLR-mediated innate immune responses [51]. For 
example, steady-state based flux balance analysis has been carried out on a 
modified version of the TLR reaction map built by Oda and Kitano [52]. By 
establishing input-output relationships based on ligand/receptor and 
transcription/anti-pathogen activities, critical reactions such as MyD88-
mediated NF$B/AP-1 activation have been identified [53]. There are also 
quantitative modeling works to study the dynamics of TLR3 and TLR4 
signaling [54-56]. However, these models are either static or over-simplified 
(no crosstalk was taken into account), which limited the use for an in-depth 
understanding of TLR pathways. To understand the pattern of TLR crosstalk, 
an accurate and validated mathematical model of TLR signaling pathways, 
taking into account of their dynamic interactive behavior need to be derived. 
This will not only enhance our understanding of TLR crosstalk, but also 
provide an invaluable platform for designing pharmaceutical strategies.  
Given the above rationale, it is important for us to investigate the 
mechanisms of cytokine synergy in macrophages from both the systems level 






1.5 Aims and approaches 
1.5.1 The biological question 
The major question this thesis seeks to address is how MyD88 and 
TRIF pathways crosstalk and collaborate to synergize cytokine production 
when an immune responsive cell encounters more than one TLR agonist. 
 
1.5.2 A proposed model to use- TLR3 and TLR7 combinatorial stimulation 
In our lab’s previous work [57], Tan et al reported that the 
combination of induction of TLR3 and TLR7 in macrophage induces the most 
significant cytokine synergy. Thus, we used poly (I:C), a viral dsRNA 
analogue which activates TLR3-TRIF (Henceforth, Poly (I:C) was denoted I), 
and R848, a viral ssRNA analogue which activates TLR7-MyD88 (R848 was 
denoted R) in our study. Mouse macrophages were stimulated with either I or 
R or a combination of I and R to study the mechanism of MyD88-TRIF 
crosstalk. In this thesis, TLR8, which also recognizes single-stranded RNA, 
was not studied, because it is not functional in mouse. A combination of viral 
dsRNA- and ssRNA- induced immune cell activation is common in a real 
infection senario. For example, influenza virus (ssRNA virus) possesses the 
ligands for both TLR3 and TLR7 [6]. And many other ssRNA viruses also 
undergo a dsRNA phage during genomic replication in the host cell, and thus 
contain both TLR3 and TLR7 ligands. Thus, studying the combination of 
ssRNA and dsRNA bear significance in a real life infection since both dsRNA 
and ssRNAs of pathogen co-exist in a host cell. 
TLR3 pathway The TLR3 pathway is initiated by binding of TLR3 and 




adaptor protein TIR domain containing adapter-inducing interferon-" (TRIF) 
dependent pathway. The activated TRIF recruits TRAF6, TRADD, FADD and 
RIP1and forms a complex, which leads to the activation of TAK1:Tab2:Tab3 
complex. The activated TAK1 complex, in turn activates the IKK complex 
(NEMO:IKKb:IKKa). NF-$B is usually associated with I$B# in the 
cytoplasm. I$B# sequesters with the transcription factor NF-$B, which renders 
NF-$B inactive. The activated IKK complex, phosphorylates I$B# (that is 
sequestered to NF-$B), this leads to the dissociation and nuclear translocation 
of NF-$B. NF-$B then induces the transcription and translation of 
inflammatory cytokines. TAK1 complex simultaneously activates the MAPKs 
Erk, p38 and JNK by inducing the phosphorylation of MAPK kinases, which 
in turn activates the AP-1 transcription factor, which then induces the 
transcription of inflammatory cytokines. More significantly, the TRIF-
dependent pathway leads to IRF3 activation and subsequent Type 1 IFN 
production. TRIF, along with TRAF3 recruits a signaling complex involving 
TBK1 and IKKi (IKK$), which catalyze the phosphorylation of IRF3 and 
induce its nuclear translocation. Phosphorylated IRF3 in the nucleus (a 
transcription factor) induces the transcription and subsequent translation of 
Type-1-IFNs. In summary, TLR3 induces antiviral immune response by 
promoting the production of type 1 IFNs predominantly and cytokines to a 
lesser extent. The main signaling intermediaries in this pathway are IRF3, NF-
$B and AP-1. IRF3 leads to the production of Type 1 IFNs while NF-$B and 
AP-1 lead to production of inflammatory cytokines [3,5].  
TLR7 pathway On the other hand, the TLR7 pathway is initiated by the 




MyD88, which in turn recruits and activates IL-1 receptor associated kinases, 
IRAK4, IRAK1, IRAK2 and IRAK-M. The activated IRAK complex interacts 
with TRAF6 and activates TAB2 and TAB3, the regulatory components of the 
kinase TAK1 complex, to activate TAK1. At this point, the TLR3 and TLR7 
pathways merge at the signaling cascade that leads to the activation of AP-1 
and NF-$B and the production of cytokines. These form the predominant 
signaling events of TLR7 pathway. To a lesser extent, the TLR7 cascade 
activates the transcription factor IRF7, which is usually constitutively 
expressed in the nucleus and is in inactive form. IRF7 binds to forms a multi-
protein signaling complex with IRAK4, TRAF6, TRAF3, IRAK1. This leads 
to the phosphorylation of IRF7, which then dissociates from the complex and 
translocates into the nucleus. The nuclear IRF7 plays a role in the transcription 








Figure 1.3. A schematic model of TLR3 and TLR7 signaling pathways. 
TLR7 recognize single stranded RNA and recruits MyD88 as its adaptor. The 
TLR7 pathway mainly activate inflammatory cytokines such as IL6 and 
IL12p40 through activating NF"B and MAPKs. On the contrary, TLR3 
recoginize double stranded RNA and recruits TRIF as its adaptor. It mainly 
induces type I IFN through activating IRF3 and mount anti-viral responses. 





















1.5.3 Specific aims 
The following 4 specific aims are each provided with an approach: 
1.5.3.1 Specific aim 1.  
To check whether synergy is a prevalent phenomenon among all the 
macrophage-secreted cytokines and the kinetic profile of cytokine - 
Approach: QuantiGene cytokine mRNA screening and realtime PCR 
 
1.5.3.2 Specific aim 2. 
To understand the dynamics of TLR3-TRIF and TLR7-MyD88 
pathways from a systems biology perspective and to unravel key signaling 
pathways of cytokine synergy- 
Approach: Computational modeling and empirical validation. 
 
1.5.3.3 Specific aim 3. 
To identify the potential synergy factors induced by TLR7-MyD88 and 
TLR3-TRIF crosstalk. 
Approach: proteomic iTRAQ analysis, cytokine gene promoter affinity 
pulldown and functional knockdown of synergy factors. 
 
1.5.3.4 Specific aim 4. 
To understand whether key signaling pathways identified by systems 
biology regulate transcriptional synergy factors uncovered by conventional 
molecular biology approach. 
Approach: MAPK and JAK-STAT inhibitor study. 



































In Chapter II, the computational modeling was carried out in 
collaboration with Prof Thiagarajan P.S. and Dr Liu Bing from the School of 
Computing, National University of Singapore. iTRAQ (including in-gel 
trypsin digestion and isobaric labeling, fractionation of isobaric tag labeled 
chromatin protein peptides by HPLC, LC-MS/MS analysis of fractionated 
peptides using QSTAR and analysis of MS data) was carried out in 
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CHAPTER II.  MATERIALS AND METHODS 
All experiments were carried out in compliance with National and 
Institutional guidelines on ethics and biosafety (Institutional Review Board, 
Reference codes: NUS-IRB 08-296) and the Institutional Animal Care and 




7-8-week old female BALB/c mice were purchased from NUS-CARE, 
which were used for derivation of bone marrow-derived macrophages 
(BMDM). 
 
2.1.2 Aseptic tools and pyrogen-free equipment 
To minimize endotoxin contamination, scissors and forceps for mice 
dissection and all glassware for cell culture were baked at 200°C for 2 h. 
 
2.1.3 Cell culture medium 
Medium for cell culture: Dulbecco’s modified Eagle’s medium 
(DMEM) powder (Gibco, Life Technologies, Carlsbad, CA, USA) was 
dissolved in pyrogen-free water (Baxter, Deerfield, IL, USA) to make 
incomplete medium. Complete medium were made with DMEM 
supplemented with fetal bovine serum (FBS) (Hyclone, Thermo Fischer 
Scientific, Waltham, MA, USA). 
 
 




Antibodies for immuno-detection are summarized in Table 2.1.  
 
Table 2.1. List of antibodies used 
Antibody Supplier Cat# Raised  Dilution 
Primary antibodies 
pp38 (Thr180/Tyr182) CST 4511 Rabbit 1:1000 
pERK (Thr202/Tyr204) CST 4370 Rabbit 1:2000 
pJNK (Thr183/Tyr185) CST 4668 Rabbit 1:1000 
pI"B# (Ser32/36) CST 9246 Mouse 1:1000 
STAT1 CST 9172 Rabbit 1:1000 
pSTAT1 (Tyr701) CST 9171 Rabbit 1:1000 
NF"B p65  Abcam ab7970 Rabbit 1:1000 
IRF3 Abcam ab25950 Rabbit 1:1000 
TATA binding protein TBP Abcam ab818 Mouse 1:2000 
C/EBP beta Thermo MA1-827 Mouse 1:1000 
JunB Santa Cruz sc-73 Rabbit 1:1000 
RelB Santa Cruz sc-226 Rabbit 1:1000 
IRF1 Santa Cruz sc-640 Rabbit 1:1000 
ICSBP* Santa Cruz sc-6058 Goat 1:1000 
GAPDH  Santa Cruz sc-32233 Mouse 1:3000 
NF kappa B p50 and p105  eBiosciences 14-6732-63 Rabbit 1:1000 
c-Rel  eBiosciences 14-6111-82 Rat 1:1000 
Actin Sigma A2066 Rabbit 1:2000 
Secondary antibodies 
Goat #-rabbit HRP Dako P0448 Goat 1:3000 
Goat #-mouse HRP Dako P044701 Goat 1:3000 
Goat #-rat HRP Biolegend 405405 Goat 1:3000 
Rabbit #-goat HRP Dako P0449 Rabbit 1:3000 
 
*ICSBP:  Interferon (IFN) consensus sequence-binding protein, or interferon 
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2.1.5  Primer sequences  
 The PCR primers used in this thesis are summarized in Table 2.2 
Table 2.2 Primer sequences 
Primer sequences for restriction enzyme accessibility assay 
Forward 5’-cccatcaagacatgctcaagtg-3’  Il6 promoter region with 
AflII restriction site Reverse 5’-gcacaatgtgacgtcgtttagc-3’  
Forward 5’-tctgtatgatagatgcactcagg-3’ Il12b promoter region 
with SpeI restriction site  Reverse 5’- ggaaacccaaagtagaaactgac-3’ 
Forward 5’- agtttcaccagtgactccagca -3’ Il12b enhancer region 
with SpeI restriction site Reverse 5’- acagtctcaaaggaccatggct -3’  
Forward 5’-gaggcagagagccagcattg-3’ Control region 
 Reverse 5’-aagggaaaaccggcaagtgag-3’ 
Primer sequences for promoter cloning 
Forward 5’-attctcgagattttaatctactctaatcgcctgt-3’  Il6 promoter Reverse 5’-cccaagcttagcggtttctggaattgactat-3’ 
Forward 5’-agttcatgctgctatcaatcca-3’ Il12b promoter Reverse 5’-cacccactgttccttctgct-3’ 
 
2.2 Derivation of bone marrow macrophages 
Bone marrow derived macrophages (BMDMs) were isolated as 
described previously [58]. Mice were euthanized with CO2 and disinfected 
with 70% ethanol. Using aseptic tools, an excision was made on the skin on 
the back of the mouse, peeling the skin from the top of each hind leg down 
and over the foot. The hind legs were broken from the hip joint and the femur 
and tibia were obtained intact. Excessive muscles were removed from the legs, 
and the femur and tibia were kept in ice-cold incomplete DMEM. The bones 
proximal to each joint were carefully severed and flushed with 3 ml ice-cold 
DMDM twice at both end. The cells were spin down at 500 g for 10 min at 
room temperature. The cells were resuspended and plated in DMEM 
supplemented with 10% (v/v) FBS, 100 U/ml recombinant M-CSF 
(Ebioscience, San Diego, CA, USA), 100 U/ml penicillin and 100 µg/ml 
streptomycin (Gibco, Life Technologies, Carlsbad, CA, USA) at a density of 
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1.5x106 cells/ml. The cells were incubated at 37°C, 5% CO2 incubator. At day 
3 post-harvest, additional (half of the original volume) MCSF conditional 
medium was added to the bone marrow cells and were incubated for another 4 
days before harvesting macrophages for experiments.  
 
2.3 Cell culture 
Primary cells (BMDM) and established mouse macrophage cell line 
(J774) were cultured in DMEM supplemented with 10% (v/v) FBS at 37°C, in 
an incubator supplied with 5% CO2, 95% air. One day before PAMP 
stimulation, cells were plated at a density of 1x106/ml for BMDM and 
0.5x106/ml for J774 cells.  
 
2.4 PAMP treatment 
R848 and low molecular weight poly (I:C) were purchased from 
InvivoGen (SD, CA, USA). R848 was used at a final concentration of 25 
ng/ml and poly (I:C) was used at a final concentration of 10 µg/ml. The 
concentration of PAMPs was previously optimized in our lab by Tan et al 
[57]. The concentrations we used here fall in the exponential part of the dose-
response curve of each PAMP, and their combinatorial response could induce 
synergy, and yet not saturated. For combinatorial stimulation with different 
time intervals and stimulation sequential, the treatment strategies and 
corresponding controls are summarized in Figure 2.1 and Table 2.3. The 
number between I and R denotes the time interval between first and second 
stimulation, and number following second stimulation denotes the treatment 
time after second stimulation. For example, I8R8 means poly (I:C) 
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pretreatment for 8 h followed by R848 treatment for another 8 h. The single 
PAMP stimulation controls for I8R8 are I16 (I stimulation for 16 h) and R8 (R 
treatment for 8 h). 
 
Figure 2.1 Stimulation strategies for combinatorial PAMP stimulation 
with different time interval between two PAMP treatments. Here the two 
PAMPs used are poly (I:C) and R848. 
 
Table 2.3 Combinatorial I and R stimulation, and their controls 
Simultaneous I and R stimulation for 4, 8, 16 and 24 h 
Combinatorial Single control Combinatorial Single control 
I4 I16 IR4 R4 IR16 R16 
I8 I24 IR8 R8 IR24 R24 
I pretreatment for 8 h followed by R stimulation for 4, 8, 16, 24 h 
Combinatorial Single control Combinatorial Single control 
I12 I24 I8R4 R4 I8R16 R16 
I16 I32 I8R8 R8 I8R24 R24 
I pretreatment for 24 h followed by R stimulation for 4, 8, 16, 24 h 
Combinatorial Single control Combinatorial Single control 
I28 I40 I24R4 R4 I24R16 R16 
I32 I48 I24R8 R8 I24R24 R24 
R pretreatment for 8 h followed by I stimulation for 4, 8, 16, 24 h 
Combinatorial Single control Combinatorial Single control 
R12 R24 R8I4 I4 R8I16 I16 
R16 R32 R8I8 I8 R8I24 I24 
R pretreatment for 24 h followed by I stimulation for 4, 8, 16, 24 h 
Combinatorial Single control Combinatorial Single control 
R28 R40 R24I4 I4 R24I16 I16 
R32 R48 R24I8 I8 R24I24 I24 
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2.5 Total RNA extraction 
Total RNA from BMDM or J774 was extracted with Trizol 
(Invitrogen) according to the manufacturer’s instruction. Briefly, cells from 1 
well of a 24-well plate were resuspended in 500 µl Trizol reagent. Samples 
were kept in -80°C for long-term storage. Before extraction, cells were kept at 
room temperature for 10 min to allow for dissociation of nucleoprotein 
complexes. 100 µl chloroform was added to each sample followed by vigorous 
shaking for 15 s. After 2-3min incubation at room temperature, samples were 
centrifuged at 12000 g for 15 min at 4°C. The aqueous phase was carefully 
aspirated and mixed with 250µl isopropanol without disturbing the interphase 
and organic phase. The mixture was incubated for another 10 min at room 
temperature before spinning down at 12000 g for 10 min at 4°C. The RNA 
pellet was then washed with 75% ethanol and pelleted by centrifugation at 
7500 g for 5 min at 4°C. The pellet was air dried and dissolved in 10 µl DEPC 
treated water. The dissolved RNA was kept in -80°C or used immediately for 
experiments. 
 
2.6 Reverse-transcription PCR 
cDNA was synthesized from RNA with SuperScript® III First-strand 
Synthesis System (Invitrogen). In each 10 µl reaction, 1-2 µg RNA was mixed 
with 0.5 µl oligo (deoxythymidine)12-18 primers (50µM) and 0.5 µl dNTP mix 
(10 mM), 2 µl MgCl2 (25 mM), 1 µl DTT(0.1 M), 1 µl RT buffer (10X), 0.5 µl 
RNase OUT (40 U/µl) and 0.5 µl SuperScript® III  RT (200 U/µl) and 
incubated in PCR machine with following program: 50 min at 50°C, 5 min at 
85°C. cDNA can be stored at -20°C. 
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2.7 Quantification of mRNA 
2.7.1 Real-time PCR 
Two types of chemistries (TaqMan® chemistry and SYBR® chemistry) 
were used to detect PCR products using Lightcycler® 480 system (Roche). 
Their working principles are summarized in Figure 2.2 and 2.3. 
 
Figure 2.2. TaqMan probe chemistry. A) Primers and probes anneal to the 
targeted DNA template. Probes are conjugated with fluorophore at 5’ end and 
quencher at 3’ end. Fluorophore could be activated by light and pass the 
energy to quencher so that no fluoresce is detected. B) During polymeriztion, 
DNA polymerase encounters the probe and hydrolyzes it to release 
fluorophore, which is no longer quenched when excited by light. C) DNA 
polymerase hydrolyzes the whole probe from the template and completes 









Figure 2.3. SYBR green chemistry. A) DNA template is denatured and 
SYBR Green molecules are free in the reaction mix. B) Primers anneal with 
the targeted DNA template and SYBR Green molecules bind to the dsDNA. 
C) DNA polymerase elongate PCR products and more SYBR GREEN 
molecules bind to double stranded DNA and they can be detected after light 




2.7.1.1 TaqMan realtime PCR 
Lightcycler® 480 probes master (Roche) was used for the Taqman 
assays, and pre-designed TaqMan® Gene Expression Assays (Life 
Technologies) Mm00446190_m1, Mm00434174_m1, Mm00446968_m1 
were used for the detection of Il6, Il12b, Hprt mRNA, respectively. 5 µl of 
Probe mastermix, 1 µl of the 1:10 diluted cDNA, and 0.5 µl primer and probe 
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were made up to a final volume of 10 µl reaction system with nuclease-free 
water. Real-time PCR was carried out with Light cycler® 480 system (Roche). 
The PCR cycles were: 1 cycle of 95°C for 10 min, 40 cycles of 95°C for 10 s, 
60°C for 20 s. The mRNA levels of Il6 and Il12b were normalized to the 
amount of Hprt.   
 
2.7.1.2 SYBR-Green realtime PCR 
SYBR Green chemistry was used to determine the percentage of DNA 
digested at the restriction site in the restriction enzyme accessibility assay. 
LightCycler® 480 SYBR Green I Master mix (Roche) was used in restriction 
enzyme accessibility assay.  Briefly, 5 µl of SYBR Green I mastermix, 3 µl of 
the 10 ng/µl DNA, and 2 µl primer mix (2.5 µM) were made up to a final 
volume of 10 µl reaction system. PCR program was: 1 cycle of 95°C for 7 min 
30 s; 45 cycles of 95°C for 10 s, 61°C for 10 s, and 72°C for 15 s.  
 
2.7.2 QuantiGene plex 2.0 assay for profiling of cytokine and chemokine 
transcription. 
The screening of cytokine mRNA expression profile of the primary 
BMDM was determined using a QuantiGene plex 2.0 assay kit 
(Panomics/Affymetrix, Freemont, CA, USA). The principle of QuantiGene 
assay is summarized in Figure 2.4.  




Figure 2.4. Principle of QuantiGene Plex 2.0 assay. The QuantiGene Plex 
2.0 Assay is a hybridization-based assay using the xMAP® Luminex® 
magnetic beads and performed on 96-well plates. The assay is based on direct 
quantification of the RNA targets using xMAP Luminex beads for 
multiplexing of 3 to 80 RNA targets and branched DNA (bDNA) signal 
amplification technology. On the first day, samples are lysed to release target 
RNAs. Then lysate is incubated with probes that recognize specific sequence 
on target RNAs. Probes include blocking probes which prevent non-specific 
binding, label extenders, which bind to target RNA and signal amplifiers, and 
capture extenders, which bind to target RNA and magenetic beads. On the 
second day the signal amplification is conducted through adding 
PreAmplifier, Amplifier and Label Probe. Each amplification unit gives a 
400x signal amplification and there are six amplification units per target RNA 
copy leaning to a 2400x signal amplification per copy RNA. The signal is 
then detected by adding SAPE substrate and using a Luminex instrument for 




A 21-plex panel containing Il6, Il1b, Csf2, Ccl3, Ccl2, Actb, Cxcl1, 
Ifnb1, Il23a, Il10, Il12b, Cxcl10, Csf3, Tnf, Cxcl2, Il1a, Hprt1, Gusb, Lif, 
Ccl5, Il12a of mouse 2.0 plex set 21310 was used to analyze the BMDM cell 
lysates. The assay was carried out according to the manufacturer’s 
instructions. Briefly, 25 µl cell lysate was diluted four times with lysis 
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mixture (Panomics/Affymetrix, Freemont, CA, USA). Then 80 µl of diluted 
cell lysate was added into each well of a 96-well hybridization plate and 
incubated overnight at 54°C with working bead-mixture containing capture 
beads and 2.0 probe set with shaking. The 2.0 probe set is composed of 
oligonucleotide probes that target RNA molecules of interest. For each RNA 
molecule of interest, three types of synthetic probes, capture extenders, label 
extenders and blockers that hybridize and span contiguous sequences of target 
RNA, was present in the probe sets. On the next day, the capture beads with 
bound RNA were washed and incubated with 2.0 pre-amplifier working 
reagent for 1 h at 50°C with shaking. After brief washing to remove the 
unbound pro-amplifier, samples were incubated with 2.0 amplifier for another 
1 h at 50°C with shaking.  Next, samples were washed and incubated with 
biotinylated probe for 1 h at 50°C with shaking. Subsequently, samples were 
washed again and incubated with Streptavidin-conjugated R-Phycoerythrin 
(SAPE), which binds to biotin-labeled probes, for 30 min at room 
temperature. Then unbound SAPE was washed away and the fluorescence 
signal of SAPE was detected and analyzed by Bio-Plex system (Bio-rad, 
Hercules, CA). Hprt was chosen as an internal control for each sample. 
 
2.8 Western blot immune-detection 
2.8.1 Cell lysis 
For whole cell lysate analysis, the culture media were removed and the 
cells were washed once with ice-cold PBS. Cells were then lysed with RIPA 
buffer (50 mM Tris-HCl pH7.5, 0.5% deoxycholate, 150 mM NaCl, 1% NP-
40, 0.1% SDS, 1 mM EDTA) in the presence of a cocktail of proteinase and 
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phosphatase inhibitor (Roche). Usually, 40 µl, 60 µl and 100 µl RIPA buffer 
was added to one well of 24-, 12- and 6- well plate, respectively. Lysis was 
carried out on ice for 20-30 min and cell lysates were then centrifuged at 
16000 g for 15 min at 4°C to remove insoluble pellet. Cell lysates can be 
stored at -80°C, but freeze and thaw cycles should be minimized. 
 
2.8.2 Bradford protein assay 
The protein concentration of the cell lysate was determined by 
Bradford protein assay according to manufacturer’s instruction (Biorad). 
Briefly, 10 µl samples (1:50 diluted in 50 µl water) were mixed with 200 µl 
Bradford reagent (1:5 diluted). After 5-min incubation, the absorbance was 
measured at 595 nm using a BioTek plate reader. To determine the protein 
concentration of the cell lysate sample, a standard curve of 0, 0.025, 0.05, 
0.075, 0.1, 0.125, 0.15, 0.175, 0.2 mg/ml BSA was used. For each sample, 
triplicate readings were obtained. 
 
2.8.3 SDS-PAGE and immunblotting analyses of cell lysate proteins. 
For whole cell lysates, samples containing 15 µg protein were first 
mixed with SDS loading buffer (62.5 mM Tris-HCl pH 6.8, 2% w/v SDS, 
10% glycerol, 50 mM DTT, 0.01% w/v bromophenol blue) and heated at 95°C 
for 10 min. Protein samples were resolved in a reducing SDS-PAGE (10%) 
and electrotransferred to polyvinyldifluoride membranes for 1 h at 10V. Blots 
were subsequently blocked with 5% dry, skimmed milk in TBST (50 mM 
Tris-base, 150 mM NaCl, 0.01% Tween-20, pH 7.6) and probed with specific 
antibodies (Table 2.1). Blots were then incubated with HRP-conjugated rabbit, 
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mouse, goat or rat secondary antibodies (Table 2.1) and were visualized with 
Western Bright ECL (Advansta, Menlo Park, CA, US) and ImageQuant 
LAS4000 mini system (GE, Fairfield, CT, US). 
 
2.9 mRNA stability test  
BMDMs were stimulated for 4 h with polyI:C (10 µg/ml) and/or R848 
(25 ng/ml). The Il6, Il12b and Hprt mRNA levels were determined by Taqman 
Real-Time PCR in samples collected before (0 min) and 30, 60, 120 min after 
the addition of actinomycin D (5 µg/ml), which halts synthesis of new 
mRNAs.  
 
2.10 Restriction enzyme accessibility assay 
In order to assess the openness of the chromatin complex, we 
measured its assessibility to various restriction enzymes. This will provide a 
clue on how open/competent the chromatin structure is for its functionality 
when the cells were stimulated by PAMPs. 
 
2.10.1 Nuclei isolation 
Cultured cells were collected by scraping, washed twice with ice cold 
PBS, centrifuged at 800 % g for 5 min 4°C and re-suspended gently. Cell 
pellets were fully suspended in 10 CPV (cell pellet volume) of lysis buffer (10 
mM Tris-HCl, pH 7.4, 60 mM KCl, 1 mM EDTA, 0.075 % Nonidet P-40, 1 
mM dithiothreitol, including the CompleteTM protease inhibitor cocktail 
(Roche), and incubated on ice for 3 min. Thereafter, the nuclei were pelleted 
by a pulse spin (14,000% g for 30 s) at 4 °C.  
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2.10.2 Restriction enzyme digestion 
The pelleted nuclei was washed once with the restriction enzyme 
buffer (10 mM Tris [pH 7.4], 50 mM NaCl, 10 mM MgCl2, 0.2 mM EDTA, 
0.2 mM EGTA, 1 mM !-Mercaptoethanol, 0.15 mM spermine, and 0.5 mM 
spermidine) [59], and re-suspended in corresponding digestion buffer (New 
England Biolabs). After the addition of enzymes (New England Biolabs) 
(AflII for Il6 promoter analysis, SpeI for both promoter and enhancer of 
Il12b), the digestion mixtures were incubated for 1 h at 37°C.  
 
2.10.3 Accessibility of restriction enzyme to chromatin detected with 
Real-Time PCR 
 
Genomic DNAs were extracted with TRizol reagent (Invitrogen) 
following the manufacturer’s instruction. The percentage of DNA digested at 
the restriction site was determined by quantitative real-time PCR, using 
LightCycler® 480 SYBR Green I Master mix (Roche). A series of diluted 
genomic DNA, which were not digested with the restriction enzymes, were 
amplified (together with those test samples mentioned above), to create 
standard curves for both target region and a control region nearby without 
targeted restriction site (to be used as internal calibrator for quantification). 
The percentage of DNA digested was calculated by subtracting the relative 
ratio of “apparent template” covering the restriction site (amplifiable) to that 
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2.11 Calculation of “fold-synergy” of TLR-ligand stimulations 
To quantify the synergistic effect, the level of cytokine produced 
under combinatorial stimulation was divided by the sum of the respective 
single stimulations to give a value we termed “fold synergy.”  
Fold synergy of cytokine expression = Combinatorial stimulation (IR)  
    I stimulation + R stimulation  
 
2.12 Proteomic profiling of chromatin binding proteins with Isobaric tag 
for relative and absolute quantitation (iTRAQ).  
 
2.12.1 Extraction of chromatin binding proteins 
Chromatin binding proteins were purified as described previously 
[60]. Briefly, cells were washed twice with PBS and resuspended in extraction 
buffer A (10 mM Tris-Cl, pH 7.4, 15 mM NaCl, 60 mM KCl, 150 mM 
sucrose, 1 mM EDTA, 1% TritonX-100, 0.1% NP40, 1 mM DTT and 
protease inhibitor) and kept on ice for 10 min. The cell suspension was passed 
through a 25G needle 3-4 times and spun down at 500 g for 10 min at 4°C to 
pellet the nuclei. The nuclear pellet was resuspended in 0.5 ml extraction 
buffer A and gently pipetted onto the surface of a 2-ml ice-cold sucrose 
cushion (10 mM Tris-Cl, pH 7.4, 15 mM NaCl, 60 mM  KCl, 300 mM 
sucrose, 1 mM  EDTA, 1 mM  DTT, and protease inhibitor). The sucrose 
gradient was centrifuged at 230g for 10 min at 4°C to pellet the nuclei, which 
was washed twice in 1 ml of wash buffer A and once with wash buffer B (10 
mM  Tris-Cl, pH 7.4, 15 mM  NaCl, 60 mM  KCl, 1 mM EDTA, 1 mM  DTT 
and CompleteTM protease inhibitor cocktail (Roche)). The nuclear pellet was 
resuspended in extraction buffer B and kept on ice for 10 min to lyse the 
nuclear membrane. The chromatin pellet was washed twice in 1 ml of wash 
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buffer A and once with wash buffer B followed by dissolving in 0.5% SDS 
solution with sonication to aid dissolution. The protein quantified using 
Bradford protein assay (see section 2.8.2). 
 
2.12.2 In-gel tryptic digestion and isobaric labeling 
The chromatin extracts were resolved in denaturing SDS-PAGE to 
remove the non-protein interfering reagents left from the sample extraction. 
Briefly, 500 µg of chromatin-binding protein from each treatment condition 
was electrophoresed on a 3-layer polyacrylamide gel composed of 4% 
stacking, and 10% and 25% resolving polyacrylamide gels. After migrating 
into the 10% layer, proteins were detained by the 25% layer, thus they were 
concentrated in a narrow strip between the 4% stacking and 25% resolving 
gel. After staining with Coommassie blue, the gel was excised into 1 % 1 mm 
pieces and completely destained. Next the diced gel was reduced in 5 mM 
Tris-(2-carboxyethyl) phosphine at 37°C for 3 h and alkylated in 10 mM 
methyl methanethiosulfonate in isopropanol at room temperature for 1 h 
before digestion with 10 ng/µl of sequencing-grade modified trypsin 
(Promega, Madison, WI) overnight at 37 C. Then an equal amount of trypsin 
was added and the mixture was incubated for another 4 h at 37 °C. The 
peptides were extracted with 1 ml 50% ACN/5% acetic acid, and the solution 
was vacuum concentrated. After dissolving in 0.5 M triethylammonium 
bicarbonate (TEAB) and ethanol, the peptides were labeled with respective 
isobaric tags using 8-plex iTRAQ reagent Multi-Plex kit (Applied 
Biosystems, Foster City, CA). Each labeled sample was vortex-mixed for 2 h 
before combining and drying in a vacuum centrifuge. 
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2.12.3 Fractionation of isobaric tag-labeled chromatin protein peptides 
by high performance liquid chromatography (HPLC) 
 
The combined and dried samples were desalted through Sep-Pak C18 
SPE cartridges (Waters, Milford, MA) and vacuum-dried again. Then the 
peptide mixture was reconstituted in mobile phase A buffer (10 mM 
CH3COONH4/85% ACN/1% formic acid [FA]) and fractionated using 
Electrostatic Repulsion-Hydrophilic Interaction Chromatography (ERLIC) as 
previously described [61].!Briefly, peptides were loaded into a PolyWAX LP 
weak anion-exchange column (4.6 x 200 mm; 5 µm, 300 Å; PolyLC) 
followed by fractionation by the UFLC system with a UV detector at a 
wavelength of 280 nm. Two solvents (30% ACN/0.1% FA) used to generate 
composition gradient were used as mobile phase A and mobile phase B. A 50-
min elution gradient started from 0-28% mobile buffer B for 40 min followed 
by 28-100% buffer B for 5 min and 100% buffer B for 5 min at a flow rate of 
1 mL/min. Thirty fractions were collected, vacuum dried and combined into 
20 fractions for LC-MS/MS analysis.  
 
2.12.4 LC-MS/MS analysis of fractionated peptides using QSTAR 
Reverse-phase separation of the peptides was performed on a home-
packed nanobore C18 column (15 cm x 75 &m; 5 &m particles) in a TempoTM 
nano-MDLC system. The samples were directly injected via a Picofrit 
nanospray tip (New Objectives, Woburn, MA, USA) at a flow rate of 300 
nl/min over a gradient of 90 min, into a QSTAR® Elite Hybrid LC-MS/MS 
system (Applied Biosystems). Data were acquired with Analyst® QS 2.0 
software (Applied Biosystems). The QSTAR system carried out a survey scan 
of peptides with mass ranging over 300–1600 m/z using positive ion mode. 
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For each MS spectrum, the three most abundant peptides of above a five-
count threshold with +2 to +4 charge states were selected for MS/MS. Once 
selected, they were placed under dynamic exclusion for 30 s with a mass 
tolerance of 0.03 Da. Smart information-dependent acquisition was adopted 
with automatic collision energy and automatic MS/MS accumulation with a 
20-time fragment intensity multiplier and 2 s of maximum accumulation time. 
Peptides from each fraction were analyzed three times on the same platform. 
 
2.12.5 Analysis of MS data 
Spectra generated from the three technical replicates were analyzed 
using ProteinPilot (v3.0.0.0, Applied Biosystems) to generate the peak-list 
and the identity and quantity of each protein. The ProteinPilot software was 
used for user-defined parameters of the Paragon algorithm with the following 
configuration: (1) Sample Type - iTRAQ 8-plex (Peptide Labeled); (2) 
Cysteine alkylation - MMTS; (3) Digestion - Trypsin; (4) Instrument - 
QSTAR Elite ESI; (5) Special factors - None; (6) Species- None; (7) Specify 
Processing - Quantitate & Bias Correction; (8) ID Focus - biological 
modifications, amino acid substitutions; (9) Database - concatenated Uniprot 
mouse database (62,604 sequences, and 27,441,367 residues; download on 12 
March 2010) and its reverse complement; (10) Search effort - thorough ID; 
(11) Result quality - Unused ProtScore (Conf) >0.05 (10.0%). The default 
precursor and MS/MS tolerance for QSTAR ESI MS instrument were 
automatically employed by the software. A cut off of 1% was adopted for the 
false discovery rates (FDR) of both peptide and protein identification (FDR = 
2.0 % decoy_hits/total_hits).  
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2.12.6 Bioinformatics analysis of iTRAQ data 
The protein classification of total reliably identified and quantified 
proteins were made with PANTHER (Protein ANalysis THrough 
Evolutionary Relationships) classification system [62]. Functional annotation 
cluster analyses of perturbed proteins were made with Database for 
Annotation, Visualization and Integrated Discovery (DAVID) [63]. 
Annotation categories used for DAVID analysis are Gene Ontology (GO) 
biological process, GO molecular function and KEGG pathway.  
 
2.13 Promoter pull down assay 
2.13.1 Nuclear extraction preparation 
Cell nuclei were isolated from macrophages treated with I, R or IR for 
5 h, as described above (2.10.1). The supernatants were removed and the 
nuclei were washed by re-suspending in lysis buffer without Nonidet P-40, 
followed by suspending in 4 CPV of nuclear extraction buffer (20 mM Tris-
HCl, pH 8.0, 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 25 % (v/v) 
glycerol and protease inhibitors), and incubated on ice for 1 h with 
intermittent mixing by vortex for 15 s each. Finally the nuclear extracts were 
cleared by centrifugation at 20,000% g for 15 min at 4 °C, snap-frozen in 
liquid nitrogen, and stored at '80 °C. Nuclear extracts (NE), in aliquots, were 
only thawed once for each experimental use. The protein concentration was 
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2.13.2 Promoter cloning 
The Il12b promoter region, -640 to +17, was amplified using primers: 
5’-agttcatgctgctatcaatcca-3’ and 5’-cacccactgttccttctgct-3’, and cloned into 
pGEM-T easy vector (Promega). Plasmid construct was double-restriction 
digested with ApaI/SacI to release the promoter fragment. The Il6 promoter 
region -1578 to +31 was amplified by primers: 5’-
attctcgagattttaatctactctaatcgcctg-3’ and 5' –cccaagcttagcggtttctggaattgactat-3’, 
using genomic DNA as template and cloned into pGL2 promoter vector 
(Promega). The IL6 promoter fragment was released from the plasmid DNAs 
by PstI and HindIII double digestion.  
 
2.13.3 DNA 3'-end biotin labeling  
The purified promoter DNAs were labeled with biotin using 3' end 
DNA labeling kit (Thermo Fisher Scientific, Waltham, MA, USA, No. 
89818), according to the manufacturer’s instructions. Labeled DNAs were 
further purified using Wizard SV Gel and PCR clean-up kit (Promega).  
 
2.13.4 Pull down assay for Il12b and Il6 promoter-binding nuclear 
proteins 
 
For promoter pulldown, 100 fmol of biotin-labeled DNA was added to 
the pre-mixture to make up a 100 µl binding reaction volume using 10 mM 
Tris-HCl, pH 7.5, 50 mM KCl, 1 mM DTT, 12.5 % glycerol, 0.05 % NP-40, 5 
µg polydI:dC (Roche), 25 µl NE (~40 µg protein). The binding mixtures were 
incubated at 25 °C for 25-30 min, chilled on ice, and transferred to 
streptavidin-conjugated magnetic Dynabeads M-280 (Life Technologies Inc.) 
that were pre-washed thoroughly with wash buffer (1x binding buffer with 
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12.5 % glycerol, 0.05 % NP-40, 2 mM MgCl2). The suspensions were agitated 
at 4 °C for 3 h. Thereafter a magnetic stand (Life Technologies Inc.) was 
employed to separate the beads from the supernatants. The beads were 
immediately washed once by re-suspension in wash buffer, and re-suspended 
in SDS-PAGE loading buffer and boiled at 100 °C for 5 min. Protein samples 
derived from 10 µl binding reaction (10 fmol, 4 µg Nucelar extract) were 
subjected to Western analysis to detect the presence of the transcription 
factors of interest.  
 
2.14 Gene specific knockdown by siRNA transfection 
For RNAi experiments, J774 cells were seeded at 0.4x106/ml and 
transfected with a scramble control (Darmacon) or ON-TARGETplus 
SMARTpool siRNA (Darmacon) against mouse Stat1 (50 nM), Junb (50 nM), 
Irf1 (50 nM) or/and Cebpb (50 nM) using X-tremeGENE HP DNA 
Transfection Reagent (Roche) for 24 h until subsequent PAMP stimulation. 
The X-tremeGene HP used per 100 µl transfection mix was 8 µl. 
 
2.15 ELISA 
Cell supernatants were collected 12 h after PAMP stimulation and 
stored at -80°C until assay. The levels of IL6 and IL12p40 were measured 
using mouse ELISA kits (Beckton Dickinson, BD OptEIA™) according to the 
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2.16 Phosphatase treatment 
In order to distinguish the two bands of JunB we observed, we treat the 
nuclear extract sample from J774 stimulated with IR for 5 h with phosphatase. 
For phosphatase treatment, 5 µg of nuclear extract was incubated with 0, 0.2, 2 
and 20 Units of phosphatase (CIAP, Promega) for 1 h at 37 °C and then 
analyzed by Western blot.  
 
2.17 Chemical inhibition of MAPK and JAK signaling study 
The respective inhibitors for JNK (SP600125), ERK (U0126) and p38 
(SB203580) were all purchased from Cell Signaling Technology (Boston, 
MA, USA). Cells were first treated with 10 µM of each of the inhibitors for 
50 min, followed by the corresponding PAMP stimulation. The inhibitor for 
JAK1/2, Ruxolitinib (INCB018424), was purchased from Selleckchem 
(Boston, MA, USA). 1 µM of the Ruxolitinib was added to the cell for 1 h, 
followed by PAMP treatment. The cell culture medium was not changed after 
inhibitor treatment in order to maintain the inhibition throughout the PAMP 
stimulation. 
 
2.18 Statistical analysis 
Data are represented as means and standard error of at least three 
independent experiments. Statistically significant differences between 
treatments were analyzed with two-tailed Student’s t-test. A value of p<0.05 







































CHAPTER III.  RESULTS 
3.1  Synergy is especially profound for secondary response cytokines, Il6       
and Il12b. 
 
Combinatorial stimulations with MyD88-activating and TRIF-
activating TLR ligands have been shown to induce synergistic levels of 
cytokines like IL10, IL6 and IL12 in macrophages [57]. To investigate 
whether cytokine synergy is a prevalent event in activated macrophages, we 
compared the mRNA levels of 18 major chemokines and cytokines that are 
known to be produced by macrophages, in mouse BMDMs under single (poly 
(I:C), I or R848, R) or combinatorial stimulation(IR) over a time course of 4, 
8, 16, 24 h (Figure 3.1A).  
Csf2, Ifnb1, Lif, Il23a and Il12a were barely detected in macrophages. 
Together with IL12p40 (encoded by gene Il12b), IL23p19 (encoded by gene 
Il23a) and IL12p35 (Encoded by gene Il12a) form cytokine IL23 and IL12 
respectively. Although Il12a and Il23a are highly expressed in DCs, we did 
not observe their abundance in macrophages. This appears to be consistent 
with different roles that DC and macrophage play in the immune system [64]. 
DC is the key player that bridges innate and adaptive immunity by inducing 
Th1 response, where IL12 is a major mediator in the process. However, 
macrophages are known to produce more Il12b than Il12a or Il23a, where 
Il12b probably acts as a macrophage chemoattractant. It has been shown that 
Il12p40 homodimer, IL12 p80, recruits macrophages to the airways to protect 
the host from respiratory tract viral infection [65]. Thus macrophages induce 
high amounts of Il12p40 to enhance innate immune response rather than 




On the whole, we found that R848 induced much higher mRNA levels 
for most of the cytokines and chemokines, except Ccl5 and Cxcl10, which 
were mainly induced by poly(I:C), and this is in agreement with a previous 
report [66]. Upon combinatorial PAMP stimulation, most of the cytokine gene 
expression is enhanced to a certain extent. While chemokine genes exhibit 
fast temporal responses, the mRNA levels for the majority of other cytokine 
genes peaked at 8 h. We further checked the fold-synergy of cytokine 
expression at 8 h by dividing co-stimulation induced cytokine levels by the 
sum of single stimulation induced-cytokine levels (Figure 3.1B). Amongst 
these, secondary response pro-inflammatory cytokine genes, Il6 and Il12b, 
which requires newly synthesized protein for their induction [67], and anti-
inflammatory cytokine gene, Il10, elicited the most significant synergy of 
above 5-fold. The remaining genes showed only moderate to negligible 
transcription synergy. 
Thus, the observed synergistic induction in macrophages appears 
confined to pro-inflammatory cytokines, Il6 and Il12b, as well as anti-
inflammatory Il10. Being anti-inflammatory, IL10 is influenced by other 
cytokines in a complex feedback manner[68]. Furthermore, a variety of 
diseases are related to uncontrolled overexpression of pro-inflammatory 
cytokines. Thus, in this thesis, we focused on investigating the mechanism of 







Figure 3.1 Analysis of the cytokine profile after R848 and poly (I:C) 
stimulation. A. Bone marrow derived macrophages (BMDMs) were 
stimulated simultaneously by adding poly(I:C) (I, 10 µg/ml) and R848 (R, 25 
ng/ml) for 4, 8, 16 and 24 h (indicated as “combinatorial” with black line), 
control for combinatorial is the levels of cytokine produced by poly(I:C) 
single treatment (blue line) and R848 single treatment (red line) and no 
treatment (NT, purple line), each for 4, 8, 16 and 24 h. Cytokine mRNAs were 
measured by Quantigene plex 2.0 assay. All the values are relative to Hprt. b. 
Fold synergy of cytokine expression 8 h after PAMP stimulation was 
calculated, when majority of the cytokines peaked. Fold synergy was 
calculated as the ratio of the amount of cytokine mRNA produced by the co-
stimulation to the sum of single stimulations by I and R. Il6 and Il12b (red 
box) above the 5-fold synergy (dashed line) are the two pro-inflammatory 




3.2 The magnitude of synergistic production of Il6 and Il12b induced by 
combinatorial TLR activation depends on time interval and 
sequential order of two PAMP stimulations. 
 
We then checked the kinetic profiles of Il6 and Il12b expressions after 
treatments with either poly(I:C) (I) or R848 (R) or combinatorial stimulation, 
over different time intervals and orders of stimulations (Figure 3.2A). 
BMDMs were treated with the first PAMP for 0, 8, 24 h followed by the 
second PAMP for 4, 8, 16, 24 h before realtime-PCR analysis (Figure 3.2B 
solid lines). The control for combinatorial stimulation was the sum of single 
PAMP stimulations (Figure 3.2B dashed lines); taking I8R8 (treatment with I 
for 8 h followed by R for 8 h) for an example, the single stimulation control 
for it is poly (I:C) single stimulation for 16 h and R848 single stimulation for 8 
h, hence annotated as I16 and R8, respectively (Detailed description of 
experimental strategies could be found in Chapter II section 2.4 at page 25). 
Compared to single stimulation with either I or R (Figure 3.2B right panel), 
cytokine expression was greatly upregulated after combinatorial (IR) 
stimulation, and the enhancement is more than the sum of single stimulations 
(Figure 3.2B left and middle panel). Co-stimulation with IR was found to 
enhance both Il6 and Il12b expression by more than 5-folds. Interestingly, 
cytokine synergy by co-stimulation was further boosted when poly(I:C) was 
given before R848 treatment. However, enhanced synergy was not observed in 
the converse treatment regime (R first followed by I), indicating that the order 
of PAMP treatment has a significant effect on cytokine synergy. Different 
time intervals between poly(I:C) and R848 treatment would also have an 
effect on synergy (Figure 3.2B and C). We tested 0, 4, 8, 12, 16 and 24 h 





Figure 3.2. Characterization of Il6 and Il12b expression profile after 
TLR3 and TLR7 co-activation with different time interval and order. A. 
Experimental design. BMDMs were treated with 1st PAMP for 0, 8, 24 h 
followed by 2nd PAMP for 4, 8, 16, 24 h. The control for the combinatorial 
stimulation is the single PAMP stimulation. Take I8R8 for example, the single 
control for it are poly (I:C) stimulation for 16 h and R848 stimulation for 8 h. 
B. Il6 and Il12b synergy is dependent on the order and time interval between 
poly (I:C) and R848 treatments. Bone marrow derived macrophages 
(BMDMs) were treated with 10 µg/ml poly(I:C) followed by 25 ng/ml R848 
(left panel) or R848 followed by poly(I:C) (middle panel) for 4, 8, 16, 24 h, or 
single stimulation for 4, 8, 12, 16, 24, 28, 32, 40, 48 h as control(right panel, 




treatment are 0(!), 8(%), 24(!) h. Solid lines are combinatorial stimulation, 
dashed lines indicate additive value of single stimulation control for 
combinatorial stimulation as described in A. Il6 and Il12b mRNA were 
analyzed with Real-Time PCR and normalized with Hprt. Data are 
representative of three independent experiments. C. 8-h pretreatment with 
poly(I:C) elicited the strongest cytokine synergy. BMDMs were treated with 
10 µg/ml poly(I:C) for 0, 4, 8, 12, 16, 24 h followed by 25 ng/ml R848 
stimulation for 8 h. Il6 and Il12b mRNA were analyzed with RT-PCR and 
normalized to Hprt. Data are presented as means ± SEM of three individual 
experiments.   
3.3 The computational modeling reveals that MAPK and JAK-STAT 
pathways are important for cytokine synergy. 
 
The above observation of time interval and order-dependent synergy 
effect suggests complex dynamic interactions of the various intracellular 
molecules and pathways of TLR3-TLR7 signaling network. To understand 
how TLR3-TLR7 crosstalk to regulate cytokine expression from a global and 
dynamic perspective, we required a systems approach to incorporate the 
known knowledge of TLR3-TLR7 signaling network with empirical data of 
kinetics of certain components in the network to construct a dynamic model 
for the whole network. With such a model, we aimed to (1) understand which 
part of the network is most critical for the signaling outcome (in our case the 
outcome is cytokine expression), (2) predict potential mechanisms of TLR3-
TLR7 crosstalk at the signaling level, (3) explain why synergy is dependent on 
time interval and order of treatment, and (4) how the dynamic network 
controls its behavior.  
We therefore collaborated with Prof P. S. Thiagarajan from the School 
of Computing, NUS, to build a model to better understand the global 
dynamics of TLR3-TLR7 crosstalk and how cytokine synergy might occur at 




3.3.1  Model construction – computational modeling of conjectured 
signaling crosstalk between TLR3-TLR7 pathways !
The computational model construction was based on the known 
signaling pathways downstream of TLR3 and TLR7 receptors (see Figure 1.3) 
and our own conjectured crosstalk signaling mechanisms between TLR3-
TLR7 pathways. The description of the main features of TLR3 and TLR7 
pathways can be found in the Introduction section 1.5.2. 
Our hypothesized mechanisms were based on the observation in Figure 
3.1 and 3.2 that R848 mediated TLR7-MyD88 pathway activation induces 
cytokine production mildly. TLR3-TRIF pathway alone produces only 
negligible level of cytokines, but it greatly enhances TLR7-MyD88 induced 
cytokine expression. This indicated that factors activated specifically by 
TLR3-TRIF might collaborate with the TLR7-MyD88 pathway [57]. The key 
features of the TRIF pathway, which distinguishes it from the MyD88 
pathway, involve the activation of IRF3 and production of type I IFN [5,69]. 
Based on this, we postulated the following IRF3- and type I IFN- related 
mechanisms that might explain cytokine synergy: (i) Activated IRF3 is known 
to bind to NF-$B and AP-1 to form an enhanceosome in the nucleus [70].  
Hence the coordinated activation of the three transcription factors after 
poly(I:C) and R848 co-stimulation might enhance the transcription of Il6 and 
Il12b. In addition, IRF3 could bind to the Interferon-Stimulated Response 
Element (ISRE) of the gene promoter and might induce other yet-to-be 
determined cytokine regulatory genes, which might be involved in cytokine 
expression (indicated as IRF3 target genes in Figure 3.3) [69]. (ii) Among the 




Secreted type I IFN protein binds to type I IFN receptor on the cell surface and 
activates its associated Janus activated kinases (JAKs) tyrosine kinase 2 
(TYK2) and JAK1. Activation of JAKs leads to tyrosine phosphorylation of 
STAT2 and STAT1, inducing the formation of STAT1–STAT2–IRF9 
complexes, which are known as ISGF3 (IFN-stimulated gene factor 3) 
complexes. These complexes translocate to the nucleus and initiate 
transcription of genes with ISREs (indicated as ISGF3 target genes in Figure 
3.3). Genes activated by ISGF3, such as IRF1, might be involved in cytokine 
synergy [71]. (iii) In addition, type I IFN could activate NF-$B p52 through 
NF-$B inducing kinase (NIK) and the tumor necrosis factor receptor-
associated factor-2 (TRAF2), which might regulate cytokine expression [72]. 
(iv) Furthermore, type I IFN could activate PI-3K-Akt pathway, leading to the 
activation of NF-$B [73].  (v) Finally, we also modeled the anti-inflammatory 
cytokine IL-10 mediated feedback. Activated ERK1/2 and p38 phosphorylate 
mitogen- and stress-activated protein kinase-1/2 (MSK1/2), which promotes 
the transcription of Il10[74]. ISGF3 target genes might also upregulate IL10 
production [75]. Secreted IL10 then binds to the IL-10R, which promotes the 
activation of JAK1 and Tyk2, resulting in the phosphorylation of STAT3. 
STAT3 is required for the repressive effects of IL-10 on TLR-mediated 
cytokine[76,77].   
A complete TLR3-TLR7 signaling network structure with both the 
known signaling pathways and conjectured crosstalk mechanisms is 
schematically summarized in Figure 3.3. The network was then converted 
into a system of ordinary differential equations (ODEs) by our collaborators 




degradation and translocation were modeled with mass action kinetics and 
processes such as activation and inhibition were modeled with Michaelis-
Menten kinetics. Gene transcription is modeled using the equation proposed 
by Kuttykrishnan et al (2010) [78]. The resulting model consists of 97 species 
(molecules), 128 equations and 147 parameters (rate constants of the 
equations) with 120 unknowns.  
 
Figure 3.3. Schematic representation of TLR3 and TLR7 signaling 
pathways. TLR3 recognizes dsRNA (and analogues such as poly(I:C)) 
derived from viruses or virus-infected cells and induces antiviral immune 
response by promoting the expression of type I IFNs and inflammatory 
cytokines (e.g. IL-6 and IL-12p40), via the TRIF-dependent pathway. TLR7 
recognizes ssRNA (and analogues such as R848) and induces the production 
of type I IFNs and cytokines via the MyD88-dependent pathway. IRF3 and 
IRF7 activated by TLR3 and TLR7 pathways respectively lead to the 
production of type I IFNs. NF-kB and AP-1 activated by both pathways lead 
to the production of inflammatory cytokines. In this model, the known 
signaling pathways downstream of TLR3 and TLR7 are indicated with solid 










Figure 3.4. Reaction network diagram of the mathematical model. 
Complexes are denoted by the names of their components, separated by a ‘‘:’’. 
Single-headed solid arrows denote irreversible reactions and double-headed 




3.3.2. Model training and validation – the calibrated model has excellent 
descriptive and predictive properties 
 
Using our empirical data, the computational model training and in 
silico validation were performed (Prof Thiagu’s team; Bing L & Qian L et al., 
manuscript in preparation). The values of 27 rate constants which correspond 
to the NF"B pathway were adapted from Lipniacki et al. (2004) [79]. To 
estimate the remaining 120 unknown parameters, empirical time course data 
for Il6 mRNA and Il12b mRNA (Figure 3.2) and several major players in 
cytokine regulation including phosphorylated ERK, p38, JNK and I"B#  (this 




[57]) were used. The following empirical data were used as training data: (1) 
The expression level of Il6 mRNA and Il12b mRNA measured at 10 time 
points (0, 4, 8, 12, 16, 24, 28, 32, 40, 48 h) under conditions of I, R single 
stimulation, and at 4 h, 8 h, 16 h and 24 h after second stimulation of IR 
(simultaneous poly(I:C) and R848 stimulation) and I8R(poly(I:C) stimulation 
with 8 hour interval followed by R848 stimulation); (2) The concentrations of 
activated ERK, activated p38, phosphorylated JNK, phosphorylated I"B# 
measured at 7 time points (5, 15, 30 min, 1, 4, 8, 12 h) after the stimulation 
with I, R, IR and I8R. We used the Il6 and Il12b time course after I24R 
(poly(I:C) pretreatment for 24 h followed by R848 stimulation), R8I (R848 
stimulation for 8 h followed by poly (I:C) stimulation) and R24I (R848 
stimautlion for 8 h followed by poly(I:C) stimulation) stimulation as the test 
data for model validation. A statistical model checking (SMC)-based  
framework developed earlier [80] by our collaborator was used for parameter 
estimation. 
Figure 3.5 A shows that the model simulation profiles generated using 
the estimated parameters (blue lines) fit well with the experimental time 
course data (red dots) for most of the cases. Although data fitting for the active 
I"B# in Figure 3.5A fourth panel (I8R) is not as tight as others, the simulation 
curve still captured the correct qualitative trend and reproduced the two rounds 
of activation behaviors. Figure 3.5B shows the comparison of the Il12b and 
Il6 expression data with the simulated profiles. The model successfully 
reproduced the time- and order- dependent synergy of cytokine production and 
its prediction matches not only the training data (R, I, IR, I8R) but also the test 




enabled us to perform subsequent in silico experiments using the calibrated 
model. 
 
Figure 3.5. Model training and validation. A. Experimental and simulated 
protein dynamics of the TLR3-TLR7 pathway. The time profiles of activated 
ERK, p38, JNK, and IkBa under the following four conditions were simulated 
using estimated parameters and compared against the experimental data: R848 
single stimulation, poly(I:C) single stimulation, poly(I:C) and R848 
combinatorial stimulation with 0 h time interval, poly(I:C) and R848 
combinatorial stimulation with 8 h time interval. Blue curves depict the model 
simulation results and red dots display experimental data. B. Model 
predictions and experimental validation of the synergistic cytokine production. 
The simulated time profiles of Il6 and Il12b expression levels under various 
conditions (right panels) reconcile the observed (left panel) time-dependent 
synergistic effect induced by the combinatorial TLR3-TLR7 activation. On the 




3.3.3 Parameter sensitivities identified crucial species and reactions for 
cytokine synergy. !
To pinpoint molecules and reactions that are crucial in determining the 
synergistic cytokine production, we conducted the sensitivity analysis, which 
is a commonly used analysis technique for assessing the relative importance of 
model parameters with respect to the model behavior. Here again we used our 
logic based statistical (SMC) technique [80].  
We first carried out the control coefficients-based local sensitivity 
analysis. In local sensitivity analysis, parameters are varied one at a time to 
see the effects on model output. We defined the model output as the integrated 
Il12b and Il6 expression in response to the five stimulation conditions (R, I, 
IR, I8R, I24R). The computed normalized local sensitivities are summarized 
in Figure 3.6A. The results for single stimulation conditions (R or I) show that 
TLR7 pathway is more sensitive than TLR3 pathway. TLR3-mediated 
cytokine production is mainly regulated by I"B#-NF"B, which possesses high 
sensitivities under all five conditions. In contrast, AP-1, another key 
transcription factor regulating cytokine production, is sensitive only under 
conditions that involve TLR7 activation (R, IR, I8R, and I24R). Mkk1/2, 
Mkk3/6, Mkk/4/7, ERK, p38, and JNK have the similar sensitivity pattern as 
their downstream AP-1, suggesting that MAPK pathways play a crucial role in 
coupling the upstream TLR3 and TLR7 regulatory modules to the downstream 
nuclear module, especially under the combinatorial stimulation conditions. 
Although three MAPK pathways can activate AP-1 in parallel, the sensitivities 
of species on the JNK pathway are positive while the sensitivities of species 
on the ERK and p38 pathways are negative. This implies the distinct roles of 




negative sensitivities that MSK1/2 and Stat3 display, it also suggests the 
importance of STAT3 pathway in inhibiting cytokine production and 
maintaining homeostasis.  Interestingly, TYK2-JAK1 and STAT1-STAT2 
expressed very strong controls over the system response while the sensitivities 
of species from other conjectured mechanisms, the AKT pathway and NIK 
pathway, are low, which implies the importance of JAK-STAT pathway 
among all the potential crosstalk mechanisms.   
We next computed global sensitivities for kinetic parameters using a 
multi-parametric sensitivity analysis (MPSA) method based on our SMC 
method. In global sensitivity analysis, all parameters are varied 
simultaneously, and the effects on output are assessed. The model output for 
global sensitivity analysis is defined as integrated Il12b and Il6 expression 
under I8R stimulation. The results are shown in Figure 3.6B. A set of 32 
kinetic parameters with high sensitivities (> 0.1) are colored in blue and their 
functions are classified in Figure 3.6C. Strong controls over the cytokine 
production are distributed among the parameters associated with the 
production of Il12b, Il16 and type I IFN, MAPKs signaling cascade, JAK-
STAT signaling cascade, and IL10-STAT3 signaling cascade. The two 
parameters (k72 and k73) with the highest sensitivities are associated with the 
transcription of Il12b and degradation of Il12b and Il16 mRNA. This is not 
surprising as these two parameters directly determine the production rate of 
Il12b and Il16 mRNA. Eleven sensitive parameters are associated with 
reactions along the MAPK pathway, which leads to the activation of AP-1. 
This result is consistent with the local sensitivity analysis, which suggests the 




sensitive reactions associated with IL10-STAT3 pathway highlights its 
important inhibitory role, compared to other inhibitors in the system, such as 
A20. More importantly, many critical reactions are involved in Type I IFN 
transcription and the activation of JAK1-STAT1/2 pathway, which can be 
connected together by our hypothesized pathway type I IFN"JAK1-
STAT1/2"cytokines. Thus, a crucial insight that emerges from these findings 
is that the time-dependent cytokine synergy we observed experimentally is 
most likely induced by the JAK1-STAT1/2 mediated crosstalk mechanism 
 
Figure 3.6. Parameter sensitivities. A. Local sensitivities (control 
coefficients) of the initial protein concentrations (listed along the ordinate) to 
the integrated response of the Il12b production under R, I, IR, I8R and I24R 
conditions. Dark colors (blue or red) refer to components that strongly 
influence the model outcome, in opposite directions (see color code on the 
right). B. Global sensitivities calculated according to the SMC-MPSA method. 
Sensitive parameters (that strongly influence the observed behavior) are 




which have little effect of the model dynamics) are colored purple. The 
highest peaks refer to Il6 and Il12b transcription or degradation rate constants. 
C. Functional classification of 33 kinetic parameters that led to the highest 
sensitivity peaks (above the dotted threshold line in panel B).  
3.3.4 The time interval between TLR3- and TLR7- activation coordinates 
cytokine synergy but not type I IFN production. !
In addition to the crucial species and reactions we identified in the 
previous section, the overall expression of both Il6 and Il12b genes are also 
highly sensitive to the time interval (!t) between the two PAMP stimulations 
as illustrated in Figure 3.2C. Here, we simulated the model by increasing !t 
from 0 h to 48 h to understand the dependency of the immune response with 
respect to the time interval (!t) between TLR3 and TLR7 activations. The 
predicted effects of !t on the immune response in terms of Il6 and Il12b 
expression levels are shown in Figure 3.7A. We calculated the peak 
amplitudes and peak time (starting from R stimulation) of each response curve 
in Figure 3.7A and plotted them as functions of time (Figure 3.7B). With 
increasing !t, the peak amplitudes of Il6 and Il12b were raised until the 
maximal values were reached, and then the expression levels started to drop. 
The optimal !t corresponding to the peak amplitude was predicted to be 
around 7 h for both Il6 and Il12b production. This is consistent with our 
experimental data shown in Figure 3.2C, which indicates that the optimal !t is 
around 8 h. On the other hand, the duration needed to reach the response peaks 
is relatively robust. The average peak time is around 4 h for Il12b and Il6.  
We also simulated the time profile of type I IFN for different values of 
!t under sequential treatments: poly(I:C) followed by R848 (I"R) and R848 
followed by poly(I:C) R"I (Figure 3.7C). For I"R stimulation, the effects of 




for R"I stimulation, the type I IFN production curve shifted along with the 
starting time point of I stimulation and maintained a constant peak amplitude 
(Figure 3.7C, right panel).  
Taken together, these results imply that the type I IFN production is 
predominantly governed by the TLR3 pathway, while the cytokine production 
is regulated by a subtle coordination of the TLR3 and TLR7 pathways. 
Although type I IFN mediates most of the hypothetical crosstalk between 
TLR3 and TLR7 pathways, it is not sufficient per se to explain the 





Figure 3.7. Dependency of the immune response on the time interval !t 
between the two stimuli. A. Predicted time evolutions of the Il6 and Il12b 
mRNA expression levels in response to various combinatorial stimulations 
with a time interval !t (between the first (I) and second (R) stimulus) varying 
from 0 h to 48 h. The series of dotted curves represent results for successive !t 
values, the ordinate referring to the time elapsed with respect to the 
application of the first stimulus. Highest cytokine production occurs when the 
time interval between the two stimuli is !t % 7 h. The results for !t = 0 (blue), 
8 h (magenta), and 24 h (dark green) are shown by the thick colored curves. 
B. Peak amplitude and peak time derived from curves in (A). C. Predicted 
expression profiles for type I IFN produced in response to the combinatorial 
I"R (left panel) or R"I (right panel) stimuli with !t ranging from 0 h to 48 




3.3.5 In silico and empirical knockdown MAPKs revealed distinct roles of 
JNK, ERK and p38 in regulating cytokine synergy. !
The sensitivity analysis highlights the significant role of MAPKs in 
modulating cytokine synergy. As shown in Figure 3.4, TAK1 complex 
activates ERK, JNK and p38 pathways in parallel, any of which is capable of 
triggering the activation of AP-1 and promoting the production of Il12b and 
Il16 mRNA. At the same time, ERK and p38 also induce the production of the 
anti-inflammatory cytokine, Il10, which leads to the suppression of Il12b and 
Il16 production through the STAT3-dependent pathway. This forms 
incoherent type 1 feed-forward loops (I1-FFL), which complicates the roles of 
ERK and p38. To assess the relative contributions of different MAPK 
pathways to elicit cytokine synergy, we performed in silico knockout of the 
phosphorylation reaction for each pathway. The predicted time profile of Il12b 
and Il16 mRNA for !t ranging from 0 to 48 h are shown in Figure 3.8A-C. 
The results indicate that knocking down 90% activated JNK significantly 
decreased the cytokine production, indicating its dominant upregulating role 
amongst the three pathways. In contrast, the knockdown of activated ERK 
increased cytokine production under various conditions (e.g. IR, I8R, I24R), 
which might be due to that its inhibitory branch mediated by IL10 and STAT3 
are stronger than the strength of the enhancing branch mediated by AP-1. 
Hence ERK is overall a negative modulator of cytokine synergy. p38 also 
down-regulated cytokine production under IR condition. However, the 
negative effect is anticipated to decay when !t increases. In other words, 
knocking down p38 did not significantly influence cytokine synergy under 





Figure 3.8. Effect of JNK, ERK and p38 inhibition on cytokine 
production. A-C Time evolution of Il12b mRNA (left) and Il6 mRNA (right) 
levels in the absence of JNK (A), ERK (B) and p38 (C) activation. The series 
of curves refer to different time intervals between the two stimuli.  JNK and 
ERK have opposite effects, i.e. upregulation and downregulation of cytokines, 
as can be seen from the comparison of the computationally predicted curves 
for !t = 0, 8 and 24 (colored, thick) with those deduced from control 




effects, if any, on cytokine production. D. Experimental verification of 
computational predictions. BMDMs were treated with 10µM MAPK 
inhibitors for 50 min followed by IR, I8R or I24R stimulation. After 8 h of 
R848 stimulation, Il6 and Il12b mRNA were then measured with RT-PCR 
normalized with Hprt. Data are presented as mean values and SEMs obtained 
from three independent experiments. 
 
To experimentally verify the model predictions, we perturbed the 
initial amount of JNK, ERK or p38 by incubating the BMDM cells with 
inhibitors SP600125, U0126 or SB203580 for 50 min. BMDMs were then 
treated first with poly (I:C) for 0, 8, 24 h followed by R848 for 8 h before 
realtime-PCR analysis of the mRNA levels. As can be seen in Figure 3.8D, 
for all the three conditions, low JNK decreased cytokine production, while low 
ERK increased cytokine production. Furthermore, low p38 mediated increase 
in cytokine production under IR stimulation condition, but did not affect 
cytokine levels under I8R and I24R condition.! /hese observations are 
consistent with the simulation results shown in Figure 3.8A-C and confirmed 
the distinct roles of MAPKs in cytokine synergy. 
3.3.6 In silico knockdown revealed the role of JAK1-STAT1/2 pathway in 
cytokine synergy. 
 
The sensitivity analysis results (Figure 3.6) also implied that JAK1-
STAT1/2 pathway is the major determinant of cytokine synergy. To confirm 
this, we carried out in silico knockout of the reactions involved in each of the 
four hypothetical mechanisms discussed earlier, namely the: (i) IRF3 
mechanism, (ii) AKT mechanism, (iii) NIK mechanism, and (iv) JAK1-
STAT1/2 mechanism. The simulation profiles of Il12b mRNA in response to 




significantly reduce the cytokine synergy (Figure 3.9). Taken together, these 
results demonstrated the essential role of JAK1-STAT1/2 pathway in 
mediating the cytokine synergy, which is consistent with the parameter 
sensitivity results.  
 
Figure 3.9. Knockout simulations highlight the significance of JAK-STAT 
pathway in triggering synergistic cytokine production. Simulation profiles 
of Il12b mRNA (A) in the absence of Akt activation reaction, (B) without 
crosstalk mechanism induced by IRF3, (C) in the absence of NIK activation, 
and (D) in the absence of STAT1-STAT2 activation.  
 
3.3.7 In silico and Empirical knockdown of STAT1 revealed a complex 
regulatory role of JAK-STAT pathway and an incoherent feed-
forward loop.!!
Similar to ERK and p38, JAK-STAT1/2 pathway mediates an I1-FFL 
since its target genes not only directly regulate the production of Il12b and 




Il12b and Il16. In previous section, we showed that knockout STAT1 would 
lead to a significant decrease of cytokine synergy (Figure 3.9D). However, the 
negative local sensitivity values of STAT1-STAT2 complex (Figure 3.6A) 
suggest that a mild decrease of STAT1 initial concentration will induce an 
increase of cytokine production. The opposite roles of STAT1 in cytokine 
synergy imply that the STAT1-mediated I1-FFL (Figure 3.10A) might lead to 
the generation of non-monotonic input-output relations, i.e. biphasic response 
[81,82]. To verify this, we simulated Il12b levels 8 h after the second PAMP 
challenge under IR, I8R and I24R conditions with the initial concentration of 
STAT1 ranging from 0.01 to 10 nM. The results summarized in Figure 3.10B 
show that under IR stimulation, knocking down of Stat1 increases cytokine 
expression. Biphasic responses could be observed under I8R and I24R 
stimulation. Reducing STAT1 concentration around normal concentration will 
first lead to an increase and then a decrease of the cytokine production. 
To confirm the role of STAT1 predicted by our model, we performed 
in vitro Stat1 knockdown experiments with mouse macrophage cell line, J744 
cells. Cells were transfected with Stat1 sequence-specific siRNA or non-target 
control siRNA. Figure 3.11A shows that the effect of knocking down Stat1 
was substantial. 24 h after Stat1 knockdown, cells were stimulated with (i) IR 
simultaneously for 8 h (IR), (ii) I for 8 h followed by R for 8 h, or (iii) I for 24 
h followed by R for 8 h. Stat1 knockdown enhanced Il6 and Il12b mRNA 
expression in cells stimulated with IR, I8R and I24R (Figure 11B). These 
observations agree well with model predictions, which confirmed the biphasic 





Figure 3.10. In silico knockdown of STAT1 revealed a complex regulatory 
role of an incoherent feedforward loop. A. STAT1-mediated incoherent 
type 1 feedforward loop. B. Simulated STAT1 initial concentration-cytokine 











Figure 3.11. In silico and empirical knockdown of STAT1 revealed a 
complex regulatory role of an incoherent feedforward loop. A. 
Knockdown efficiency of Stat1. J774 cells were transfected with either anti-
Stat1 siRNA or control scramble siRNA for 24. Cell lysates were collected for 
Western analysis. Data are representative of two independent experiments. B. 
Stat1 knockdown enhanced cytokine production. 24 h after either anti-Stat1 
siRNA or control siRNA transfection, cells were stimulated with IR, I8R, 
I24R for 8 h. Then expression of Il6 and Il12b mRNAs were analyzed by real-




3.4 Synchronization of transcription factors, IRF1, JunB and C/EBP" 
orchestrated timely cytokine synergy during TLR3-TLR7 crosstalk. !
Although systems biology method showed us a big picture of the TLR 
signaling network and predicted key signaling pathways that contribute to 
synergy, it could not specifically identify unknown molecules, especially 
transcription regulators which directly regulate cytokine synergy. Thus, 
conventional cell and molecular biology approach is still needed to enhance 
and fully validate the computational predictions and search for potential 




3.4.1 Dissection of possible mechanisms at multiple levels indicated that 
cytokine synergy was mainly and directly regulated at transcription 
level. !
To solve the molecular mechanism of cytokine synergy, we first 
checked the level at which synergy occurs. Although we observed synergy at 
the cytokine mRNA level, synergy might not necessarily happen at the 
transcription level. It is possible that under combinatorial stimulation, a 
synergistic activation of signaling molecules upstream of cytokine 
transcription, or enhanced openness of the cytokine gene promoter structure, 
or a more stabilized mRNA (post-transcriptional regulation) occurs (Figure 
3.12). Thus, we checked each possibility systematically, one at a time. 
 
Figure 3.12. A schematic representation of possible regulatory levels 
where synergy might occur. Although in section 3.1, we observed synergy at 
the cytokine transcriptional level, it might not be the original level where 
synergy occurs. Synergy might occur at signaling level, where signaling 
molecules might be synergistically activated under combinatorial stimulation. 
Synergy could also happen at chromatin remodeling level by enhancing the 
cytokine gene promoter openness after combinatorial stimulation. Post-





3.4.1.1 Signaling molecules are not synergized by combinatorial 
stimulation. !
To check whether synergy occurs, before cytokine production, at the 
signaling level, we measured the profiles of MAPK and NF"B, which are two 
major signaling families that regulate cytokine expression (this was done in 
collaboration with our lab member, Rebecca Tan). This work was published 
[57]). BMDMs were stimulated with either 10 µg/ml poly(I:C) or 25 ng/ml 
R848 alone, or poly(I:C) and R848 simultaneously (IR). The cells were 
harvested at 5, 15 and 30 min, 1, 4, 8, 12 and 24 h time points. Cell lysates 
were resolved on SDS-PAGE gel and probed with anti-phospho-JNK, anti-
phospho-ERK, anti-phospho-p38, anti-phospho-I"B antibody and loading 
control anti-actin.  
In general, both the MAPK and NF"B signals are more responsive to 
the R848 stimulation (Figure 3.13). Notably, poly(I:C) seemed to inhibit the 
R848 induced p-JNK, indicating a negative regulation of the TRIF pathway on 
the MyD88 pathway. Phosphorylation of ERK by poly(I:C) stimulation was 
weak and late compared to R848, and so is the poly(I:C) induced phospho-p38 
signaling. None of the signaling tested was enhanced after combinatorial 
stimulation except pERK. However, the enhancement of pERK was only 
additive, not synergistic. The enhancement of pERK by combinatorial 
stimulation might contribute to cytokine synergy, but this may occur in an 
indirect way possibly by activating certain transcription factors [57]. Thus, 
here we draw the conclusion that synergy does not directly happen at the 
signaling level per se, but enhanced ERK signaling might contribute to 







Figure 3.13. Synergy does not happen directly at signaling levels. A. 
BMDMs were treated with either poly(I:C) or R848 alone, or poly(I:C) and 
R848 together. Cells were collected after 5, 15, 30 min, or 1, 4, 8, 12, 24 h 
later to measure the levels of phospho JNK, phospho-ERK, phospho-p38, 
phospho-I"B and actin by western blot. Data is representative of three 
independent experiments. (Experiments for this figure were done in 
collaboration with a previous lab member, Rebecca Tan, and published on 
[57]). 
3.4.1.2 DNA accessibility is not affected by combinatorial stimulation 
compared with single stimulation. !
Transcriptional synergy may occur through different mechanisms, 
including chromatin remodeling, a crucial event for the transcriptional 
activation of pro-inflammatory cytokine genes [16,83,84]. Topologically 
closed promoter and enhancer of murine Il6 and Il12b were shown to become 
significantly opened and accessible to TFs when the macrophages were 
treated with LPS [47,57,85,86]. Thus we speculated that the synergistic action 
of TLR3-TRIF and TLR7-MyD88 activation pathways might occur through 
chromatin remodeling. To test this hypothesis, we carried out restriction 
enzyme accessibility assay as described for the study of LPS response [85], to 
examine whether poly(I:C)- and R848- activated pathways cooperate during 
the chromatin remodeling stage. Surprisingly, although poly(I:C) by itself is a 




chromatin in the Il12b enhancer, similar to the effect of R848 (Figure 3.14). 
Both poly(I:C) and R848 significantly induced an open chromatin in Il6 and 
Il12b promoters. Compared to single stimulation, combinatorial stimulations 
did not significantly enhance Il6 promoter remodeling, but it considerably 
remodeled the Il12b promoter (possibly an additive effect), which is even 
higher than the level induced by LPS stimulation. Arguably PAMP-induced 
chromatin remodeling of pro-inflammatory cytokine genes in macrophages 
could be a global primary event that may not involve the synergistic action of 
distinct TLR-signaling pathways.  
 
Figure 3.14. Chromatin remodeling might not contribute to cytokine 
synergy. Macrophages were treated with poly(I:C) (10 µg/ml, I), R848(25 
ng/ml, R) or LPS(100 ng/ml), or co-stimulated with both poly(I:C) and R848 
(IR), for 5 h before collection for restriction enzyme accessibility assay as 
described in the Material and Method 2.10. Data are representative of two 
independent experiments. 
 
3.4.1.3 mRNA stability is not enhanced by combinatorial stimulation. !
Next, we tested whether cytokine synergy was attributable to 
enhanced mRNA stability. After a 4 h stimulation with poly(I:C) and/or R848, 
BMDMs were treated with actinomycin D to halt further mRNA synthesis. 
We found that over 2 h, the Il12b mRNA remained highly stable under all 




degradation, especially under combinatorial stimulation, with a T( of ~25 
min. While Il6 and Il12b mRNAs exhibited different stability profiles, 
combinatorial stimulation consistently reduced the mRNA stability.   
 
Figure 3.15. Cytokine synergy is not due to enhanced mRNA stability. 
BMDMs were incubated for 4 h with poly(I:C) (10 µg/ml, I, dashed line) or 
R848 (25 ng/ml, R, solid grey line) or poly(I:C)+R848 (IR, solid black line). 
The Il6, Il12b and Hprt mRNA levels were determined by real-time PCR in 
samples collected before (0 min) and 30, 60, 120 min after the addition of 
actinomycin D (5 µg/ml), which halts synthesis of new mRNAs. The amounts 
of Il6 and Il12b mRNAs after actinomycin D treatment are shown as a 
percentage of the levels in the cells at the start, time 0. Data are presented as 
means ± SEM of three independent experiments. * P <0.05 (Student’s t-test). 
  
3.4.2 Proteomic analysis revealed candidate synergy factors. !
Evidence from both the chromatin remodeling and mRNA stability 
experiments support that synergistic expression of Il6 and Il12b is attributable 
to their elevated transcriptional activity when under co-stimulation. Evidence 
shown above, together with the notion that newly synthesized protein(s) are 
required for the induction of both IL6 and IL12p40 [67], prompted us to look 
for the newly synthesized/ activated transcriptional regulators, which may 
regulate the crosstalk of MyD88- and TRIF- mediated pathways. To define 
such “transcriptional synergy factors”, we performed functional proteome 
profiling of chromatin binding proteins purified from stimulated macrophages, 




compared their profiles on the basis that transcriptional synergy might be 
facilitated by collaboration between the R848-specific and poly(I:C)-specific 
TFs, or by co-stimulation (IR)-activated TFs.  
3.4.2.1 iTRAQ experiment shows reliable protein identification. !
To obtain sufficient amount of proteins, we used J774 macrophage cell 
line instead of the primary BMDM cells, which were limited. We first 
confirmed whether J774 cells exhibit cytokine synergy consistent with that of 
the primary cells by stimulating J774 cells with 10 µg/ml poly (I:C), 25 ng/ml 
R848 separately or together. Consistent with BMDM, the J774 cells produced 
negligible amount of cytokines under I single stimulation and produced 
moderate amount of cytokines under R single stimulation. But when I and R 
were given together (IR), the cytokine expressions were synergized (Figure 
3.16A). Thus henceforth, we used J774 cells to study the proteome profile of 
chromatin binding proteins after different treatments.  
J774 cells were stimulated with poly(I:C) (I), or R848 (R), or both (IR) 
for 1 or 5 h, as this duration of stimulation falls within the peak range of 
mRNA production (Figure 3.1). Chromatin-binding proteins of two biological 
replicates were extracted. The quality of chromatin binding proteins were 
examined by Western blot for both cytosolic and nuclear markers, GAPDH 
and TBP. As shown in Figure 3.16B, the chromatin binding proteins acquired 
were free of cytosol protein contamination. The proteins were then digested 
in-gel, labeled with isobaric tag (8-plex iTRAQ labeling kit), pooled, 
fractionated by HPLC. Each of the 30 fractions acquired from HPLC was 




Based on the LC-MS/MS data, we identified 1163 proteins from both 
replicates (see Appendices for detailed information of proteins reliably 
identified by iTRAQ), with false discovery rates (FDR) of <1%. We then 
calculated the geometric mean of the two replicates and analyze the data using 
the geometric mean of iTRAQ ratio from biological duplicates. 
 
 
Figure 3.16. iTRAQ analysis of chromatin binding proteins under 
different PAMP treatments. A. J774 showed synergy effect under 
combinatorial stimulation, consistent with primary cells. J774 cells were 
stimulated with polyI:C (10 µg/ml), R848 (25 ng/ml) alone or combinatorially 
for 8 h followed by mRNA analysis. B. Western blot analysis of the purity of 
chromatin binding protein samples (10 µg) from different treatments with 
nuclear marker, TBP and cytosolic marker, GAPDH. NT, non-treated control; 
treatment with polyI:C (I) or R848 (R) or polyI:C+R848 (IR) for 1 h or 5 h. C. 
Experimental strategy. Chromatin proteins were extracted from two biological 
replicates of J774 cells, which were stimulated with I, R, IR, or no treatment 
(NT) for 1 h or 5 h. Data are presented as means ± SEM of three independent 




3.4.2.2  iTRAQ data analysis revealed several potential transcriptional 
synergy factors !
To gain an overview of chromatin-binding proteins, we first analyzed 
all the reliably identified proteins with PANTHER (Figure 3.17A) according 
to their protein classification. As anticipated, the majority of the proteins are 
nucleic acid binding proteins, and the next abundant protein classes are 
transcription factors. Next, we checked the proteins downregulated or 
upregulated under different treatment with a threshold of )1.5 used for iTRAQ 
ratios (Figure 3.17B). The thresholds set for the ratios, which were derived 
from quantification of isobaric tags, are generally considered significant due to 
the intrinsic tendency of ratio under-estimation by compression in iTRAQ 
[87]. More proteins were perturbed 5 h after treatment. Furthermore, IR 
treatment tended to make more changes to the protein profile. Interestingly, at 
1 h post-stimulation, more proteins are upregulated by R and IR stimulation 
than I alone. However, fewer proteins were observed to be upregulated at 5 h 
after IR stimulation while more were downregulated, indicating the existence 
of certain immune regulatory mechanisms, which may protect against 
overwhelming immune responses.  
Then we looked into protein groups that are up- or down- regulated by 
different PAMP treatments using DAVID. With DAVID analysis, we could 
reveal what GO molecular function, biological processes and KEGG pathways 
are enriched in the perturbed protein group (Figure 3.18A, B). Interestingly, 
the GO functions of the “transcription regulation” group were enriched only in 
proteins upregulated by IR combinatorial stimulation for 5 h (Figure 3.18B 






Figure 3.17. Preliminary iTRAQ data analysis. A. PANTHER-
classification of proteins identified by iTRAQ. B. Numbers of differentially 
regulated proteins (fold difference *0.67 or )1.5) under different treatments.  
 
Next, we checked the iTRAQ ratios of proteins, which are upregulated 
by IR5 and belong to the cluster of transcription regulatory function (Table 
3.1). Proteins were earmarked with “b” as candidate synergy factors if they are 
(1) significantly upregulated in the presence of R848 or poly (I:C), but not 
further enhanced by combinatorial stimulation, which indicates they are either 
I responsive or R responsive and might collaborate when both pathways are 
activated. (2) more enhanced after combinatorial stimulation compared with 
single treatments. C/EBP! and NF"B-p105 were more responsive to R 




only. JunB and ATF3 are more upregulated after co-stimulation than single 
stimulation, indicating synergistic actions of two distinct pathways. 
 
Figure 3.18 Functional analysis of proteins perturbed under different 
treatment. A. Functional annotation clusters enriched in proteins down 
regulated (with arbitrary threshold of fold difference *0.67) under different 
treatment (analysis using the DAVID v6.7). There was no functional 
annotation cluster enriched in proteins down-regulated, by I for 5 h and I for 
1h (indicated as N.A, not applicable). B. Functional annotation clusters 
enriched in proteins up regulated (with arbitrary threshold of fold difference 
)1.5 ) under different treatments. Annotation cluster of “regulation of 
trasncription” (indicated in box) was exclusively enriched in 5 h combinatorial 
stimulation. C. Validation of iTRAQ ratio of potential synergy factors with 
Western blot. Same chromatin binding protein samples used for iTRAQ were 
dissolved in SDS page to check whether the profile of JunB, C/EBP!, NF"B-






As a negative regulator of cytokines [88], ATF3 was not further 
studied here. Being relatively uncharacterized, Ifi204 was also excluded. 
Western blot of NF$Bp105, JunB and C/EBP! (Figure 3.18C) validated their 
changes in expression detected by iTRAQ. Thus, these three transcription 
factors are shortlisted as candidate synergy factors and further examined. 
 
Table 3.1. Transcriptional regulatory proteins upregulated after IR 
combinatorial stimulation for 5 h 
 












Interferon regulatory factor 5 
(P56477) 
1.08 1.20 1.24 1.66 1.54 1.53 
ETS translocation variant 3 
(Q8R4Z4) 
0.87 1.17 1.10 1.42 1.12 1.69 
Zinc finger E-box-binding 
homeobox 2 (Q9R0G7) 
1.03 1.12 1.15 1.28 1.60 1.61 
Poly [ADP-ribose] polymerase 14 
(Q2EMV9) 
1.35 1.36 1.16 2.70 1.28 1.80 
Forkhead box protein P1 (P58462) 1.03 1.00 1.24 0.91 1.35 1.52 
Bromodomain adjacent to zinc 
finger domain protein 1A 
(O88379) 
1.06 1.15 1.09 1.23 1.29 1.55 
CCAAT/enhancer-binding protein 
beta (P28033)b 
1.05 1.10 1.16 1.58 3.65 2.73 
C-terminal-binding protein 2 
(P56546) 
0.87 1.01 0.91 1.34 1.33 1.57 
DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 5 (Q8BTS0) 
1.37 1.36 1.21 4.27 4.47 2.83 
Transcription factor jun-B 
(P09450)b 
1.54 2.81 2.91 3.48 6.49 11.27 
Cyclic AMP-dependent 
transcription factor ATF-3 
(Q60765)b 
1.23 1.02 0.90 0.97 1.16 2.42 
Mothers against decapentaplegic 
homolog 4 (P97471) 
0.65 1.07 1.06 1.56 1.35 1.53 
Transcriptional repressor p66 
alpha (Q8CHY6) 
0.68 0.93 0.94 1.72 1.71 1.70 
Nuclear factor NF-kappa-B p105 
subunit (P25799)b 
1.92 3.45 3.93 1.35 2.70 3.58 
Interferon-activated protein 204 
(P15092)b 
1.06 1.32 1.17 3.61 0.99 3.08 
C-terminal-binding protein 1 
(O88712) 
0.87 1.00 0.95 1.61 1.49 1.58 
 
Ear mark a are iTRAQ ratio indicating fold change of proteins perturbed by I, 
R, IR treatments compared to untreated control (NT). Potential synergy factors 




3.4.3 JunB, C/EBP!  and IRF1 are the core transcription factors which 
interact with Il6 and Il12b promoters. !
While proteome profiling has identified candidate TFs that might 
regulate cytokine synergy, an examination of gene-specific association is 
required to demonstrate their direct or indirect involvement in the regulation 
of Il6 and Il12b transcription. Thus, we performed in vitro promoter affinity 
pulldown assay, in a comparative manner using nuclear extracts prepared 
from macrophages, which were challenged with poly (I:C) or R848 alone or 
together. We analyzed the promoter association of shortlisted candidates and 
other core cytokine regulatory factors, which might have been missed in 
iTRAQ analysis due to their scarcity in absolute abundance or their 
hydrophilic properties. In total, we examined: (1) JunB, (2) C/EBP!, (3) 
NF"B family members (RelA, RelB and c-Rel, NF"Bp50), and (4) IRF 
members (IRF1, IRF3, and IRF8), which have been documented to be 
downstream of the TRIF signaling pathway and are involved in the production 
of type I interferon. The proteins associated with either of the 3’ end-biotin 
labelled Il6 or Il12b promoter that were pulled down using streptavidin-
conjugated magnetic beads from the nuclear extracts, were immunoblotted 
and probed using antibodies against the selected targets (Figure 3.19A). We 
observed consistent association of JunB, IRF1 and C/EBP! with both 
promoters. To make sure the binding we observed is specific, and not due to 
non-specific binding by beads, we also pulled down with empty beads as 
negative control. Although there was a band for IRF1 in the empty beads in 
the presence of polydI:dC, it is negligible compared to specific bands in the 




detection signal appeared roughly proportional to their respective levels in the 
nuclear extract, suggesting that the association of these TFs to the respective 
promoter is independent of one another.  
The IRF1 and C/EBP! were strongly induced by poly(I:C) and R848, 
respectively, as seen in the nuclear extracts, and no additive effect was 
observed with co-stimulation. This suggests that IRF1 and C/EBP! are 
regulated under distinct pathways; TRIF- and MyD88- signaling, respectively. 
In contrast, JunB, which was induced only weakly by poly (I:C) but strongly 
by R848, showed a higher expression in co-stimulation, indicating that 
crosstalk between the TRIF- and MyD88- pathways might regulate JunB 
expression. Surprisingly, Rel proteins were not significantly associated with 
either of the Il12b or Il6 promoters, although NF"B is functionally important 
for pro-inflammatory responses, and there is a characterized NF"B binding 











Figure 3.19. In vitro promoter-affinity pulldown revealed transcription 
factor C/EBP! , IRF1 and JunB bind to Il6 and Il12b promoter. A. For 
promoter pulldown, nuclear extracts were prepared from J774 cells stimulated 
with poly(I:C) (I), R848 (R) and both (IR) or left untreated (NT) for 5h. 
Aliquots of 100 fmol of biotin- labeled DNA were incubated with different 
nuclear extracts (as indicated in Materials and Methods) in a 100 µl binding 
reaction. DNA-protein complexes were affinity-absorbed to streptavidin-
conjugated beads, and released by boiling in SDS-PAGE sample buffer. 
Nuclear extracts (NE) and protein samples derived from 10 µl binding 
reaction (10 fmol DNA: 4µg nuclear proteins) each were resolved on a 10 % 
gel, transferred to PVDF membrane, and probed using antibody against 
interested target. B. Nuclear extracts from macrophages stimulated 
simultaneously (combinatorially) by IR for 5 h were incubated with empty 
beads (ctrl 1 and ctrl 2), beads with Il6 promoter or beads with Il12b promoter 
in a 100 µl binding reaction. In the binding reaction, polydI:dC was added for 
all conditions except ctrl 1. DNA-protein complexes were affinity-absorbed to 
streptavidin-conjugated beads, and released by boiling in SDS-PAGE sample 
buffer. Protein samples derived from 10 µl binding reaction (10 fmol DNA: 4 
µg nuclear proteins) each were resolved on a 10 % SDS reducing gel, and 
probed using respective antibody against interested target. All the targets, 
except IRF1, showed only specific binding to the promoters. The non-specific 
binding of IRF1 to empty beads was not significant compared to that bound to 
the promoters, especially when blocking DNA poly (dI:dC) was included. 
Data are representative of three independent experiments.  
 
 
3.4.4 Combinatorial stimulation synchronizes IRF1, JunB and C/EBP!  
activities, and MyD88 pathway inhibits IRF1 activity. !
Next, we examined the dynamic profile of IRF1, C/EBP! and JunB 
under different treatments with different time points (Figure 3.20A). C/EBP! 




but marginally and transiently upregulated for 1 h by R. This is likely due to 
the rapid primary activation of NF"B, which is known to be required for IRF1 
expression [91]. However, R-induced MyD88 pathway activation apparently 
represses the I-induced expression of IRF1. The IRF1 returned to a low basal 
level at 12 h post co-stimulation, correlating with subdued cytokine gene 
transcriptions. In contrast, JunB was rapidly upregulated within 1 h, by all 
stimulations. Notably, over 4-8 h, R induced a stronger JunB response than I. 
By 12 h, both I and R separately induced comparable levels of JunB, 
indicating equally limited potentials in single stimulations. Nevertheless, in 
co-stimulated macrophages, JunB expression was sustained and accumulated 
over 8-24 h. As we consistently observed two bands of JunB, we further 
tested whether they were differently modified forms of JunB proteins. 
Treatment with phosphatase showed a dose-dependent conversion of the 
upper to lower band (Figure 3.20B), indicating that JunB was extensively 
phosphorylated upon induction. 
Taken together, the coincidence /synchronization of the levels of IRF1, 
C/EBP! and JunB in the 4-8 h post-combinatorial stimulation and the obvious 
correlation with the mRNA peaks of Il6 and Il12b (Figure 3.1), strongly 






Figure 3.20. Combinatorial stimulation synchronizes C/EBP", IRF1 and 
JunB. A. J774 cells were treated with either 10 µg/ml poly(I:C) or 25 ng/ml 
R848 alone, or poly(I:C) and R848 in combination (IR) for 5 and 30 min, 1, 5, 
8, 12 and 24 h or no treatment (NT). Cells were harvested and analyzed by 
Western blot and probed with anti-JunB, IRF1, C/EBP! and GAPDH 
antibody. B. J774 cells were harvested after 5 h treatment with R848. 5 µg of 
the nuclear extracts were treated with 0, 0.2, 2 and 20 Units of phosphatase 
for 1 h at 37°C and were analyzed by Western blot probed with anti-JunB 
antibody. The upper band of JunB is a phosphorylated form. Data are 
representative of three independent experiments. 
3.4.5 IRF1, JunB and C/EBPb functionally collaborate with each other to 
facilitate cytokine expression. !
Although we observed synchronized induction of IRF1, Junb and 
C/EBP! under combinatorial stimulation and confirmed their binding with Il6 
and Il12b promoter, it is not clear whether they are functionally required for 
cytokine production and whether they functionally collaborate with each 
other. Thus, we then checked their functional role with siRNA knockdown.  
3.4.5.1  TRIF- and MyD88- signaling pathways collaborate to synergize 
IL6 and IL12p40 expression through synchronized activities of 
IRF1 and C/EBP! . !
We next examined the functional cooperation between TRIF-
responsive IRF1 and MyD88-responsive C/EBP!, in macrophages using 




At 24 h post-transfection with Irf1-specific siRNA (siIrf1), or Cebpb-specific 
siRNA (siCebpb) or scramble (control) siRNA, macrophages were co-
stimulated with poly(I:C) and R848, and the expression levels of IRF1 and 
C/EBP! were monitored for up to another 24 h. C/EBP! and IRF1 expression 
was suppressed over the 24-h time course (Figure 3.21A). However, no 
significant difference in efficiencies was observed between single and double 
knockdown conditions for either IRF1 or C/EBP!, indicating that the 
expressions of IRF1 and C/EBP! are regulated independently of each other. 
Subsequently, we compared mRNA (Figure 3.21B) and protein 
(Figure 3.21C) levels of Il6 and Il12b in the single (Irf1 or Cebpb) or double 
(Irf1 and Cebpb) knockdown cells. Significant attenuation of both the mRNA 
and protein levels was observed in R848 and co-stimulated cells (Figure 
3.21B, C). In poly(I:C)-stimulated cells, Il6 and Il12b mRNAs remained at 
their basal levels. In the co-stimulated cells, the effects of single knockdown 
appeared only incremental, while double knockdown achieved the greatest 
reduction of Il6 and Il12b (IL12p40: ~50% by siIrf1+siCebpb; IL6: ~75% by 
siIrf1+siCebpb). Interestingly, C/EBP! exerts a stronger influence on the Il6 
expression than Il12b expression. The knockdown results clearly indicate that 
significant expression of Il6 and Il12b can only be induced by co-stimulation 
of TLR3 and TLR7, and the presence of a certain level of both IRF1 and 
C/EBP! is necessary and sufficient for the optimal transcription activity of Il6 








Figure 3.21. Collaboration of IRF1 with C/EBP!  is required for 
synergistic production of cytokines. A. Irf1 and Cebpb were successfully 
knocked down by siRNA. Cells were transfected with either siRNA targeted 
on Irf1 or Cebpb alone or together, or scramble control for 24 h, followed by 
0, 1, 4, 8, 12 and 24 h stimulation with IR. Cell lysates were immunodetected 
for IRF1 and C/EBP!, and with GAPDH as control. B. 24 h after Irf1 and 
Cebpb siRNA transfection alone or together, cells were stimulated with I 
and/or R for 8 h or were not treated with any PAMP as negative control (NT). 
Then expression of Il6 and Il12b mRNA were analyzed by real-time PCR. C. 
24 h after Irf1 and Cebpb siRNA transfection alone or together, cells were 
stimulated with I and/or R for 12h or were not treated with any PAMP as 
negative control (NT). IL6 and IL12p40 were quantified by ELISA. Data are 
representative of three independent experiments (A) or presented as means ± 








3.4.5.2  TRIF- and MyD88- signaling pathways collaborate to synergize 
cytokine expression through enhancing JunB production and 
synchronizing IRF-JunB activation. 
 
To functionally characterize JunB-mediated regulation of expression 
of Il6 and Il12b and its potential cooperation with IRF1, we knocked down 
Junb alone or both Junb and Irf1 (Figure 3.22A). The efficiencies of 
knockdown were verified to be approximately 80% and this was consistent 
between single and double knockdown, indicating that the expressions of Irf1 
and Junb are regulated independently of each other. Significant reduction in 
R- or IR- induced Il6 and Il12b was observed in Junb knockdown cells 
(Figure 3.22B, C) at both the mRNA and protein levels. With I-stimulation, 
both Il6 or Il12b mRNAs remained extremely low, similar to non-treated cells 
(Figure 3.21B, C), thus the impact of JunB knockdown on I-induced cytokine 
expression was not further assessed. The drastic difference in the induction of 
cytokines between single and co-stimulation, compared to the smaller 
difference caused by Junb knockdown, clearly indicates the involvement of 
additional critical cofactors induced by the TRIF-pathway, which is necessary 
for the synergistic transactivation of Il6 and Il12b promoters. This is 
supported by the double knockdown of Junb and Irf1, which yielded more 
pronounced attenuation of Il6 and Il12b (IL12p40: ~75% by siJunb+siIrf1; 
IL6: ~80% by siIrf1+siJunb) at both mRNA and protein levels (Figure 3.22B, 
C) compared to single knockdown. Thus co-stimulation-mediated 
enhancement of JunB itself promoted cytokine expression and at the same 






Figure 3.22. IRF1 works together with JunB to synergize cytokine 
production under combinatorial stimulation. A. Irf1 and/or Junb was 
successfully knocked down by siRNA. J774 cells were transfected with either 
siRNA targeted on Irf1 or Junb alone or together, or scramble control for 24 
h, followed by 0, 4 and 12 h stimulation with IR. Cell lysates were 
immunodetected for IRF1 and JunB, and with GAPDH as control. B and C. 
24 h after Irf1 and Junb siRNA transfection alone or together, cells were 
stimulated with R alone or IR for 8 h. Then cells were collected for Il6 and 
Il12b mRNA expression analysis by real-time PCR. (B) and supernatant were 
subject to IL6 and IL12p40 proteins measurement by ELISA(C). Data are 
representative of two independent experiments (A), or presented as means ± 
SEM of three individual experiments (B, C). * P <0.05,  ** P < 0.01 
(Student’s t-test). 
 
Taken together, R strongly upregulates and sustains MyD88-
responsive JunB and C/EBP! but R only transiently activates IRF1, resulting 
in mild transcription activation of Il6 and Il12b. In contrast, I induces a high 




its own, IRF1 appeared insufficient to drive the basal transcription. However, 
combinatorial stimulation synchronized the activation of IRF1, JunB and 
C/EBP! for up to 8-12 h, where these TFs probably worked in concert to 
achieve optimal cytokine expression.  
3.5 MAPK pathway activates synergy factors JunB and C/EBP! , but 
ERK and p38 inhibits IRF1 induction under R848 stimulation.  !
Although we have identified JunB, C/EBP! and IRF1 to be required 
for optimal cytokine production, it is still unclear what upstream pathways 
lead to their activation. As MAPK pathway was predicted to be critical for 
cytokine expression in computational modeling, we checked whether MAPK 
could regulate the induction of synergy factors: JunB, C/EBP! and IRF1. 
BMDMs were treated with JNK, ERK or p38 inhibitors as described in 3.3.5 
followed by I or R single stimulation or IR combinatorial stimulation or no 
PAMP treatment (NT). Cells were then lysed and dissolved in SDS page to 
check for JunB, C/EBP! and IRF1 expression with Western blot (JunB 
expression level measurement was done in collaboration with our lab 
member, Lu Ning).  
As can be seen in Figure 3.23, poly (I:C) induced JunB could be 
inhibited by p38 inhibitor. But under R or IR stimulation, inhibition of all 
three MAPKs could reduce the production of JunB. Induction of the other 
MyD88 responsive synergy factor, C/EBP!, was not affected by JNK 
pathway, but regulated by ERK and p38 under R and IR stimulation. C/EBP! 





Notably, the IRF1 induction was greatly enhanced by ERK and p38 
inhibitors under R and IR stimulations. However, inhibition of ERK and p38 
did not further enhance IRF1 expression after single stimulation by I. This is 
very interesting because we observed enhancement of cytokine expression 
after ERK and p38 inhibition under R and IR stimulation. And the 
upregulation of IRF1 expression by the same condition might be responsible 
for the enhancement of cytokine production. In addition, we have also 
previously observed an inhibitory role of R848-induced MyD88 pathway on 
IRF1 expression (Figure 3.20A). This might also be explained by Figure 3.23 
that MAPK activated by R848 might inhibit IRF1 expression through some 
unknown mechanism and inhibition of MAPK thus increase IRF1 expression. 
 
Figure 3.23. MAPK’s role on JunB, C/EBP!  and IRF1 expression. 
BMDMs were treated with 10mM JNK, ERK or p38 inhibitor for 50 min, 
followed by I, R, IR or no treatment (NT) for 5 h. Cells were then lysed and 
analyzed with western blot against JunB, C/EBP!, IRF1 and GAPDH 
antibody. Data are representative of three independent experiments. (Western 
blot for JunB and GAPDH were done in collaboration with lab mate Lu Ning) 
3.6 JAK-STAT pathways upregulate synergy factor IRF1 induction 
under poly (I:C) stimulation.   
 
Computational modeling predicted that JAK-STAT1 pathway to be 
important for cytokine expression. To check whether JAK-STAT1 pathway is 
involved in the regulation of synergy factors IRF1, JunB and C/EBP!, we 




Ruxolitinib for 1 h followed by I, R or IR treatment or no treatment  (NT) 
control for 4 h before collected with RIPA buffer and analyzed with Western 
blot. As can be seen in Figure 3.24, the inhibition of JAK1/2 is successful 
because the phosphorylation of STAT1 at Tyr 701 was reduced when the 
inhibitor was added. JAK1/2 is known to phosphorylate STAT1 at Tyr 701 
site after IFN activation [92]. In Figure 3.24, we observed reduced expression 
levels of IRF1 when cells were treated with poly (I:C) alone as well as the IR 
combinatorial stimulation. Under R stimulation, the expression level of IRF1 
was very low and barely affected by the JAK1/2 inhibitor. This is not 
surprising, as poly (I:C) induced TLR3-TRIF pathway could induce type I IFN 
expression. Secreted type I IFN activates JAK-STAT1, which further activates 
its downstream signaling molecules, IRF1. However, the JAK1/2 inhibitor 
barely has any effect on the induction of JunB and C/EBP! under all 
conditions, indicating the JAK-STAT1/2 pathway is not involved in the 
regulation of JunB and C/EBP!. 
This results indicate that the TLR3-TRIF pathway contributes to the 
induction of IRF1 through activating JAK-STAT1/2 signaling, and activated 
IRF1 could cooperate with TLR7-MyD88 induced JunB and C/EBP! to 
regulate cytokine synergy. However, as shown previously in section 3.3.7, 
inhibition of JAK-STAT1/2 signaling by Stat1 siRNA knockdown increased 
cytokine expression. Similar results have also been observed by other group, 
where inhibition of JAK1/2 increases LPS induced cytokine expression in 
macrophages [75]. This could be explained by the JAK-STAT1 induced I1-
FFL loop as mentioned earlier in section 3.3.7. On one hand, JAK-STAT1/2 




upregulates cytokine expression. On the other hand the JAK-STAT1/2 
pathway also induces anti-inflammatory cytokine IL10, which inhibits 




Figure 3.24. The JAK-STAT1 pathway upregulates IRF1 expression 
under I stimulation. BMDMs were incubated with JAK1/2 inhibitor 
Ruxolitinib (1mM) for 1 h before I or/ and R treatment for 4 h, or no PAMP 
treatment (NT). Cells were then dissolved in SDS PAGE and detected with 
Tyr701 phospho-STAT1, JunB, C/EBP!, IRF1 and GAPDH. Data are 























































CHAPTER IV.  DISCUSSION 
During an infection, innate immune cells such as tissue resident 
macrophages are the first to sense the foreign invasion through their PRRs. 
Activation of macrophages leads to production of cytokines and chemokines, 
which recruit more immune cells and initiate adaptive immune response. The 
amount of cytokines produced could vary a lot depending on the type of PRRs 
activated by the pathogen. Some combinations of TLRs, which activate both 
MyD88 and TRIF pathways, could induce cytokine synergy. The timing and 
magnitude of production of each cytokine in the immune system is finely 
tuned in response to infection. Loss of the balance and precision in cytokine 
production results in insufficient immune response or acute and/or chronic 
inflammatory diseases. However, the precise molecular mechanisms 
governing the expression of individual cytokine genes are only poorly 
investigated. 
In our study, we identified key transcription factors, that regulate the 
expression of cytokine genes and we also found their upstream signaling 
pathways by computational modeling and empirical validation. Our results 
unravel the collaboration mechanism of TLR3-TLR7 signaling network to 
synergize cytokine expression. 
4.1 Cooperation of transcription factors in the cytokine gene regulation. !
Most of the proinflammatory cytokines are regulated by a collective of 
transcription factors, which bind to their promoters. After pathogen infection, 
numerous transcription factors are activated. And the activation of a given 




set of signaling pathways. By binding cooperatively to the control regions and 
forming a three-dimensional structural architecture for the recruitment of 
other coactivators, the factors will activate the transcription of the given gene 
synergistically. A classic example of cooperative binding and synergy 
between multiple transcription factors is the selective activation of human 
IFNB gene upon Sendai virus infection [93,94]. In Sendai virus-infected cells, 
a highly stable protein complex composed of NF"B, IRF3/IRF7 and ATF-
2/cJun binds cooperatively on the promoter region of IFNB, maximizeing the 
production of IFNB.  
Similar to the human IFNB promoter, we found that transcription 
factors cooperation also occurs during the activation of mouse Il6 and Il12b 
genes after PAMP stimulation. By promoter pulldown, we demonstrated that 
IRF1, C/EBP! and JunB are the critical components of the active 
transcription initiation complex of Il6 and Il12b. siRNA knockdown further 
demonstrated that all these TFs are critical for optimal transcription of Il6 and 
Il12b. Additionally, we showed that IRF1 and C/EBP! are responsive 
respectively, to TLR3/TRIF- and TLR7/MyD88-activation, while JunB is 
preferentially responsive to and sustained by TLR7-MyD88 under co-
stimulation. Thus, under combinatorial stimulation, TLR3/TRIF responsive 
IRF1 and TLR/MyD88 responsive C/EBP! and JunB collaborate and activate 
transcription of Il6 and Il12b synergistically (Figure 4.1). However, we 
cannot rule out other yet-to-be defined “transcriptional synergy factor(s),” 
indicated as the X factor in Figure 4.1, which may be the product(s) of the 
cooperation of distinct pathways responsive to co-stimulation [85] or just 





Figure 4.1. A schematic representation of IRF1, JunB and C/EBP!  
cooperation in cytokine Il6 and Il12b regulation. Factor X is other 
unidentified TFs that might be involved in cytokine regulation. 
 
Of the three transcription synergy factors we identified, IRF1 is of 
particular interest. Although known to be strongly induced in macrophages by 
IFN-&, the detailed functional role and the mechanisms of IRF1 in regulating 
immune-responses are poorly documented [95]. An IRF1-binding element (-
72 to -58) was characterized in the Il12b promoter [96] but not in the mouse 
Il6 promoter. IRF1 was shown to play a major role in the transcriptional 
activation of the Il12a gene but not Il12b previously [97]. Current 
investigation revealed that IRF1 is the principle TF induced by the TLR3-
TRIF signaling pathway and it binds both Il6 and Il12b promoters. We also 
showed that C/EBP! is necessary for cytokine synergy under combinatorial 
stimulation. C/EBPs recruit co-activators such as CBP and p300 [98,99], 
which in turn recruit basal TFs. An earlier investigation using Il12b-promoter 
reporter assay demonstrated that a proper distance and orientation of AP1 
binding site ('79 to '74) and the adjacent C/EBP binding sites ('96 to '88) 
[100] are important for the promoter activation [101]. This correlates with our 
observation of the functional co-operation between C/EBP! and AP1 
member, JunB. On Il6 promoter, binding sites of C/EBP! and JunB have also 
been identified at -178~ -168 and -78~ -72, respectively [102]. JunB and 
C/EBP! collaboratively form the core-transcriptional complex for the 
transcription of pro-inflammatory genes. However, to achieve a full 




functions as a bridging factor in the transcriptional regulation of Il6 and Il12b, 
a hypothesis, which warrants further study. 
Surprisingly, in the promoter pull-down analysis, we could not detect 
significant association of well-recognized master regulators such as NF"B 
and IRF3, to either Il6 or Il12b promoter. NF"B-binding element has been 
characterized in the murine Il12b ('132 to '122) [89] and Il6 ('75 to '63) 
[90]. However, as a primary response regulator, NF"B members likely 
function at the outset of the assembly of transcriptional initiation complex of 
pro-inflammatory cytokine gene Il6 and Il12b [88]. The promoter-binding 
activity of NF"B could thus be transient and highly dynamic, and therefore 
not captured by pulldown assay. This is consistent with the observation of 
extremely weak signals of Rel members (Figure 3.19B), compared to the 
strong signals of IRF1, C/EBP! and JunB. As for IRF3, which is deemed a 
master regulator of response to viral stimulations, it may simply function in 
upstream events (e.g. induce/activate other IRF members), but may not be 
physically involved in the transcription of pro-inflammatory cytokine genes.   
4.2 Selective transcription of cytokine gene and immune homeostasis – an 
important role of R848-induced suppression of IRF1. !
An inflammatory response is initiated by finely tuned activation of 
transcription factors. A central goal of immune system is to selectively 
modulate proinflammatory genes to maintain a robust host defense while 
suppressing genes responsible for inflammation-associated pathologies to 
avoid overwhelming inflammatory response. 
In support of the above-mentioned notion, we found that the regulation 




magnitude and timing of cytokine expression. It is clear from Figure 3.20 that 
R848-induced MyD88 pathway is suppressing the expression of IRF1. Under 
single stimulation with poly(I:C), the up-regulated production of IRF1 is 
sustained and accumulated in the cells. In contrast, under co-stimulation, the 
expression level of IRF1 is curtailed. It falls back to a low basal level at 12 h 
post-stimulation. This inhibition of IRF1 expression correlates with the 
waning of Il6 and Il12b transcription over time, thus controlling the timing 
and magnitude of cytokine production. 
Interestingly, the MAPK inhibitor study (Figure 3.24) revealed that 
R848-induced suppression of IRF1 might be through MAPK pathways. We 
observed enhanced IRF1 expression as well as increased cytokine expression 
when ERK and p38 are inhibited. IRF1 is known to be a target gene of 
STAT1. According to previous reports, activation of STAT1 requires 
phosphorylation at both the Tyr701 and Ser727 sites by JAK1/2 and p38, 
respectively [92]. However, when STAT1 is only phosphorylated at Ser727 
site, it is retained in the cytoplasm and functions as a cytoplasmic inhibitor of 
TLR signaling. It is known that mice with mutation at Ser727 site of STAT1, 
has altered gene expression profile, with Il12p40 higher than wildtype mice 
[103]. In our study, it is possible that under R848 stimulation, IFN! was 
barely produced, thus autocrine IFN!-induced JAK1 is unlikely to be 
activated. But R848 could activate p38, which phosphorylates Ser727, but not 
Tyr701, leading to the altered STAT1 activity, and subsequently STAT1 target 
gene IRF1. The inhibition of IRF1 reduced the overwhelming production of 




is unclear why ERK also inhibited the expression of IRF1. This prompts a 
future study to check the phosphorylation site of STAT1 after ERK activation.  
4.3 Cooperation of PRR signaling pathways in innate immune defense. !
In our study, we demonstrated that TLR3 and TLR7 activate different 
combinations of transcription factors, which are collectively required for 
optimal transcription of cytokine gens, through activating distinct signaling 
pathways. TLR3 and TLR7 have been shown previously to be the most 
“cooperative” pair to induce cytokine synergy [57]. Although, theoretically, a 
combination of MyD88 and TRIF activating TLRs could induce cytokine 
synergy, some combinations are much weaker in inducing synergy. Only a 
low level of TNF, IL6 and IL12p40 synergy was observed when TLR2 was 
activated together with TLR3 and TLR4 [15,104]. In addition, TLRs with 
different subcellular localization might have distinct downstream signaling. 
An example is provided that TLR9 could activate different signaling pathways 
when they are located on different stage of endosome (early or late endosome) 
[105]. Thus the different cellular localizations of TLRs and the accessory 
molecules used that govern their signaling properties might affect their ability 
to interact “synergistically”.  It is possible that our findings on the interactive 
mechanism of TLR3-TLR7 is not a universal one for all combinations of 
TLRs that induces synergy. 
Apart from TLRs, other PPRs including RLRs, CLRs and NLRs also 
contribute to PAMP recognition and the regulation of innate immunity [106]. 
As pathogens often contain various PAMPs which activate multiple PRRs, 




the crosstalk is between NLR and TLR, as bacterial peptidoglycans (TLR2 
ligands) can be degraded into compounds that activate NOD1 and NOD2 
[107-109]. In addition, double stranded RNA, poly(I:C), could activate both 
TLR3 (membrane binding receptor) and RLRs, MDA5 and RIG-I, in 
cytoplasm. Thus the synergy between TLR- and other PRRs can amplify the 
response not only to a single pathogen but also to a single component of a 
pathogen. Therefore, it is also important to reveal how immune responses are 
coordinated and regulated by different PRRs. 
 
4.4 Computational modeling of signaling network crosstalk 
Conventional cell and molecular biology look at genes, proteins and 
pathways separately at individual level. However, the molecules in a living 
cell work as a system and needs to be studied at global level, which make the 
collaboration of conventional research approach and computational biology an 
urgent need. 
Our combined experimental and model-based computational analysis 
identified MAPK and JAK1-STAT1/2 to be critical signaling pathways for 
cytokine synergy. We elucidated the kinetic role of AP-1 and NF$B in 
determining cytokine production, and showed different roles of JNK, ERK 
and p38 in cytokine expression regulation, which are verified by empirical 
data. Notably, one of our key findings is that STAT1 level induces a biphasic 
response of cytokine production through an incoherent type 1 feedforward 
loop (I1-FFL). I1-FFL is one of the most frequently observed network motifs 
in biological networks. It appears hundreds of times in bacteria [110], yeast 




include (see a recent review [81]): (i) shortening gene-circuit response time, 
(ii) generating of gene expression pulses, [81](iii) distinguishing time-varying 
inputs, (iv) filtering out noise, (v) detecting fold change of input signal, and 
(vi) generating non-monotonic input-output relations [81]. There exists several 
I1-FFLs in our model, mediated by ERK, p38 and STAT1 respectively. We 
found that the STAT1-dependent I1-FFL, exhibiting biphasic response, is 
crucial to both amplifying antiviral response and avoiding excessive 
inflammatory response. This is a case study that further demonstrated the 
importance of I1-FFL in innate immune system.  
Notably, I1-FFL might be a good explanation for the controversial 
effect of type I IFN autocrine loop (Details in section 1.4.2). Some groups 
added exogenous IFN", but did not further enhance the cytokine production 
[16,43]. On the contrary, knockout of IFN" receptor abolished synergism in 
cytokine production completely or partially [15]. This controversy might be a 
result of biphasic response of STAT1-dependent I1-FFL. On one hand, 
STAT1 induces IRF1, which is needed for cytokine expression. On the other 
hand, JAK-STAT pathway increases the level of anti-inflammatory cytokine 
IL10, which inhibits cytokine expression. The blockage of JAK-STAT 
pathway through manipulating the upstream inducer IFN might affect the two 
arms of JAK-STAT pathway. And the outcome is difficult to predict 
depending on the level of pathway blockage. Such kind of biphasic response is 
difficult to control through experiment, but can be predictable with 
computational modeling. 
In the past two decades, intense research has identified and 




Various systems biology approaches have been used for enhancing our 
understanding of TLR-mediated innate immune responses [51]. However, an 
accurate and validated mathematical model of TLR signaling pathways, taking 
into account of their dynamic crosstalk has not yet been derived 
[52,53,56,113-121]. In our project, we developed the first calibrated ODE 
based kinetic model for two specific TLR pathways and their crosstalk. This is 
an important step towards a comprehensive mathematical model for all TLR 
pathways. But in the mean time, we cannot overlook some of the limitations of 
our model. As we have adopted most of the protein-protein interaction 
information from literature, some of the interaction information is achieved by 
overexpression experiments in HEK cells, which might not be reproducible in 
immune cells. In addition, the TLR signaling is a very complex network with a 
lot of cell type specific regulatory mechanisms, feedback loops, which are not 
considered in our model. Most importantly, our model didn’t incorporate the 
synergy factors identified with conventional biological methods and their 
presumable upstream signaling. Thus, as new knowledge becomes available, 
our present model should be refined and extended exhaustively to reveal the 
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CHAPTER IV.  CONCLUSIONS AND FUTURE PERSPECTIVES 
5.1 Conclusion !
During pathogen infection, host innate immune cells encounter 
multiple PAMPs, which activate multiple TLRs. Ligands that activate both 
MyD88 and TRIF pathways could induce synergistic expression of cytokines, 
but the underlying mechanism is still an enigma. In this study, we clarified 
that activation of NF$B members, chromatin remodeling (unpacking and 
DNA modification) and post-transcriptional regulation may be redundantly 
and/or additively induced by PAMP stimulations, and showed that the TLR3-
TRIF- and TLR7-MyD88- signaling pathways synergize directly at the 
transcription of Il6 and Il12b. TRIF pathway activates JAK1-STAT1 pathway 
which induces activation of IRF1, while MyD88 pathway induces JunB and 
C/EBP! through activating MAPK pathways. Activated IRF1, JunB and 
C/EBP! are required for optimal cytokine expression. Thus, TLR3-TRIF and 
TLR7-MyD88 combinatorial activation synchronized and sustained the 
activation of transcription factors that are necessary for cytokine expression. 
Under single stimulation with poly(I:C), there is only mild expression 
of JunB, plausibly induced by p38 (In Figure 3.24, p38 inhibitor could inhibit 
the expression of JunB under I single stimulation), and barely any C/EBP! 
production. IRF1 is mainly produced under TRIF pathway through JAK1/2-
STAT1 pathway, which was activated by autocrine type I IFN (Figure 5.1). 
Thus, only IRF1 and a small amount of JunB is present, which is not sufficient 
for the expression of cytokines and only a negligible level of Il6 and Il12b can 
be detected under I stimulation. 




Figure 5.1. The signaling and transcriptional events occur after poly (I:C) 
single stimulation. Under poly (I:C) (dsRNA analogue) single stimulation, 
TLR3-TRIF gets activated, which mainly induces the expression of type I 
IFN. The autocrined type I IFN binds to its receptor and activate TYK2-JAK1, 
which activates STAT1 and its target genes including IRF1. TRIF pathway 
could also activate a marginal amount of JunB, plausibly through p38 MAPK. 
Both IRF1 and JunB are required for cytokine expression, however another 
necessary TF, C/EBP! could not be induced under TRIF alone pathway, 
which results in negligible amount of cytokine Il6 and Il12b production. 
 
Under single stimulation with R848, C/EBP! and more JunB are 
activated through MAPK pathways. However, MyD88 pathway is not the 
major activator of type I IFN, which activates IRF1 through an autocrine loop. 
Furthermore, MAPK p38 and ERK activated by MyD88 pathway inhibit the 
expression of IRF1. Thus, there is only transient induction of IRF1 (Figure 
5.2). The optimal condition for cytokine expression, where all of the three 
transcription factors are present, is transient and thereafter, only mild 
expressions of cytokine Il6 and Il12b were detected under R848 single 
stimulation.  




Figure 5.2. The signaling and transcriptional events occur after R848 
single stimulation. Under R848 (ssRNA analogue) single stimulation, TLR7-
MyD88 is activated, which could activate JunB and C/EBP! through MAPK 
pathways. However, TLR7-MyD88 pathway is not the main inducer of type I 
IFN, and it activates p38 and ERK, which inhibits IRF1 expression. Thus only 
transient and little amount of IRF1 is induced under R848 stimulation. A mild 
amount of cytokine level could be detected under this condition, but cytokine 
synergy is not observed due to insufficient amount of IRF1. 
 
Under combinatorial stimulation, C/EBP! and JunB are activated 
through MyD88-MAPK pathways, providing sufficient amounts of these two 
transcription factors for cytokine expression. Although the MyD88 induced 
p38 and ERK MAPK inhibited IRF1, the autocrine type I IFN, which is 
significantly induced by TLR3-TRIF pathway, sustained the IRF1 activation 
longer than R848 single stimulation (Figure 5.3). Thus, under combinatorial 
stimulation, TLR3-TRIF and TLR7-MyD88 pathway collaborate to 
synchronize and sustain the activation of IRF1, JunB and C/EBP!, which 
provides optimal condition for cytokine transcription and make cytokine 
synergy occur. Notably, the inhibitory role of R848 on IRF1 controls the 
magnitude of immune responses and maintains immune homeostasis. 
However, we cannot rule out other possible transcriptional synergy factors 
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(factor X), which might be induced only after combinatorial stimulation or 
favorably induced by either MyD88 or TRIF pathway, and are needed for 
cytokine synergy. 
In addition, by turning to computational methods, our study 
demonstrated that the SMC-based framework [80] was able to obtain good 
estimates for hundreds of unknown parameters by fitting noisy cell-population 
data and qualitative knowledge. We developed the first calibrated ODE based 
kinetic model for two specific TLR pathways and their crosstalk. Furthermore, 
we also showed that this framework enables the computation of local and 
global sensitivities of parameters for a large signaling network and has 
excellent descriptive and predictive properties. This is an important step 
towards a comprehensive mathematical model for all TLR pathways. The 
model also provides an invaluable platform for designing pharmaceutical 
strategies on regulating the immune priming of host cells, which could 
improve the immunotherapy efficacy. 
 
 




Figure 5.3. The signaling and transcriptional events occur after poly (I:C) 
and R848 combinatorial stimulation. Under combinatorial stimulation, both 
MyD88 and TRIF pathway are activated. MyD88 induces activation of JunB 
and C/EBP! through activating MAPKs. Although the MyD88 induced p38 
and ERK MAPK inhibit IRF1, the autocined type I IFN, which is significantly 
induced by TLR3-TRIF pathway, sustained the IRF1 activation longer than 
R848 single stimulation. Thus all of the three transcription factors are present 
for sufficient time to maximize cytokine expression. But other potential 
synergy factors which might be produced only under combinatorial 
stimulation or favorably induced by either MyD88 or TRIF pathway could 
also exist, which might be necessary for cytokine synergy. 
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5.2 Future perspectives !
Based on this thesis work, there are several interesting directions for 
future study to shed more light on the signaling mechanism of TLR pathways. 
 
5.2.1 The regulatory mechanism on IRF1 expression !
From this thesis work, we observed an interesting inhibitory effect of 
R848 on IRF1 expression. We also demonstrated that R848 might be 
inhibiting IRF1 expression through p38 and ERK pathway. However, the 
detailed mechanism of how p38 and ERK pathway inhibit IRF1 expression 
needs to be elucidated. In addition, MyD88 pathway is not known to be a 
major inducer of type I IFN. Thus, the autocrine type I IFN is not sufficient to 
induce IRF1 expression under R848 stimulation. Nevertheless, we did observe 
decent amount of IRF1 expression in the presence of p38 and ERK inhibitor 
under R848 single stimulation, and these IRF1 might be induced through 
mechanisms other than type I IFN induced autocrine signaling. Thus it would 
be interesting to further investigate the upstream signal of IRF1 under R848 
stimulation and the detailed mechanism of how MAPK inhibit IRF1 
expression. 
 
5.2.2 The upstream signal of JunB and C/EBP!  
Although we have found that MAPK plays a role in JunB and C/EBP! 
expression through MAPK inhibitor study, there might be other upstream 
signaling pathways responsible for the induction of JunB and C/EBP!. As 
both JunB and C/EBP! are closely related to cytokine expression, it’s 
necessary to find out more about their regulatory mechanism.!
Conclusions and Future Perspectives 
 
! %.,!
5.2.3 The function of IL12p40 produced by macrophages 
IL12p40 is known to be a subunit of IL12 and IL23. It could form 
heterodimer with IL12p35 to make IL12, and with IL12p19 to make IL23, 
respectively. However, we detected high level of IL12p40 expression in 
macrophages but not IL12p35 and IL12p19, indicating that IL12p40 might 
have other roles besides functioning as a subunit of IL12 and IL23. One 
previous research on IL12p40 suggest that it could form a homodimer of 
IL12-p80 to serve as pro-inflammatory cytokine to recruit more innate 
immune cells [65]. However, other researches indicate it as an inherently 
agonistic cytokine [122]. Thus the precise role of IL12p40 produced by 
macrophages need to be verified. 
5.2.4 TLR crosstalk with other PRRs 
Apart from TLRs, other PPRs including RIG-I-like receptors (RLRs), 
C-type lectin receptors, NOD-like receptors, also contribute to PAMP 
recognition and the regulation of innate immunity [106]. As pathogens often 
contain various PAMPs activating multiple PRRs, TLRs in crosstalk with 
other PRRs, orchestrate both host innate and adaptive immune responses to 
combat the infections [106]. For instance, hepatitis C virus (HCV) can be 
recognized by both TLR3 and retinoic acid-inducible gene 1 (RIG-I). The 
HCV RNA delivered from infected hepatocytes can also trigger TLR7 
pathway [123]. PRR crosstalk can either positively or negatively regulate the 
eventual immune responses. For example, combinatorial stimulation of NOD2 
and TLR2 attenuates IL12 production in human DCs, whereas NOD2 
activation significantly enhanced IL12 induction in response to activation of 
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other TLRs such as TLR7 and 8 [6]. Interestingly, the production of cytokines 
induced by TLR2 ligands, but not by other TLR ligands, was shown to be 
higher in mice deficient for NOD2 compared with wild-type mice [124]. 
Different types of collaborative responses have been reviewed by Tan et al 
[125]. Thus, it is important to reveal how immune responses are coordinated 
and regulated by different PRRs.  
 
5.2.5 Cell type-specific TLR crosstalk 
Different cells behave differently to PAMP stimulation. For example, 
macrophages produce high level of IL12p40 but marginal level of IL12p35 
after PAMP stimulation, whereas DCs produce more IL12p35. In this thesis 
work, our main focus is on macrophages. However, same synergy mechanism 
might not apply to other cell types such dendritic cells, as they produce 
different sets of cytokines, plausibly through activation of different 
downstream pathways of MyD88 and TRIF. In this context, an intriguing 
future direction will be to extend our study on TLR crosstalk in different cell 
types. !
5.2.6 The mechanism of synergistic IL10 production under combinatorial 
TLR3-TLR7 activation. 
In the cytokine screening, IL10 also showed high synergy fold. As an 
anti-inflammatory cytokine, the regulatory mechanism of IL10 is very 
different from IL6 and IL12p40. Since IL10 is anti-inflammatory, it can 
regulate the crosstalk between TLR3 and TLR7, although not at the 
transcriptional level. Many autocrine cytokines would feed back and 
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upregulate the production of IL10. In addition, as a primary response gene, 
Il10 might also be regulated at post-transcriptional level instead of 
transcriptional level. Thus the mechanisms of synergistic production of Il10 
would be interesting to further study. 
 
5.2.7 TLR3-TLR7 crosstalk in human system 
Our study was carried out in mouse model. Translation of our findings 
in mouse system may be performed using human cells such as PBMC 
(Peripheral Blood Mononuclear Cell) derived macrophages. 
 
5.2.8 The regulation of synergy factors in human patient with auto-
immune diseases 
Patients with autoimmune diseases tend to have uncontrolled 
production of cytokine. As mentioned in Introduction 1.3.3, elevated levels of 
IL6, IL12p40 and IL12p19 were observed in SLE patients as well as mouse 
models. MyD88 deficient mouse produces less IFN#, IL6 and IL12, and 
delays the mortality of SLE and prevents nephritis and immunologic 
aberrations than wild type mouse. Thus it would be interesting to examine the 
expression level of synergy factors IRF1, CEBP! and JunB in autoimmune 
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Figure 1.2. Schematic representation of the structure, cellular localization 
and major components of the PRR families 
Trinchieri G, Sher A (2007) Cooperation of Toll-like receptor signals in innate 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The synergy in cytokine production through
MyD88-TRIF pathways is co-ordinated with
ERK phosphorylation in macrophages
Rebecca Suet Ting Tan1,7, Bin Lin2,7,8, Qian Liu2, Lisa Tucker-Kellogg3,4, Bow Ho5, Bernard PL Leung6,9
and Jeak Ling Ding1,2,9
Although specific single Toll-like receptor (TLR) ligands are known to drive the development of Th1 or Th2 immunity, the
outcome of different combinations of TLR ligands on innate immunity is not well defined. Spatiotemporal dynamics are critical
in determining the specificity of the immune response, but the mechanisms underlying combinatorial TLR stimulation remain
unclear. Here, we tested pairwise combinations of TLR ligands separated by different time intervals for their effect on cytokine
production in macrophages. We observed that stimulation via a combination of MyD88- and TRIF-utilizing adaptors leads to a
highly synergistic cytokine response. On a timescale of 4–24h, macrophages pretreated with poly(I:C) (TLR3 ligand) are cross-
primed to a second stimulation with R848 (TLR7 ligand) and vice versa, and each condition exhibits different optimal time
windows of synergistic response for each cytokine. We show that the synergy resulting from combinatorial stimuli (poly(I:C) and
R848 is also regulated by the order and dosage of the TLR agonists. Secondary response genes, which depend on new protein
synthesis for transcription, show greater synergy than primary response genes, and such enhancement is abolished when new
protein synthesis is inhibited. Synergistic cytokine production appears concordant with sustained ERK phosphorylation,
suggesting that the de novo factors act via inhibition of ERK dephosphorylation, for example, by the downregulation of dual
specificity phosphatase 6. Taken together, our findings illustrate a checkpoint in the innate immune system, where the
synchronization of timing of both MyD88 and TRIF pathways is required for a maximal cytokine response and potential
memory effect in macrophages.
Immunology and Cell Biology (2013) 91, 377–387; doi:10.1038/icb.2013.13; published online 9 April 2013
Keywords: macrophage; pathogen recognition; signaling crosstalk; Toll-like receptor
The innate immune system possesses a range of receptors, which
detect conserved microbial ligands called pathogen-associated mole-
cular patterns (PAMPs).1 In the mouse and human Toll-like receptor
(TLR) system, a total of 13 different receptors are known, each of
which recognizes distinct bacterial or viral PAMP such as single-
stranded and double-stranded RNA (TLR7 and TLR3, respectively).2
In spite of the recognition of a diverse range of PAMP, TLR signaling
converges on only two adaptors, MyD88 and TRIF. All TLRs utilize
MyD88 with the exception of TLR3, which depends exclusively on
TRIF. TLR4 is unique as it signals via both MyD88 and TRIF.
Although TLRs make use of a shared set of signal transduction
molecules downstream of these two adaptors, the biological effect of
each TLR agonist can differ considerably. For example, in vitro
stimulation of dendritic cells (DCs) with TLR5 agonist, flagellin,
induces Th1 responses, whereas TLR2 agonist, Pam3CSK4, induces a
Th2 response.3 Further complexity occurs in vivo when immune cells
encounter pathogens bearing multiple TLR ligands. The importance
of this complexity is reflected in several studies,4–10 which have
noted that certain pairwise combinations of TLR ligands induce much
higher cytokine production when administered simultaneously
rather than individually, a phenomenon described as synergy.
Most of these studies have focused on the synergistic induction
of interleukin (IL)-12p70 by DC, which acts on adaptive immunity
to drive Th1 responses.4–8 However, the effect of combinatorial
PAMP stimulation on macrophages, which are normally the
first cells to encounter pathogens in host tissues and exert their
1NUS graduate School for Integrative Science and Engineering, National University of Singapore, Singapore; 2Department of Biological Sciences, Faculty of Science, National
University of Singapore, Singapore; 3Computational and Systems Biology, Singapore-MIT Alliance, Singapore; 4Mechanobiology Institute, National University of Singapore,
Singapore; 5Department of Microbiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore and 6Department of Physiology, Yong Loo Lin School of
Medicine, National University of Singapore, Singapore
Correspondence: Professor JL Ding, Department of Biological Sciences, Faculty of Science, National University of Singapore, 14 Science Drive 4, S1A #05-03, Singapore
117543, Singapore.
E-mail: dbsdjl@nus.edu.sg
7These two authors are first coauthors.
8Current address: Laboratory of Systems Biology, NIAID, NIH 9000 Rockville Pike Building 4, Room 228 Bethesda MD 20892.
9These two authors are senior coauthors.
Received 30 April 2012; revised 12 March 2013; accepted 12 March 2013; published online 9 April 2013
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& 2013 Australasian Society for Immunology Inc. All rights reserved 0818-9641/13
www.nature.com/icb
effect on innate rather than adaptive immunity,9,10 remains relatively
unexamined.
Although synergistic combinations of TLR agonists are known, the
underlying logic governing TLR–TLR interaction and the resulting
non-additive responses to complex stimuli remains unclear. The
presence of multiple receptors and adaptors make it possible for
crosstalk and nonlinear responses to occur, thus maintaining a more
finely controlled, rapid and lower-energy system.11 Both empirical
and in silico data suggest that the temporal aspects of immune
signaling can have profound effects on biological outcomes.12,13 In
adaptive immunity, the second response to a pathogen is much higher
due to immunological memory of the first infection. However, this
occurs on the timescale of several days to weeks, whereas innate
immunity responds within hours. Our preliminary data showed that
certain combinations of TLR ligands led to an enhanced cytokine
response. We hypothesized that cells of the innate immune system
could show either (1) an enhanced response to a second stimulation
with a different TLR ligand (cross-priming) or (2) a reduced response
to a second stimulation with the same TLR ligand (tolerance or
antagonism), demonstrating a ‘memory’ of the first stimulation.
Therefore, we examined the effect of dosage and temporal intervals
between two TLR agonists known to induce synergistic cytokine
production: poly(I:C) (TLR3 ligand) and R848 (TLR7 ligand) in
macrophages. Our results show that appropriate timing and dosage of
TLR agonists are critical parameters regulating the synergistic
production of different cytokines, with variable optimal time
windows for different classes of cytokines. In addition, we showed
that while poly(I:C) dose-dependently enhances synergistic responses,
R848 exhibits a threshold effect, suggesting two different mechanisms
by which each signal contributes to synergy. We also demonstrate that
synergy is dependent on new protein synthesis and is associated with
enhanced and sustained ERK phosphorylation, which may be caused
by the downregulation of dual specificity phosphatase 6 (DUSP6).
RESULTS
Combinatorial stimulation with poly(I:C) and R848 induces
highest synergy in cytokine production
As a preliminary study, we stimulated RAW264.7 cells with pairwise
combinations of TLR ligands for up to 24h and measured a panel of
18 cytokines via a multiplex cytokine assay. We found that out of the
Figure 1 Multiplex cytokine assay of cells stimulated with various TLR ligand combinations. (a) RAW264.7 cells and (b) bone marrow-derived macrophages
derived from BALB/c mice were stimulated with the indicated combinations of TLR ligands and cell culture supernatants were harvested after 24h. The
dosages of the TLR ligands were as follows: poly(I:C) 10mgml!1, Pam3CSK4 10ngml!1, R848 25ngml!1 and LPS 10ngml!1. ‘þ þ ’ Indicates a double
dose of the same ligand. The profiles of a panel of five cytokines (TNF, IL-6, IL-12p40, IL-12p70 and IL-10) were analyzed by a multiplex cytokine bead
array (Panomics) according to the manufacturer’s instructions.
TLR pathway crosstalk modulates cytokine synergy
RST Tan et al
378
Immunology and Cell Biology
18 cytokines measured, only tumor necrosis factor (TNF), IL-6, IL-10
and IL-12p40 were synergistically upregulated (Figure 1a). Based on
this initial study, these four highly upregulated cytokines and IL-12p70
were further examined in BALB/c-derived bone-marrow macrophages
(BM-DMs; Figure 1b). We observed comparable profiles of cytokine
synergy in both the RAW 264.7 cell line and primary BM-DM cells
derived from BALB/c mice, under similar conditions of TLR ligand
stimulation (Figures 1a and b). Poly(I:C) was used as a TLR3 ligand,
which signals exclusively via TRIF. Pam3CSK4 (TLR2 ligand) and R848
(TLR7 ligand) were used as MyD88-exclusive ligands, which signal via
Figure 2 Combinatorial ligand stimulation of TRIF and MyD88 shows the greatest synergy in mouse macrophages. BALB/c bone marrow-derived
macrophages (BM-DM) were stimulated with the indicated combinations and doses of TLR ligands as indicated in (a) for 24h and cytokine concentration in
cell-free supernatants were measured by ELISA. (b) Cytokine production and (c) fold synergy of IL-10, IL-6 and IL-12p40. Single TLR ligand stimulated
values are indicated with open symbols and black lines: poly(I:C) (triangle), R848 (square), Pam3CSK4 (diamond) and LPS (circle). Combinatorial TLR
ligand-stimulated values are indicated by filled and coloured symbols: poly(I:C) and R848 (blue square), poly(I:C) and Pam3CSK4 (purple diamond), LPS
and R848 (red square), LPS and Pam3CSK4 (orange diamond), R848 and Pam3CSK4 (green diamond), or poly(I:C) and LPS (cyan triangle). Data shown are
representative of three independent experiments. Student’s t-test was performed to compare double TLR ligand stimulation (coloured lines) with the sum of
single stimulations (white symbols, black lines) *Po0.05, **Po0.01.
TLR pathway crosstalk modulates cytokine synergy
RST Tan et al
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the cell surface and endosomal compartments, respectively. Lipopoly-
saccharide (LPS) was included as a positive control that activates both
the TRIF and MyD88 pathways. We found that simultaneous
stimulation with two TLR ligands induced higher cytokines than
double dose of a single TLR ligand (Figure 1, þ þ ) if the TLR ligands
collectively activated both MyD88 and TRIF pathways.
In order to dissect the logic governing synergistic cytokine
production in response to dual TLR ligand stimulation, we challenged
BALB/c BM-DM with different pairwise combinations of MyD88-
and TRIF-utilizing TLR ligands at increasing doses as indicated in
Figure 2a, and cytokine production was measured 24h later
(Figure 2b). Using these different TLR ligands, we then tested the
hypothesis that induction via MyD88 and TRIF combinations
(poly(I:C)þR848/Pam3CSK4) would lead to synergistic cytokine
production due to an interaction between the two pathways,
whereas combinations of ligands inducing MyD88-MyD88
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(R848þPam3CSK4) and TRIF-TRIF (poly(I:C)þ LPS) would not.
We observed that only low to moderate levels of both pro- and anti-
inflammatory cytokines were produced when the BM-DM were
challenged with single TLR ligands (Figure 2b, blank symbols), even
at increasing doses. When challenged simultaneously with two TLR
ligands, there was no significant increase in cytokine production if the
two ligands activated the same signaling pathways (Figure 2b, green,
R848þPam3CSK4; both engage only MyD88). However, when
challenged with the combination of MyD88- and TRIF-utilizing
ligands (Figure 2b, blue, poly(I:C)þR848; or purple, poly(I:C)þ
Pam3CSK4), the production of pro- and anti-inflammatory cytokines
was much greater (Figure 2b, filled symbols) than that observed for
single ligand stimulation (Figure 2b, open symbols). This was
especially profound in the case where poly(I:C) (TRIF only) was
paired with R848 or Pam3CSK4 (MyD88 only; Figure 2b, blue and
purple, respectively). In an intermediate condition, where cells were
challenged with LPS (MyD88 and TRIF ligand), further addition of
MyD88-utilizing ligands, R848 or Pam3CSK4 (Figure 2b, LPSþR848,
red; LPSþPam3CSK4, orange), caused no synergy in the production
of IL-6 and IL-12p40 (Figure 2b, red and green, respectively),
although there was still synergistic production of IL-10.
To quantify the synergistic effect, the cytokine production under
combinatorial stimulation was divided by the sum of the respective
single stimulations to give a value we termed ‘fold synergy’
(Figure 2c). For the proinflammatory cytokines, IL-6 and IL-12p40,
the levels produced by combinatorial stimulation is much greater than
the single stimulated cells, with up to 20- to 60-fold synergy at low
doses. However, as the dose increases, single stimulated cells also
began to increase cytokine production, whereas the double stimulated
cells approached saturation levels of cytokine production, causing the
calculated fold synergy to drop. Interestingly, the anti-inflammatory
cytokine, IL-10, shows a reverse trend, with synergy increasing as the
dose increases (Figure 2c). This indicates that synergy affects different
classes of cytokines in opposing ways, and that there is a negative
feedback regulation limiting the amount of proinflammatory cyto-
kines produced. Importantly, these patterns were reproduced in
C57BL/6-derived primary macrophages (Supplementary Figure 1),
showing that this was a general rather than strain-specific
phenomenon.
Appropriate timing and order of TLR stimulation influence the
optimal synergy
Following from the demonstration that the combination of different
doses of poly(I:C) and R848 leads to synergy, we further investigated
the kinetic effects with these two ligands. During the course of
infection, macrophages may encounter different TLR ligands in a
sequential manner. Thus, we tested the effect of both poly(I:C)
followed by R848 [I-R combinatorial] and R848 followed by
poly(I:C) [R-I combinatorial], measuring mRNA expression of
TNF, IL-10, IL-6 and IL-12p40. Briefly, cells were pretreated with
the first TLR ligand for 0, 8 or 24h and then collected 8 h after
stimulation with the second TLR ligand. To discriminate additive
effects from potential synergy or antagonism, stimulations with single
TLR agonists were included as controls (Figure 3a). The synergy of all
cytokine mRNA was sensitive to the duration of pre-stimulation, with
synergy increasing from 0 to 8 h and declining by 24h (Figure 3b).
Interestingly, the effect of the order of stimulation also strongly
influenced the response where [I-R combinatorial, dark grey] led to
much higher expression of cytokine mRNA than [R-I combinator-
ial, black] at the same time points. Importantly, our data show that
priming by poly(I:C) is crucial for optimal synergy in cytokine
gene expression in the macrophages, possibly via the action of synergy
factor(s).
De novo protein synthesis is required for synergy effect on
secondary response genes
To examine whether the ‘synergy factor’ is a newly synthesized or pre-
existing protein, we used cycloheximide (CHX) to inhibit de novo
protein synthesis in BM-DM and measured its effect on the cytokine
transcripts. For IL-6 and IL-12p40, CHX treatment abrogated the
synergy (Figure 3c), indicating a strong requirement for the newly
synthesized protein. For TNF, there was only a low synergy of B1.5-
fold observed at the transcriptional level, which was slightly reduced
by CHX treatment. It appears that synergy for the expression of
secondary response genes (Il6 and Il12b) mainly occurs at the
transcriptional level and is highly dependent on new protein synth-
esis. In contrast, the synergy of primary response genes (Tnf and Il10)
more likely occurs at the post-transcriptional level, and may not
require new protein synthesis. Our observation is consistent with
previous reports that LPS induction of secondary response genes but
not primary response genes requires new protein synthesis.14
Both timing and dose of stimulation affects cytokine protein
production
Next, we extended our study to the protein level using both BM-DM
and RAW cells, as there is no apparent difference in the cytokine
expression profiles for the primary cells and cell line (Figures 1a and b
and Supplementary Figure 2). Briefly, BM-DM were stimulated with
Figure 3 Synergy in mRNA expression is dependent on de novo protein synthesis. (a) Graphical summary of experimental design. Bone marrow-derived
macrophages (BM-DMs) were treated with either poly(I:C) followed by R848 [I-R combinatorial, dark grey] or R848 followed by poly(I:C) [R-I
combinatorial, black]. Assuming a purely additive effect of two TLR stimulations, the single stimulation control for I-R [I-R additive, white] was taken to
be the sum of cytokines produced by cells stimulated first with poly(I:C) for 0, 8 or 24h followed by a mock stimulation with water for 8h, and cells which
were mock stimulated first with water for 0, 8 or 24h followed by R848 stimulation for 8h. Similarly, the single stimulation control for R-I [R-I
additive, light grey] was the sum of cytokines produced by cells stimulated with R848 for 0, 8 or 24h followed by water for 8h and cells stimulated with
water for 0, 4, 8, 16 or 24h followed by poly(I:C) for 8 h. (b) BM-DM were pretreated with one TLR ligand for 0, 8 or 24h, followed by a second TLR
ligand for another 8 h. 0h pretreatment denotes simultaneous stimulation. [I-R] (dark grey) symbolizes poly(I:C) as the first TLR ligand, followed by R848
as the second TLR ligand. [R-I] (black) indicates the same stimulations in reverse order. The single stimulation controls are computed for [I-R] (white)
and [R-I] (light grey) as described in a. IL-10, TNF, IL-6 and IL-12p40 mRNA were measured by real-time PCR using Taqman probes specific to each
cytokine. Similar results were obtained in two other independent experiments. Data represent means±s.d. of triplicate measurements in a representative
experiment. Student’s t-tests were performed from the data of all three independent experiments (*¼Po0.05, **¼Po0.01). (c) BM-DM were pretreated
with poly(I:C) for 8 h, followed by R848 for another 4 h in the absence (white bars) or presence (black bars) of 10mgml#1 CHX for 15min. Fold synergy
was calculated by dividing the experimental group by the control group data. Similar results were obtained in two other independent experiments. Data
represent means±s.d. of triplicate measurements in a representative experiment. Student’s t-tests were performed from the data of all three independent
experiments (*¼Po0.05).
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poly(I:C) for 0–24h followed by R848 for 24h [I-R] or R848 for
0–24h followed by poly(I:C) [R-I]. At these time points, combina-
torial cells were still healthy, showing a level of apoptosis similar to
that of untreated cells (Supplementary Figures 2a and b). Similar to
our previous findings, stimulation with single TLR ligands led to only
a low level of response (Figure 4a, white and light gray bars).
However, double TLR ligand stimulation led to a high and synergistic
response for all cytokines tested and at all time intervals, as indicated
by the difference between the white and dark grey bars or the light
grey and black bars (Figure 4a). This enhancement of cytokine
production was also seen by intracellular cytokine staining for IL-6
and IL-12p40 (Supplementary Figure 2c) Interestingly, each of the
cytokines showed differential sensitivity to the order and timing of the
second TLR stimulation. First, the anti-inflammatory cytokine, IL-10,
was produced at a high and synergistic level (Figure 4a) regardless of
the timing of the second TLR stimulation. In stark contrast, proin-
flammatory TNF was produced at a much higher level under [I-R]
stimulation than [R-I] when the time interval between stimulations
was 8h or more. At 8 h interval, the difference in the order of
stimulation was the most apparent, where [R-I] showed 9.5 ngml!1
TNF production, whereas [I-R] only showed six times less TNF
production (1.5 ngml!1, Figure 4a). This suggests that there are
different mechanisms of synergy depending on the order of stimula-
tion, where the synergy is greatest for R848-primed cells at 4 h after
first stimulation and was sustained over longer time. In contrast,
poly(I:C)-pretreated cells remain highly cross-primed to second
stimulation with R848 from 8 to 24 h after pre-stimulation. The
[R-I] stimulation induced a pattern of production of IL-6 and
IL-12p40 similar to TNF, where 4 h pre-stimulation with R848 followed
by poly(I:C) led to the highest cytokine production (Figure 4a).
Figure 4 Time and dosage of TLR ligands induce synergy in cytokine production. (a) Pattern of cytokine protein production induced by different time
intervals between poly(I:C) and R848 stimulation. Bone marrow-derived macrophages were pretreated with one TLR agonist for 0, 4, 8, 16 or 24h (0h pre-
stimulation denotes simultaneous stimulation), followed by a second TLR agonist for 24h. [I-R combinatorial] (dark grey) symbolizes 10mgml!1 of
poly(I:C) as the first TLR agonist, followed by 25ngml!1 of R848 as second TLR agonist. [R-I combinatorial] (black) indicates the same stimulations in
reverse order. The hypothetical additive effects are computed for [I-R additive] (white) and [R-I additive] (light grey). IL-10, TNF, IL-6 and IL-12p40 in
cell-free supernatants were measured by ELISA. Data are means±s.d. of triplicate measurements in a representative experiment. Similar results were
obtained in two other independent experiments. (b) In RAW264.7 cells, stimulation with single TLR agonists results in low levels of cytokine production. (c)
Poly(I:C) dose-dependently enhances R848-induced IL-6 production when both TLR ligands were applied simultaneously to RAW264.7 cells (upper panel).
Stimulation with poly(I:C) for 8 h before R848 also shows dose-dependent effect on IL-12p40 production (lower panel). Cell-free supernatants were
collected 24h after the second stimulation. IL-6 and IL-12p40 concentrations were measured by ELISA. ND describes ‘not detectable’ within the limits of
assay (lower limit of detection, 5ngml!1). Data represent means±s.d. of triplicate measurements in a representative experiment. Similar results were
obtained in two other independent experiments. Student’s t-tests were performed from the data of all three independent experiments (*Po0.05).
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Longer intervals (8–24h) between the first and second stimulations
remained synergistic, but the fold synergy declines as the interval
increases. This suggests that priming with poly(I:C) induced
a factor which is maximally active 4 h after R848 stimulation. In
contrast, longer pre-stimulation with poly(I:C) from 8 to 16h
led to the maximal production of IL-6 and IL-12p40 under [I-R]
stimulation. Thus, poly(I:C) may be acting via a mechanism that is
most active 8–16h after poly(I:C) stimulation. Taken together, our
results show that crosstalk between signaling pathways induced by
poly(I:C) and R848 must be synchronized for maximal cytokine
production, with different time windows for different classes of
cytokines.
Poly(I:C) strongly enhances R848-induced cytokine production
although it is a weak inducer by itself
The requirement for signaling synchronization prompted us to
examine the respective roles of poly(I:C) and R848 in signaling
crosstalk. Similar to others,4–6 we observed that R848 alone induced a
basal level of IL-6 and IL-12p40 production, whereas poly(I:C) alone
induced a low or undetectable amount of cytokines (Figure 4b).
However, we observed that poly(I:C) strongly enhanced R848-induced
cytokine production at the mRNA level (Figure 3). To substantiate
this finding, we tested whether poly(I:C) and R848 would contribute
to the synergy in a dose-dependent manner by using three doses each
of poly(I:C) (0.3, 1 and 10mgml!1) followed by R848 (5, 25 and
100 ngml!1; Figure 4c). By testing all nine possible combinations of
poly(I:C) and R848 with various doses each, and measuring IL-6 and
IL-12p40 production 24h after the second TLR stimulation, we
observed no significant synergy at 5 ngml!1 of R848, even when the
dose of poly(I:C) was as high as 10mgml!1. Increasing the dosage of
R848 to 25ngml!1 led to significant synergy, but no further
enhancement was observed at 100 ngml!1 (Figure 4c). Taken
together, these results further support the notion that R848 alone is
not able to induce a high level of cytokine production even at
increasing dosage, although it contributes a basal level of induction.
In contrast, under 25 and 100 ngml!1 of R848, poly(I:C) enhanced
IL-6 production dose dependently (Figure 4c), although on its own,
poly(I:C) did not induce detectable amounts of IL-6 (Figure 4b).
These data suggest that poly(I:C) contributes to synergy via induction
of ‘synergy factors’ rather than a direct induction of IL-6. Similar
observations were made for IL-12p40 (Figure 4c, lower panel).
Collectively, these results support our observation that R848 stimu-
lates basal levels of cytokine production, whereas poly(I:C) dose-
dependently induces ‘synergy factors’, which seemed to greatly
enhance the R848-induced cytokine production. Although blocking
the type I interferon receptor slightly reduced the amount of
cytokines produced (Supplementary Figure 3a), suggesting that the
‘synergy’ factor might be a type I interferon, addition of exogenous
IFN-b failed to induce high levels of cytokine synergy compared with
poly(I:C) pretreatment for 8 h (I8R) (Supplementary Figure 3b). The
priming effect of poly(I:C) is robust as a low concentration
(0.3mgml!1) was sufficient to synergize with R848 for effective
cytokine induction. Our results also underscore the concept that the
innate immune system elicits a memory response after the first
encounter with a PAMP, and it is able to adjust the level of synergy
according to the dose and timing/order of infection.
Figure 5 Synergy in cytokine expression is associated with sustained ERK phosphorylation. (a) Bone marrow-derived macrophages were treated with either
10mgml!1 poly(I:C) or 25ngml!1 R848 alone, poly(I:C) and R848 together simultaneously (IR) or pretreated with poly(I:C) for 8h followed by a
second stimulation of R848 (I8R). After second PAMP stimulation, cells were harvested at the indicated time points. Cell lysates were resolved on
SDS-polyacrylamide gel electrophoresis gel, transferred to poly(vinylidene fluoride) membrane and probed with anti-phospho-ERK, anti-total-ERK, anti-
phospho-p38, anti-phospho-JNK, anti-phospho-IkB and anti-actin. (b) ERK inhibition reduces but does not completely abolish synergistic cytokine
production (boxed). Cells were left untreated (NT) or stimulated with 10mgml!1 poly(I:C) for 24h (I24) or 32h (I32), 25ngml!1 R848 for 24h (R24),
poly(I:C) and R848 simultaneously for 24h (IR24), or pretreated with poly(I:C) for 8h followed by R848 for 24h (I8R24), in the presence or absence of
increasing doses ERK inhibitor, PD98059 (5mM, 10mM or 50mM). TNF, IL-10, IL-6 and IL-12p40 in cell-free supernatants were measured by ELISA.
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Synergy is associated with sustained cytoplasmic ERK
phosphorylation
Next, we investigated the involvement of signaling molecules in the
synergy resulting from combinatorial TLR stimulation of BM-DM.
Single TLR stimulation is known to result in transient mitogen-
activated protein kinase (MAPK) activation, upstream of cytokine
expression. In human DCs, synergistic induction of IL-12p70 is
known to be associated with sustained c-Jun phosphorylation.4,15
Thus, we measured the phosphorylation of three key components of
the MAPK pathway, extracellular signal-regulated kinase (ERK), p38
and c-Jun N-terminal kinase (JNK), as well as phosphorylated IkBa,
in macrophages over time. We found that while single stimulations
with either poly(I:C) or R848 led to similar profiles of p38, JNK and
IkBa phosphorylation, simultaneous stimulation with both poly(I:C)
and R848 (IR) enhanced ERK phosphorylation, which was sustained
up to 8 h (Figure 5a). This result suggests that strong and sustained
ERK phosphorylation might have a role in enhancing cytokine
production observed when poly(I:C) and R848 are simultaneously
encountered by the macrophages. Interestingly, this effect is even
more pronounced when cells were pretreated with poly(I:C) for 8 h
(Figure 5a, I8R). In this experiment, cells were either pretreated with
or without poly(I:C) for the first 8 h, then stimulated with R848 and
collected at the indicated time points. Our data show that although
there is no direct phosphorylation caused by poly(I:C) from 4h
onwards, poly(I:C) pre-stimulation led to a much stronger phosphor-
ylation of ERK upon second challenge with R848 (Figure 5a).
To confirm the role of sustained ERK signaling in synergy, we
investigated the effect of PD98059, a chemical inhibitor of MEKs
upstream of ERK. We found that inhibition of ERK reduced the
production of all cytokines tested (Figure 5b), showing that sustained
ERK phosphorylation is a possible mechanism of cytokine synergy.
Localization of ERK in synergy
ERK signaling regulates a vast number of cellular processes, from
development to proliferation and apoptosis, sometimes in opposing
ways. Other than the strength and duration of the ERK signal,
specificity in response might also be determined by the subcellular
localization of activated ERK, which determines substrate specificity.
Cytoplasmic ERK is known to be associated with the cytoskeleton and
activates various substrates such as Raf-116 and epidermal growth
factor receptor17, whereas nuclear-localized ERK activates trans-
cription factors such as Elk-118 and c-Jun.19 Thus, we sought to
Figure 6 Phospho-ERK is localized to the cytoplasm following TLR stimulation. Bone marrow-derived macrophages were treated with either 10mgml!1
poly(I:C) or 25ngml!1 R848 alone, poly(I:C) and R848 together simultaneously (IR) or poly(I:C) for 8 h followed by R848. Cells were fixed at the indicated
time points with 4% paraformaldehyde in phosphate-buffered saline (PBS), permeabilized with 0.1% Triton X-100 PBS and stained overnight at 4 1C, for
phospho-ERK and total ERK, using antibodies raised in rabbit and mouse, respectively. Cells were washed in PBS and then stained with goat anti-rabbit
Alexa-488 and donkey anti-mouse Alexa-546 for 1 h at room temperature. Nuclei are stained (blue) with 40-6-diamidino-2-phenylindole. Images were taken
on LSM510 confocal microscope (Zeiss). Scale bar indicated is 10mm.
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determine the subcellular localization of phosphorylated ERK under
dual TLR ligand stimulation. Consistent with the western blot data,
single stimulation with either poly(I:C) or R848 led to a transient
phosphorylation of ERK with a peak of 30–60min, whereas dual TLR
ligand stimulation (IR or I8R) led to sustained ERK phosphorylation
up to 12h post-stimulation (Figure 6). In either single or dual TLR
stimulation, phosphorylated ERK was cytoplasmically distributed,
suggesting that synergy might be mediated by a cytoplasmic target
of ERK.
To further investigate the mechanism by which phosphorylated
ERK was being retained in the cytoplasm, we examined the mRNA
levels of DUSPs by real-time PCR. DUSPs are involved in the negative
regulation of MAPK signaling, acting by dephosphorylating and thus
inactivating their substrates.20 We hypothesized that if sustained ERK
signaling is the cause of synergy, we would see a reduction of DUSP
under synergistic conditions. ERK is known to be a substrate of
DUSPs 1–9 and 14. The mRNAs of DUSPs 3, 4, 5, 7, 8, 9 and 14 were
not detected by reverse transcription PCR in untreated or stimulated
samples. We were, however, able to detect transcripts of DUSP1, 2 and
6 (Figure 7). Interestingly, DUSP2 is known to be localized to the
nucleus21, whereas DUSP6 is localized in the cytoplasm.22 Our data
show that although DUSP1 and DUSP2 are upregulated upon
synergistic stimulation, DUSP6 is downregulated (Figure 7). This
suggests that the sustained ERK signaling responsible for synergistic
cytokine production is plausibly due to a downregulation of DUSP6.
DISCUSSION
We have shown that innate immune response to complex stimuli is
determined not only by the combination of TLR ligands, but also by
the timing, order and dosage of TLR agonists. The requirement for
optimal timing and order indicates that signaling pathways elicited by
the two TLR agonists (double-stranded RNA poly(I:C) and single-
stranded RNA R848) must be synchronized for optimal induction of
the respective cytokines. Our results recapitulate the concept that the
immune system is able to adjust the level of synergy according to the
dose and timing/order of infection. Therefore, it is important to
consider the context of infection when studying immune-signaling
crosstalk. In addition, we have narrowed down the range of possible
synergy factors to newly synthesized protein(s), which appear(s) to
sustain ERK phosphorylation and cytoplasmic localization, facilitating
future identification and characterization.
Synergistic cytokine induction has been extensively studied in DC,
with a focus on IL-12p70 production and subsequent Th1 adaptive
immune responses.4–8 In contrast, macrophages are known to
produce much lower levels of IL-12p70 in a non-synergistic
manner.15 This is unsurprising, given that macrophages function
primarily in innate rather than adaptive immunity. Indeed, DC and
macrophages are known to produce different cytokine profiles in
response to the same pathogen, with DC secreting higher amounts of
IL-12p70 in response to Mycobacterium tuberculosis, compared with
that of macrophages.23 We have shown, however, that macrophages
are able to synergistically secrete high amounts of IL-12p40, one of
the subunits of IL-12p70. Nevertheless under the same conditions,
only low amounts of IL-12p70 and IL-23 were secreted
(Supplementary Figure 4), raising the possibility that macrophages
produce large amounts of IL-12p40 as a monomer or homodimer
(p80). In this form, IL-12p40 can act as a macrophage chemoat-
tractant, and it has shown to be involved in the recruitment of
macrophages to the lung in response to Sendai virus infection in
mice, conferring resistance to lethality.24 It is noteworthy that Sendai
virus is a single-stranded RNA virus, which undergoes a double-
stranded RNA phase during genomic replication in the host cell, and
thus contains both TLR3 and TLR7 ligands similar to those used in
our study. Therefore, synergistic levels of production of IL-12p40 by
macrophages may promote innate immunity by increasing the
Figure 7 DUSP 1, 2 and 6 mRNA expression under synergistic conditions.
Bone-marrow derived macrophages were pretreated with a first TLR ligand
for 0, 8 or 24h, followed by a second TLR ligand for another 8 h. 0h pre-
stimulation denotes simultaneous stimulation. [I-R combinatorial, dark
grey] symbolizes poly(I:C) as the first TLR ligand, followed by R848 as
second TLR ligand. [R-I combinatorial, black] indicates the same
stimulations in reverse order. The hypothetical additive effects were
computed for [I-R additive, white] and [R-I additive, light grey]. DUSP1,
DUSP2 and DUSP6 mRNAs were measured by real-time PCR in the SYBR
green format using primers specific to each mRNA. Data represent
means±s.d. of a representative experiment. The fold downregulation of
DUSP6 mRNA for each of the combinatorial stimulations compared with
their respective controls are as labeled.
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number of immune cells at the site of infection, rather than
combining with IL-12p35 to form IL-12p70 and drive Th1
responses. These cell type-specific differences may be attributed to
differential usage of TLRs,23 or differential chromatin status (the IL-6
promoter is constitutively open in fibroblasts but closed in
macrophages),25 or cell type-specific synergy factors.
Although there are differences in IL-12p70 secretion, both macro-
phages and DC synergistically produce IL-6 and TNF in response to
combinatorial stimulation by poly(I:C) and R848.4 This is consistent
with the idea that the activation of both MyD88- and TRIF-mediated
pathways is required for synergy.8,9 From our data, poly(I:C) was
unable to induce IL-6 or IL-12p40 production (Figure 4c) and yet it
boosted the fold synergy of these two cytokines in a dose-dependent
manner. It is likely that R848 elicits a basal level of cytokine induction
(Figure 4c), which was enhanced by poly(I:C) signaling through a
protein synthesis-dependent mechanism (Figure 3c). This possibility is
supported by our study of signaling molecules, which shows that
poly(I:C) is a weaker inducer than R848 alone, but has a modulating
effect when simultaneously administered with R848, prolonging and
enhancing the ERK phosphorylation signal (Figures 5 and 6). However,
these results do not rule out the possible involvement of other
signaling pathways such as the interferon regulatory factors. An
alternative explanation could be that poly(I:C) causes synergy with
R848 through chromatin modifications, a mechanism that has been
demonstrated in other studies.26–29 Taken together, our results show
that a first encounter with poly(I:C) seems to imprint a memory effect,
which cross-primes the macrophages for a more rapid, higher and
sustained immune response to the second PAMP challenge with R848.
Previous microarray studies have found that DUSP genes are
synergistically upregulated under combinatorial TLR stimulation.4,30
Our study is the first to implicate the downregulation DUSP proteins
in the regulation of synergistic cytokine production, linking DUSP6
downregulation to the sustained phosphorylation of ERK. Regulation
of the phosphoproteome is a key mechanism regulating innate
immunity,31 and our findings suggest that dephosphorylation events
are just as important as kinase activity in modulating the magnitude
of the response.
Our results showed that secondary response genes such as Il6 and
Il12b elicited a greater extent of synergy (70- to 90-fold) at the mRNA
level than primary response genes such as Tnf (1- to 2-fold; Figure 3b,
white bars) in response to poly(I:C) and R848. Our observation is
consistent with previous reports that secondary response gene (for
example, Il6, Il12b) production in response to LPS strictly requires
both MyD88 and TRIF signaling, whereas primary response genes (for
example, Tnf, Il10) still have residual production in the absence of
either MyD88 or TRIF, and this is probably regulated by a newly
synthesized protein.14 Interestingly, we found that the fold synergy of
secondary response genes is highly dependent on new protein
synthesis (Figure 3c), whereas the primary response genes are not
affected. Considering the importance of trans-regulatory elements13
and chromosome remodeling14,25,32 in gene regulation, the newly
synthesized proteins are plausibly enhancer-binding proteins or
proteins which may influence chromatin remodeling. Identification
of these ‘synergy-inducing proteins’ is warranted in future studies to
further understand the mechanism of signaling crosstalk and
regulation of secondary response genes in innate immune memory.
METHODS
Materials
Media and supplements were purchased from Gibco, Life Technologies
(Carlsbad, CA, USA). Fetal bovine serum was purchased from Hyclone,
Thermofischer Scientific (Waltham, MA, USA). Recombinant mouse macro-
phage colony stimulating factor (M-CSF) was purchased from Ebioscience
(San Diego, CA, USA). TLR ligands R848 and low-molecular-weight poly(I:C)
were from Invivogen (San Diego, CA, USA), Pam3CSK4 from Calbiochem,
EMD Biochemicals (Darmstadt, Germany) and Escherichia coli 055:B55 LPS
from Sigma-Aldrich (St Louis, MO, USA). Maxisorp microtitre 96-well plates
were obtained from Nunc (Roskilde, Denmark). Rabbit monoclonal antibodies
against phospho-p38 (#4511), phospho-ERK1/2 (#4370) and phospho-JNK
(#4668) were obtained from Cell Signaling Technologies (Boston, MA, USA).
Rabbit monoclonal antibody to b-actin and goat polyclonal horse radish
peroxidase (HRP)-conjugated secondary antibodies to rabbit IgG were from
Sigma-Aldrich. Alexa Fluor-488 secondary goat anti-rabbit (Hþ L) highly
cross-absorbed was from Molecular Probes, Invitrogen (Carlsbad, CA, USA).
Animals
Mouse BM-DM were prepared as described previously.33 Briefly, femurs were
isolated from 8-week-old female BALB/c mice, and the resulting bone-marrow
cells were resuspended in Dulbecco’s modified Eagle’s medium containing 10%
(v/v) fetal bovine serum, 100Uml"1 penicillin, 100mgml"1 streptomycin and
100Uml"1 recombinant M-CSF at a density of 4# 106 cells per ml. On day 3
post harvest, additional M-CSF media was supplied and cells were cultured for
another 4 days before plating. Experiments on mice were performed according
to the guidelines and regulations of the Institutional Animal Care and Use
Committee (IACUC protocol number: 049-11).
Cell culture
Primary BM-DM and mouse macrophage cell line RAW 264.7 were cultured in
Dulbecco’s modified Eagle’s medium with 10% fetal bovine serum. Cells were
stimulated 24h after plating with 1ml of fresh medium per well with the
respective TLR ligands. At indicated time intervals, the second PAMP or
pyrogen-free water (mock) was applied to the cells as second stimulation. The
final concentrations of TLR ligands in the culture were 25ngml"1 of R848,
10mgml"1 of poly(I:C), 10ngml"1 Pam3CSK4 or 10ngml"1 E. coli 055:B55
LPS.
CHX treatment
BM-DM at a density of 1# 106 cells per ml in 0.5ml was plated per well into
24-well plates. At 24 h after plating, the cells were pre-treated with 10mgml"1
of CHX (Sigma, St Louis, MO, USA) for 15min, and then 2ml of poly(I:C) at
2.5mgml"1 or pyrogen-free water was applied as first stimulation. This was
followed 8 h later by a second stimulation with 2ml of R848 at 6.25ngml"1 or
pyrogen-free water.
Measurement of cytokine production
Culture supernatants were collected at 24h after the second stimulation and
stored at "80 1C. The levels of IL-12p40, IL-6, IL-10, TNF (BD Biosciences
Inc.) were measured according to the manufacturer’s instructions. For the
multiplex cytokine assay, a luminex kit (Panomics/Affymetrix, Freemont, CA,
USA) was used according to the manufacturer’s instructions. The lower limit
of detection was 2.5 pgml"1 for all cytokines tested. Student’s t-tests were
performed from the data of three independent experiments and Po0.05 were
considered significant. For CHX treatment, BM-DM were pretreated with
10mgml"1 of CHX from Sigma-Aldrich for 15min before stimulation.
Real-time PCR
Cells were harvested with Trizol (Invitrogen) and frozen at "80 1C until
mRNA extraction. cDNAs were synthesized with Superscript III reverse
transcriptase (Invitrogen). All real-time PCR were carried out with Light
cycler 480 (Roche, Penzburg, Germany). Lightcycler 480 probes master mix
(Roche) were used for the Taqman assays, and pre-designed TaqMan Gene
Expression Assays (Life Technologies) Mm00446190_m1, Mm00434174_m1,
Mm01290062_m1 Mm00446968_m1 were used for the detection of Il6, Il12b,
Il10, Tnf and Hprt mRNA, respectively. The PCR cycles constituted 1 cycle of
95 1C for 10min, followed by 40 cycles of 95 1C for 10 s, 60 1C for 20 s. The
mRNA levels were normalized to that of Hprt and expressed as relative amount
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to Hprt. DUSP1, DUSP2 and DUSP6 mRNAs were detected with SYBR Green
method by using Lightcycler 480 SYBR Green I Master Mix (Roche), and
the mRNA levels were normalized to that of b-actin. Forward primer:
50-CACCCGCGAGCACAGCTTCT-30 and reverse primer: 50-TGCTCTGG
GCCTCGTCACCC-30 was used for detection of b-actin mRNA. Forward
primer 50-TTCGCTTTCAACGCCGGCCA-30 and reverse primer 50-AGCTC
AGGGCAGGAAGCCGA-30 was used for DUSP1 mRNA detection. Forward
primer 50-CCGTGTGCTTCTTGCGAGGC-30 and reverse primer 50-TTG
GGGCAGCTGGCAGAGACA-30 was used for DUSP2 mRNA detection.
Forward primer 50-ACCGCTTTACCAGGCGCTGC-30 and reverse primer
50-TCGCAGTGCAGGGCGAACTC-30 was used for DUSP6 mRNA detection.
All primers were designed to amplify intron spanning cDNA products, thereby
excluding the amplification of genomic DNA. The PCR reaction conditions
were 95 1C for 10min, followed by 40 cycles of 95 1C for 10 s, 62 1C for 10 s
and 72 1C for 15 s.
Western blot analysis
Cells were lysed in RIPA buffer in the presence of protease and phosphatase
inhibitor cocktail from Roche. A measure of 10mg total protein was separated
on 10% SDS-polyacrylamide gel electrophoresis and electrotransferred to a
poly(vinylidene fluoride) membrane. Transblots were washed three times in
Tris buffered saline with Tween-20 (TBST) (50mM Tris-base, 150mM NaCl,
0.01% Tween-20, pH 7.6) before blocking with 5% skimmed milk in TBST for
1 h. Primary antibodies diluted in 5% bovine serum albumin TBST and
incubated with the membranes overnight at 4 1C with gentle agitation.
Following incubation with primary antibodies, membranes were washed three
times with TBST. Protein detection was carried out by incubating blots with
respective HRP-conjugated secondary antibodies (1:5000) for 1 h. Molecular
weights were calibrated in proportion to the running distance of Precision Plus
dual colour protein standards from Bio-Rad (Richmond, CA, USA). The
immunodetected bands were visualized on Kodak film using an ECL system
from Pierce, Thermofischer Scientific.
Immunofluorescence microscopy
BALB/c derived BM-DM were cultured on glass coverslips in 24-well tissue
culture plates overnight, followed by stimulation with poly(I:C) or R848 or
both. After the indicated time points, cells were fixed in 4% paraformaldehyde
in phosphate-buffered saline for 15min, then permeabilized with 5% bovine
serum albumin/phosphate-buffered saline with 0.1% Triton X-100 for 15min.
Cells were then stained with rabbit anti-phospho-ERK (1:250) and mouse anti-
total ERK (1:250) followed by Alexa Fluor-488 secondary goat anti-rabbit
(1:500) and Alexa Fluor-546 secondary donkey anti-mouse (1:500). Nuclei
were stained with 40-6-diamidino-2-phenylindole in ProLong Gold antifade
reagent. Images were obtained on a Carl Zeiss LSM 510 Meta microscope.
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Multiple PAMP4-induced TLR-pathway crosstalk provokes proinflammatory cytokine synergy 
in macrophages, which is important for pathogen resistance and immune homeostasis. But the 
detailed mechanisms are unclear. Here, we demonstrate viral RNA-analogue induced 
transcription synergy of Il6 and Il12b via IRF1 (TLR3-TRIF-responsive), C/EBP! (TLR7-
MyD88-responsive) and JunB (all-responsive). Co-activation of TLR3 and TLR7 pathways 
synchronizes the interaction of IRF1, JunB and C/EBP! with the Il6 and Il12b promoters, 
facilitating maximal gene expression. MyD88 pathway-activation suppresses TRIF-induced 
IRF1 in a delayed mode, thus controlling the magnitude and timing of cytokine expression. 
Our findings provide novel mechanisms of cooperation of different TLR pathways to achieve 
optimal immune responses, with potentials for immunomodulatory strategies. 
 
 




Tissue-resident macrophages are deployed in frontline immunity, providing 
surveillance on invading pathogens. Macrophages use TLRs as central sensors of pathogens 
(1) to recognize pathogen-associated molecular patterns (PAMPs) unique to the microbes, for 
example, viral single-stranded (ss) and double-stranded (ds) RNAs. Activated resident 
macrophages produce cytokines to recruit and communicate with other immune cells. 
Effective and coordinated cytokine production contributes to elimination of the infectious 
agents, builds up memory and repairs tissues without compromising homeostasis. Any 
imbalance or imprecision in cytokine production could either reduce resistance to pathogen 
infection or cause a fatal cytokine storm and chronic inflammatory diseases (2-4).  
Production of cytokines induced by PAMP-activated TLRs mainly occur through the 
recruitment of two adaptors, MyD88 and TRIF (5). MyD88, used by all TLRs except TLR3, 
activates NF!B, which is a core transcription factor (TF) for pro-inflammatory cytokines. In 
contrast, TRIF, the adaptor for TLR3 and TLR4 (1), activates interferon regulatory factor 3 
(IRF3), a master transcription controller of antiviral responses. In addition, both MyD88 and 
TRIF activate MAPK pathway (6). Invading pathogens are likely to interact with multiple 
TLRs and the magnitude and timing of cytokine production, which determines the quality of 
immune response, are dependent on the coordinated sum of the signals induced by these 
different TLRs. Co-stimulation with MyD88- and TRIF-activating TLR ligands has been 
observed to synergize cytokine production in innate immune cells (7-9), indicating crosstalk 
between MyD88 and TRIF pathways. By co-stimulation of mouse macrophages with R848 
(R) (an ssRNA analogue, recognized by TLR7) and poly(I:C) (I) (a dsRNA analogue, 
recognized by TLR3), we demonstrate that TLR3-TRIF and TLR7-MyD88 pathways 
!""
collaborate to induce synergistic and timely expression of pro-inflammatory cytokines through 
coordinated actions of transcription factors JunB, C/EBP! and IRF1.  
!""
 
Materials and Methods 
All experiments were carried out in compliance with the Institutional Animal Care and Use 
guidelines (IACUC Protocol Ref: 049/11). 
 
Reagents and assays  
QuantiGene plex 2.0 (Affymetrix) was used to profile cytokine expressions in murine BMDM. 
TaqMan Gene Expression Assays (Life Technologies) Mm00446190_m1, Mm00434174_m1, 
and Mm00446968_m1 were used for quantifying expression of Il6 and Il12b relative to Hprt. 
In knockdown experiments, IL6 and IL12p40 were measured using ELISA kits (BD 
OptEIA™). Scramble control or ON-TARGETplus SMARTpool siRNA (Darmacon) against 
mouse Junb, Irf1 or/and Cebpb (at 50 nM each), were transfected into J774 macrophages 
using X-tremeGENE HP DNA Transfection Reagent (Roche). Antibody against JunB (sc73), 
RelB (sc226), IRF1 (sc640), IRF8 (sc6058) and GAPDH (sc32233) are from Santacruz; RelA 
(ab7970), TBP (ab818) and IRF3 (ab25950) from Abcam; C/EBP beta (MA1-827) from 
Thermo; NF!B p50 (14-6732-63) and cREL (14-6111-82) from eBiosciences. 
 
Macrophages and stimulations  
BMDM was isolated as described previously (10). Isolated BMDM or mouse macrophage 
J774 cell line were cultured and stimulated singly with 10 µg/ml of poly(I:C) (I) or 25 ng/ml 
of R848 (R), or simultaneously co-stimulated (IR) as described previously (9).  
 
Chromatin binding protein extraction and iTRAQ analysis 
Chromatin binding proteins were purified and analyzed by iTRAQ (11).  
 
!""
Nuclear extract (NE), promoter cloning and 3'-end biotin labeling, and pull down assay 
Details of Il6 and Il12b promoter cloning and 3’-end biotin labeling are described in the 
legend to supplemental figure 2A. NE was prepared from J774 treated with I, R or IR for 5 h 
as described previously(12) with modification (pelleting nuclei by a 14,000 !g pulse spin for 
15s). 100 fmol Biotin labeled promoters were incubated with 25 µg NE in 100 µl binding 
mixture of 10 mM Tris-HCl, pH 7.5, 50 mM KCl, 1 mM DTT, 12.5 % glycerol, 0.05 % NP-
40, 5 µg polydI:dC (Sigma) at 25 °C for 25-30 min. Biotin labeled promoters were then pulled 
down from the binding mixture with streptavidin-conjugated magnetic Dynabeads M-280 




Co-stimulation of TLR7 and TLR3 induces transcriptional synergy of Il6 and Il12b. 
 
To investigate whether cytokine synergy is a prevalent event in the activated 
macrophages (9), we compared the fold synergy of macrophage-specific major chemokines 
and cytokines, in mouse BMDM. Fold-synergy was evaluated as described in the legend to 
figure 1. Proinflammatory cytokines (Il6 and Il12b) and anti-inflammatory Il10, elicited the 
highest synergy of >5-fold (Figure 1). This study focused on proinflammatory cytokines. The 
synergistic expression of Il6 and Il12b is neither attributable to chromatin remodeling (Figure 
S1A) nor to enhanced mRNA stability (Figure S1B), indicating elevated transcriptional 
activity under co-stimulation.  
 
Proteomic analysis revealed potential synergy factors 
Next, we searched for newly synthesized/activated TFs, which may play a role in the 
observed synergy. We compared the profiles of chromatin binding proteins from differently 
stimulated macrophages on the basis that transcriptional synergy might be facilitated by the 
collaboration of R-induced and I-induced TFs, or by co-stimulation (IR)-activated TFs. J774, 
which exhibits synergy consistent with that of primary BMDM (Figure S1C), was used for 
this study. iTRAQ (13) analysis of chromatin binding proteins from two biological replicates, 
identified proteomes of ~1100 proteins with false discovery rates of <1%. As anticipated, the 
majority is nucleic acid binding proteins and TFs (Figure S1D). The enriched functional 
clusters within the proteins perturbed were sorted (Figure S1E, F). Interestingly, the GO 
(gene ontology) functional annotation cluster of the “regulation of transcription” was enriched 
in the proteins upregulated by 5 h co-stimulation but not other treatments. We listed the IR5 
!""
upregulated proteins from the “regulation of transcription” cluster and their iTRAQ ratios 
under different treatments in Table 1, with potential synergy factors earmarked. C/EBP! and 
NF"B-p105 were more responsive to R stimulation, while interferon activated protein 204 
(Ifi204) responded to I only. JunB and ATF3 are more upregulated after co-stimulation than 
single stimulation, indicating synergistic actions of two distinct pathways. As a negative 
regulator of cytokines (14), ATF3 was not further studied here. Being relatively 
uncharacterized, Ifi204 was also excluded. Western blot of NF!Bp105, JunB and C/EBP! 
(Figure S1G, H) validated their changes in expression detected by iTRAQ, and they are 
shortlisted as potential synergy factors. 
 
JunB, C/EBP!  and IRF1 are the core interaction partners of Il6 and Il12b promoters  
 
By promoter affinity pulldown of nuclear extracts, we examined the direct or indirect 
involvement of TFs in the regulation of Il6 and Il12b transcription. Candidates shortlisted by 
iTRAQ and other low abundance cytokine regulatory factors, which might have been missed 
in iTRAQ analysis, were analyzed. In total, we examined: (1) JunB, (2) C/EBP!, (3) NF"B 
family members (RelA, RelB and c-Rel, NF"Bp50), and (4) IRF1, IRF3, and IRF8, that are 
known to be downstream of the TRIF signaling pathway and are involved in the production of 
type I interferon. We observed consistent association of JunB, IRF1 and C/EBP! to both Il6 
and Il12b promoters (Figure 2A), compared to controls (Figure S2A). The intensities of the 
detection signal appeared roughly proportional to their respective levels in the nuclear extract, 
suggesting that these TFs associate with the respective promoter independently of each other. 
Notably, the dominant upper band of JunB was dose-dependently sensitive to phosphatase 
treatment (Figure S2B), indicating that JunB was extensively phosphorylated upon induction. 
Surprisingly, Rel proteins were not significantly associated with either Il12b or Il6 promoter, 
!""
although NF!B is functionally important for pro-inflammatory responses, and there is a 
characterized !B binding element in Il12b (15) and Il6 promoters (16). 
 
Co-stimulation synchronizes the activation of C/EBP!, IRF1 and JunB. 
The IRF1 and C/EBP" were strongly induced by I and R, respectively (see nuclear 
extracts, Figure 2), and no additive effect was observed with co-stimulation by IR. This 
suggests that IRF1 and C/EBP" are separately regulated under TRIF- and MyD88- signaling 
pathways, respectively. In contrast, JunB expression, which was induced weakly by I but 
strongly by R, was substantially higher in co-stimulation.  
Next, we examined the dynamic profile of IRF1, C/EBP" and JunB under different 
treatments (Figure 3). C/EBP" responded mainly to R stimulation. IRF1 was upregulated and 
sustained by I, but transiently (1 h) upregulated by R, likely due to the rapid primary activation 
of NF!B, which is known to be required for IRF1 expression (17). However, R-induced 
MyD88 pathway activation apparently represses the I-induced expression of IRF1 in a delayed 
mode. The IRF1 returned to a low basal level at 12 h post co-stimulation, correlating with 
subdued cytokine gene transcriptions. In contrast, JunB was rapidly upregulated within 1 h, by 
all stimulations. Notably, over 4-8 h, R induced a stronger JunB response than I. By 12 h, both 
I and R induced comparable levels of JunB, indicating equally limited potentials in single 
stimulations. Nevertheless, in co-stimulated macrophages, JunB expression was sustained and 
accumulated over 8-24 h. Taken together, the coincidence of the levels of IRF1, C/EBP" and 
JunB in the 4-12 h post-combinatorial stimulation and the obvious correlation with the mRNA 




TRIF- and MyD88- signaling pathways collaborate to synergize IL6 and IL12p40 
expression through synchronized IRF1 and C/EBP!  activities 
 
 The functional cooperation between TRIF-responsive IRF1 and MyD88-responsive 
C/EBP! in macrophages was examined using single and double knockdown with gene-
specific siRNAs of Irf1 and Cebpb (Figure S2C). Irf1 and/or Cebp! knockdown significantly 
attenuated both the mRNA and protein levels of Il6 and Il12b in R- and IR- stimulated cells 
(Figure 4A and 4B). In I-stimulated cells, the Il6 and Il12b mRNA levels remained basal. In 
IR-stimulated cells, the effect of single knockdown was only incremental, while double 
knockdown further reduced Il6 and Il12b (IL12p40: ~50% by siIrf1+siCebpb; IL6: ~75% by 
siIrf1+siCebpb). This indicates that co-stimulation of TLR3 and TLR7 significantly induced 
expression of Il6 and Il12b, and the co-presence of a certain level of IRF1 and C/EBP! is 
necessary and sufficient for the optimal transcription of Il6 and Il12b. 
 
TRIF- and MyD88- signaling pathways collaborate to synergize cytokine expression 
through enhancing JunB production and synchronizing IRF-JunB activation. 
 
To functionally characterize JunB-mediated regulation of expression of Il6 and Il12b 
and its potential cooperation with IRF1, we knocked down Junb alone or both Junb and Irf1 
(Figure S2D). Significant reduction in R- or IR- induced Il6 and Il12b was observed in Junb 
knockdown cells (Figure 5A and 5B) at both the mRNA and protein levels. With I-
stimulation, both Il6 or Il12b mRNAs remained extremely low, similar to non-treated cells 
(Figure 4A and 4B), thus the impact of JunB knockdown on I-induced cytokine expression 
was not further assessed. The drastic difference in the induction of cytokines between single 
and co-stimulation, compared to the smaller difference caused by Junb knockdown, clearly 
indicates the involvement of additional critical cofactors induced by TRIF-pathway, which is 
necessary for the synergistic transactivation of Il6 and Il12b. This is supported by the double 
!!""
knockdown of Junb and Irf1, which yielded more pronounced attenuation of Il6 and Il12b 
(IL12p40: ~75% by siJunb+siIrf1; IL6: ~80% by siIrf1+siJunb) at both mRNA and protein 
levels (Figure 5A and 5B) compared to single knockdown. Thus co-stimulation mediated 
enhancement of JunB itself promoted cytokine expression and at the same time, Junb 
collaborates with TRIF-responsive IRF1 to augment cytokine production.  
Taken together, R strongly upregulates and sustains MyD88-responsive JunB and 
C/EBP! but R only transiently activates IRF1, resulting in mild transcription activation of Il6 
and Il12b. In contrast, I induces a high level of TRIF-responsive IRF1 but only minimally of 
JunB and C/EBP!. On its own, IRF1 appeared insufficient to drive the basal transcription. 
However, co-stimulation synchronized the activation of IRF1, JunB and C/EBP! for up to 8-




Thus far, the precise molecular mechanisms governing the expression of individual 
cytokine genes are only poorly investigated, although NF!B, AP1 and/or IRFs activities are 
known to be involved. Also, how cytokine synergy is induced by TRIF- and MyD88- coupled 
TLR signaling pathways remains unknown. Our findings demonstrated that the TRIF- and 
MyD88- signaling pathways synergize directly at the transcription of Il6 and Il12b, although 
the activation of NF-!B members and chromatin remodeling appeared redundantly or 
additively induced by PAMP stimulations. Of particular significance is our identification of 
the critical active core transcription complex of Il6 and Il12b - IRF1, C/EBP"  and JunB. 
IRF1 and C/EBP" are respectively responsive to TLR3/TRIF- and TLR7/MyD88-activation, 
while JunB is responsive to both TLR3/TRIF- and TLR7/MyD88- activation, but 
preferentially more responsive to and sustained by TLR7-MyD88 signaling, and enhanced by 
co-stimulation. siRNA knockdown further demonstrated that all these TFs are crucial for 
optimal transcription of Il6 and Il12b. Thus, we propose that TLR3/TRIF- and TLR7/MyD88- 
signaling pathways synergize the transcription of Il6 and Il12b through contributing distinct 
newly synthesized TFs as the core components of optimal transcriptional complexes (Figure 
S2E). However, we cannot preclude other yet to be defined “transcriptional synergy factors” 
(X), which may be the products of cooperation of distinct pathways in co-stimulation (18). 
Thus, both mechanisms (1. TLR3/TRIF and TLR7/MyD88 each contribute newly synthesized 
TFs to cooperate in cytokine regulation, or 2. TLR3/TRIF and TLR7/MyD88 cooperate to 
produce a new transcription factor which is not present under single stimulation but has a 
regulatory role on cytokine production) could participate in a network to regulate Il6 and Il12b 
expression in vivo.  
!"##
While IRF1 is known to be strongly induced in macrophages by IFN-!, the detailed 
functional role and the mechanisms of IRF1 in regulating immune responses are poorly 
understood (19). IRF1 plays a major role in the transcriptional regulation of the Il12a but not 
Il12b (20), although an IRF1-binding element was characterized in the Il12b promoter (21). 
Current investigation revealed that IRF1 is the principle TF induced by the TLR3-TRIF 
signaling pathway and it binds both Il6 and Il12b promoters. As IRF1 has not been reported to 
bind mouse Il6 promoter before, we employed EMSA and identified a 142 bp region (-344 to -
203) in the mouse Il6 promoter to bind IRF1 (Figure S2F, G). Binding of JunB and C/EBP" to 
both the mouse Il6 and Il12b promoters has been reported previously (22-24). An earlier 
investigation using Il12b-promoter reporter assay demonstrated the cooperation between AP1-
binding site and the adjacent C/EBPs-binding site (24). However, we found that IRF1 is 
required to achieve optimal transcription of both Il6 and Il12b. Surprisingly, we did not detect 
significant association of the well-recognized master regulator, NF#B, to either Il6 or Il12b 
promoter. Plausibly, as a primary response regulator, NF#B members function at the outset of 
the assembly of pre-initiation transcriptional complex for Il6 and Il12b (14). The promoter-
binding of NF#B could be transient and highly dynamic, and thus not captured by pulldown.  
In summary, we show, for the first time that the pro-inflammatory cytokine genes, Il6 
and Il12b, share a similar core configuration of transcriptional complex (including IRF1, 
C/EBP" and JunB), which facilitates an optimal and timely expression of IL6 and IL12p40 in 
macrophages, to precisely respond to viral signals of infection. The delayed inhibition of IRF1 
expression by TLR7-MyD88 signaling correlates with the progressive waning of Il6 and Il12b 
transcription. Thus, the crosstalk of TLR3-TRIF and TLR-MyD88 signaling pathways 
probably controls the timing and magnitude of IL6 and IL12p40 production, through down-
regulating IRF1, a critical event that warrants future investigation. A comparison of Il6 and 
!"##
Il12b transcriptional proteome would provide information on additional regulatory factors, 
specific to either Il6 or Il12b or both, which are anticipated to exist in vivo. These factors could 
fine-tune the regulation leading to specific outcome of each cytokine expression. Such insights 
on how cytokine synergy is orchestrated will help us develop novel strategies to resolve 
immune over-activation and regain homeostasis. Furthermore, knowledge on cytokine synergy 
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Figure 1. Transcriptional synergy of Il6 and Il12b under TLR7-TLR3 co-stimulation. 
BMDMs were treated with I and/or R for 8 h followed by QuantiGene analysis. Fold-synergy 
was obtained by:
! 
Fold synergy = mRNA induced by IRmRNA induced by I + mRNA induced by R . 
Proinflammatory cytokine genes with fold synergy above 5 (red line), eg, Il6 and Il12b (red 
box) were further studied.  
 
Figure 2. C/EBP! , IRF1 and JunB bind to Il6 and Il12b promoter. Cells were stimulated 
with I, R or IR for 5 h followed by nuclear extraction. Control cells were non-treated (NT). 
Biotin labeled Il6 and Il12b promoters were separately incubated with nuclear extracts to 
pulldown transcription factors. Pulldown samples were then subjected to Western blot 
analysis. The data shown are representative of three independent experiments.  
 
Figure 3. Co-stimulation synchronizes C/EBP!, IRF1 and JunB. J774 cells were 
stimulated with I, R, IR or non-treated control (NT), for 5, 30 min, 1, 4, 8, 12, 24 h. Whole 
cell lysates were collected to check the dynamic profiles of C/EBP!, JunB and IRF1 by 
Western blot immunodetection using the respective antibodies. The detected protein bands 
were densitometrically quantified relative to GAPDH. The data are representative of three 
independent experiments.  
 
Figure 4. IRF1 and C/EBP!  collaborate to synergize IL6 and IL12p40 production. J774 
cells were transfected with sequence-specific siRNA targeting Irf1 or Cebpb, singly or doubly, 
or transfected with a non-targeting scramble siRNA control for 24 h. Cells were then 
!"##
stimulated with I, R, IR or no treatment (NT) for: (A) 8 h to test for cytokine mRNA or (B) 12 
h to measure cytokine protein. Data are presented as means ± SEM of three independent 
experiments. * P <0.05, ** P < 0.01 (two tail student’s t-test). 
 
Figure 5. IRF1 and JunB collaborate to synergize IL6 and IL12p40 production. J774 
cells were transfected with sequence-specific siRNA targeting Irf1 or Junb singly or doubly or 
transfected with a non-targeting scramble siRNA control for 24 h. Cells were then stimulated 
with I, R, IR or no stimulation (NT) for: (A) 8 h to test for cytokine mRNA or (B) 12 h to 
measure cytokine protein. Data are presented as means ± SEM of three independent 
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Toll-like receptor (TLR) pathways recognize pathogen-associated molecular patterns (PAMPs) and 
trigger innate immune response by producing cytokines. The innate immune response is highly 
dependent on the timing of encountering PAMPS, suggestive of a short-term ‘memory’ that primes 
the cell for enhanced/modified immune response once it has been triggered by a first stimulus. In 
particular, TLR3 activation appears to prime macrophages for a subsequent TLR7 activation, leading 
to synergistic production of cytokines. However, the detailed mechanism governing this synergy is 
unclear. Here, by developing the first calibrated mathematical model for the kinetics of TLR3 and 
TLR7 pathways and their crosstalk, followed by experimental validation, we demonstrate the 
involvement of JAK-STAT pathway in controlling the induction of cytokine synergy. This pathway 
plays a dual role: it mediates cytokine synergy thus boosting the immune response, while maintaining 
homeostasis to avoid excessive inflammatory response. Thus our results suggest a ‘cytokine rheostat’ 
mechanism regulated by the JAK-STAT1 pathway, which enables macrophages to fine tune their 
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As front-line innate immune defense cells, macrophages distinguish foreign microbial organisms by 
recognizing their unique structures known as pathogen-associated molecular patterns, PAMPs (Gubler 
et al, 1984). PAMPS are recognized by pattern recognition receptors (PRRs) on host cells, which 
signal the onset of the immune response. Toll-like receptors (TLRs) are the best characterized PRRs. 
They are evolutionarily conserved type I transmembrane proteins that are localized on the cell surface 
as well as the membranes of intracellular vesicles such as endosomes, lysosomes and endolysosomes 
(Takeuchi & Akira, 2010); (Kawai & Akira, 2010). TLR signaling triggers different biological 
responses depending on the adaptor proteins involved, e.g. myeloid differentiation primary-response 
gene 88 (MyD88) and/or TIR-domain-containing adapter-inducing interferon-! (TRIF). MyD88 is 
recruited by all the TLRs except TLR3, and it activates NF-"B and mitogen-activated protein kinases 
(MAPKs) to produce mainly inflammatory cytokines. On the other hand, TRIF is exclusively 
recruited by TLR3 and TLR4 to activate interferon regulatory factor (IRF) family members and NF-
"B, which then leads to the induction of type I interferons (IFNs) as well as inflammatory cytokines 
(Takeuchi & Akira, 2010).  
As the ‘lingua franca’ used by both innate and adaptive immune cells, cytokines exert various 
local and distal effects including the recruitment and activation of leukocytes. The invading pathogens 
often contain multiple PAMPs and hence it is highly likely that they interact with various TLRs 
simultaneously or at different stages of the infection (Tan et al, 2014). It has been reported that 
combinatorial TLR activations can alter the levels of cytokine production, and in some cases, induce 
synergistic levels of cytokines (Bagchi et al, 2007; Bohnenkamp et al, 2007; De Nardo et al, 2009; 
Krummen et al, 2010; Makela et al, 2009; Napolitani et al, 2005; Zhou et al, 2007). The magnitude 
and timing of cytokine production by the innate immune cells significantly affect subsequent events. 
Deficient or excessive cytokine production may either cause an ineffective immune protection or 
disrupt immune homeostasis. It is therefore crucial to understand how the TLR pathways 
communicate with each other to modulate the levels of cytokines, which may otherwise manifest in 
disorders such as acute and chronic inflammation.  
Recent evidence indicated that synergistic production of cytokines depends on the order and 
timing of TLR stimulations. Specifically, the activation of TRIF followed by the activation of MyD88 
pathways in macrophages generates a significantly stronger immune response compared to that 
triggered when the reverse order of the two activations (Tan et al, 2013; Zhou et al, 2007; Zhu et al, 
2008). This observation suggests that the activation of the TRIF pathway could create a certain short-
term innate immune ‘memory’ which could prime the cell for enhanced response to a subsequent 
PAMP challenge. However, the mechanistic basis of this immune memory is unclear. It is also 
uncertain how host cells restore homeostasis after the cytokine ‘storm’ resulting from combinatorial 
!""
stimulations. Therefore, there is a need for a systems-level understanding of the time-dependent 
mechanism of crosstalk between TLR signaling pathways. 
Previous efforts using systemic approaches for studying TLR networks (see a recent review, 
(Vandenbon et al, 2012)) made it possible to construct a comprehensive map of the TLR signaling 
network using existing data in the literature (Oda & Kitano, 2006). However, this provided a static 
visualization of the protein-protein interaction network implicated in TLR signaling. To assess the 
dynamics of this network, the TLR map has been reformulated to enable a steady-state based flux 
balance analysis (Li et al, 2009). However, the lack of detailed information on the reaction kinetics 
hindered the use of the map for further quantitative studies. Earlier efforts on quantitative modeling of 
specific TLR pathways have focused on the TLR3 (Helmy et al, 2009) and TLR4 pathways, with 
special emphasis on the NF-!B signaling module (Basak et al, 2007; Cheong et al, 2008; Covert et al, 
2005; Gutierrez et al, 2010; Litvak et al, 2009; Selvarajoo et al, 2008; Shih et al, 2009; Werner et al, 
2005). While these models elucidated various aspects of TLR signaling, their utilities have been  
limited by the over-simplification by imposing linear dynamics (Helmy et al, 2009; Selvarajoo et al, 
2008), the lack of model calibration (Gutierrez et al, 2010), or the exclusion of key interactions such 
as the AP-1 activation branch and cytokine production (Basak et al, 2007; Cheong et al, 2008; Covert 
et al, 2005; Litvak et al, 2009; Shih et al, 2009; Werner et al, 2005). More importantly, none of these 
models took into account of the dynamic crosstalk between the different TLR pathways, which 
appears to be crucial for understanding the regulation of cytokine synergy. 
Here, we focus on the interplay between the TLR3 and TLR7 pathways towards uncovering the 
main mechanisms responsible for the creation of an immune system memory and synergistic 
production of cytokines while maintaining homeostasis. An important first step towards this goal is 
the construction of a computational model containing the necessary components and the 
determination of the model parameters.  To this aim we used both existing data in the literature and 
new data from our own experiments, and determined the unknown parameters by an optimal fit to 136 
data points used for model training via a statistical logic-based computing framework that we 
developed recently (Palaniappan et al, 2013). The calibrated model was verified to reproduce the 
dependence of the synergistic production of cytokines on the time interval and order of stimuli. For 
example, an 8 h time lag between TLR3 and TLR7 activations would lead to maximal synergy. The 
same model was further observed to successfully reproduce 30 additional data points reserved for 
model testing. Having established the model and parameters, we proceeded to a sensitivity analysis 
which pointed to the crucial role of type I IFN, MAPK and STAT pathways in regulating cytokine 
synergy. Simulations with different sequential orders and time intervals of stimuli further showed that 
the production of type I IFN is mainly due to TLR3 activation, which explained the order-dependency 
of cytokine production. Both in silico simulations and experimental analyses consistently revealed the 
distinct roles of MAPKs in regulating cytokine production. In particular, JNK was found to upregulate 
cytokine synergy, while ERK and p38 would mainly downregulate the synergy, possibly through an 
!""
anti-inflammatory cytokine, IL-10.  Among the possible crosstalk mechanisms, we determined that 
JAK-STAT pathway was responsible for time-dependent synergy of antiviral immune response. We 
also found that cytokine response to STAT1 was biphasic due to the dual opposing effects of STAT1 
on cytokine production and the ensuing formation of an incoherent feed-forward loop (I1-FFL; a 
network motif noted by (Hart & Alon, 2013)). STAT1 appears to be indispensable for creating an 
immune memory that may boost the cytokine levels and even lead to a cytokine ‘storm’ in response to 
a succeeding PAMP challenge; while it also helps restore homeostasis by downregulating cytokine 






Cytokine synergy is dependent on the order of TLR3 and TLR7 activations, and on the 
intervening time between the two stimuli. 
Combinatorial activations of TLR3 and TLR7 by a simultaneous challenge with their respective 
ligands, poly(I:C) (double-stranded RNA analogue) and R848 (single-stranded RNA analogue) (Zhou 
et al, 2007), can lead to significant upregulation of the proinflammatory cytokine genes e.g. 
interleukin-6 gene (Il6) and interleukin-12 gene (Il12b) (Liu et al; Zhou et al, 2007). To understand 
the underlying mechanism, we first examined the time-dependent expression profiles of Il6 and Il12b 
transcripts after poly (I:C) (denoted as I) and R848 (denoted as R) treatments (Figure 1A). To this 
end, bone marrow derived macrophages (BMDMs) were treated with both I and R, but in different 
orders (1st PAMP (I) followed by 2nd (R) or vice versa) and with different time intervals (!t = 0, 8 and 
24 h) between the two treatments. Cells were collected for real time quantitative PCR analysis at 4, 8, 
16 or 24 h after the second PAMP stimulation. For example, in the case of I followed by R, the cells 
were first treated with poly (I:C) for 0, 8 or 24 h, and then with R848 for another 4, 8, 16 or 24 h. The 
control for combinatorial stimulation was single stimulation with either I or R.  
Cytokine expression was observed to be upregulated after combinatorial stimulation regardless of 
the time intervals and sequence of the two PAMP treatments (Figure 1B). However, the upregulation 
was significantly more pronounced when cells were treated with I first followed by R rather than the 
converse regime, indicating that the treatment order had a significant effect on cytokine synergy 
(Figure 1B). Furthermore, different time intervals between I and R treatments also affected the level 
of synergy: in particular a pretreatment of 8 hours with I elicited the strongest cytokine synergy in 
response to the 2nd treatment (by R) (Figure 1B upper left and C). 
  
Kinetic model for TLR3 and TLR7 signaling network 
In order to understand the potential mechanisms governing the cytokine synergy observed under 
combinatorial stimulations, we built a computational model that includes known signaling cascades as 
well as the interactions potentially enabling the crosstalk between the TLR3 and TLR7 pathways 
(Figure 2). Here we briefly depict the main features of the TLR3 and TLR7 pathways followed by a 
description of the potential crosstalk mechanisms. Supplementary Table S1 lists all acronyms used 
below, as well as the initial concentrations adopted in our simulations. 
 
TLR3 pathway. In our model, the TLR3 signaling (Takeuchi & Akira, 2010) is initiated by the 
sensing of poly(I:C) by TLR3. This in turn activates the adaptor protein, TRIF, which then recruits 
TRAF6, TRADD, FADD and RIP1 to form a multi-protein complex. The latter activates the TAK1 
complex, which, in turn, simultaneously activates the IKK complex and the MAPKs (i.e. ERK, p38 
!""
and JNK), which drive the translocation of NF-!B to the nucleus and the activation of AP-1 
transcription factor, respectively, to end up inducing the transcription and translation of inflammatory 
cytokines. Simultaneously, the TRIF-dependent pathway also activates the interferon-regulatory 
factor IRF3 via a TRAF3-dependent pathway, which leads to subsequent type I IFN production. In 
summary, TLR3 induces antiviral immune response by promoting the production of type I IFNs 
predominantly, and cytokines (e.g. IL-6 and IL-12) to a lesser extent. 
 
TLR7 pathway. In contrast to the TLR3 pathway, the TLR7 pathway is initiated by the sensing of 
R848 (Kawai & Akira, 2010; Takeuchi & Akira, 2010). The activated TLR7 in turn activates MyD88, 
which recruits and activates the IL-1 receptor associated kinases, IRAK4, IRAK1, IRAK2 and IRAK-
M. The activated IRAK complex interacts with TRAF6 and activates the TAK1 complex. At this 
point, the TLR3 and TLR7 pathways merge, leading to the above mentioned activation of AP-1 and 
NF-!B and production of cytokines. These constitute the predominant signaling events in the TLR7 
pathway. To a lesser extent, the TLR7 pathway also activates the transcription factor IRF7, which 
then translocates into the nucleus and promotes the production of type I IFNs.  
 
Potential crosstalk mechanisms. Our data in Figure 1B show that R848-stimulated TLR7-MyD88 
pathway induces cytokine production mildly. Also, the poly(I:C)-stimulated-TLR3-TRIF pathway 
alone produces only marginal levels of cytokines, but it greatly enhanced TLR7-MyD88 induced 
cytokine expression, indicating that downstream components activated specifically by TLR3-TRIF 
might cooperatively interact with TLR7-MyD88 pathway (Tan et al, 2013) to boost cytokine 
expression.  
The key downstream events in TLR3-TRIF pathway which distinguish it from the MyD88 
pathway are the activation of IRF3 and the associated production of type I IFN (Doyle et al, 2002; 
Kawai & Akira, 2010) (Figure 2). Our model includes the following IRF3- and type I IFN-mediated 
mechanisms: (i) Activated IRF3 is known to bind to NF-!B and AP-1 to form an enhanceosome in the 
nucleus (Oeckinghaus et al, 2011) to boost the transcription of Il6 and Il12b. In addition, IRF3 can 
bind to the Interferon-Stimulated Response Element (ISRE) of the gene promoter and induce cytokine 
regulatory genes (Doyle et al, 2002). (ii) Secreted type I IFNs are recognized by the interferon-
associated receptors 1 and 2, IFNAR1 and IFNAR2 on the cell surface, which, in turn, activate the 
Janus activated kinases (JAKs) tyrosine kinase 2 (TYK2) and JAK1. Activation of JAKs leads to the 
tyrosine phosphorylation of STAT2 and STAT1, inducing the formation of the STAT1–STAT2–IRF9 
complex, also known as ISGF3 (IFN-stimulated gene factor 3) complex. This complex translocates to 
the nucleus and initiates the transcription of genes at the ISREs. Genes activated by ISGF3, such as 
IRF1, might be involved in cytokine synergy (Platanias, 2005). (iii) Secreted type I IFN can also 
activate NF-!B p52 through NF-!B inducing kinase (NIK) and the tumor necrosis factor receptor-
associated factor-2 (TRAF2), which may regulate cytokine expression (Yang et al, 2005). (iv) Type I 
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IFN in the nucleus can also activate PI3K-AKT pathway, leading to the activation of NF-!B (Yang et 
al, 2001). (v) We also modeled the anti-inflammatory cytokine, IL-10-mediated feedback. Activated 
ERK and p38 phosphorylate mitogen- and stress- activated protein kinase-1/2 (MSK1/2), which 
promotes the transcription of Il10 (Newton & Dixit, 2012). STAT1 target genes may also upregulate 
Il10 expression (Pattison et al, 2012). Secreted IL-10 then inhibits proinflammatory cytokine 
production via a JAK-STAT3-dependent pathway (Murray, 2006).   
The reaction network of our model is summarized in Figure S1 and the corresponding set of 
kinetic equations (ODEs) is presented in Text S1. Protein associations, degradations and 
translocations are described by mass-action kinetics while activation and inhibition reactions were 
modeled with Michaelis-Menten kinetics. Gene transcription was modeled using the equation 
proposed by (Kuttykrishnan et al, 2010). The resulting mathematical model consists of 97 molecules 
or molecular complexes, 126 reactions and 143 parameters. The parameter selection and evaluation is 
described next. 
 
The descriptive and predictive powers of the calibrated model 
The values of 27 rate constants for the reactions associated with the NF-!B pathway were adopted 
from the literature (Lipniacki et al, 2004). To estimate the remaining 116 unknown parameters, we 
utilized our experimental data on the time courses of Il6 and Il12b mRNAs (Figure 1B) measured 
under the following conditions: (1) single poly(I:C) stimulation (I), (2) single R848 stimulation (R), 
(3) simultaneous poly(I:C) and R848 stimulation (IR), (4) poly(I:C) stimulation followed by R848 
stimulation with an 8-hour interval between the two treatments (I8R), (5) poly(I:C) stimulation 
followed by R848 stimulation with a 24-hour interval (I24R), (6) R848 stimulation followed by poly 
(I:C) stimulation with an 8-hour interval (R8I), and (7) R848 stimulation followed by poly (I:C) 
stimulation after an 24-hour interval (R24I). The expression levels of Il6 and Il12b were measured at 
10 time points (0, 4, 8, 12, 16, 24, 28, 32, 40, 48 h) under conditions of R or I single treatment, and at 
4 h, 8 h, 16 h and 24 h after second stimulation (IR, I8R, I24R, R8I and R24I). In addition to these 
newly generated data, we also used our published data (Tan et al, 2013) on the expression levels of 
several major players in cytokine regulation, including phosphorylated ERK, p38, JNK and I!B". 
The concentrations of these signaling molecules were measured at 7 time points (5, 15, 30 min, 1, 4, 8, 
12 h) under the conditions of R, I, IR, I8R and I24R. We reserved the Il6 and Il12b time course under 
I24R, R8I, and R24I conditions as the test dataset and used the remaining data to train/calibrate the 
model parameters (unknown rate constants) by using a statistical logic-based framework developed 
recently (Palaniappan et al, 2013) (see Materials and Methods). The initial concentrations of proteins 
were allowed to vary 5% around their nominal values in order to account for cellular heterogeneities. 
The resulting kinetic parameters are shown in Supplementary Table S2.  
!""
Figure 3A shows the profiles generated by our simulations using the optimized set of parameters 
(blue curves) in comparison to experimental data (red dots). The simulation curves broadly capture 
the experimentally observed qualitative trends and reproduce the two rounds of activation behaviors 
of I!B". Figure 3B shows the comparison of the Il12b and Il6 expression data (left) with the 
simulated profiles (right) for different conditions. The model successfully reproduced the time- and 
order-dependent synergy of cytokine production and its predictions matched not only the training data 
(R, I, IR, I8R) but also the test data (I24R, R8I, R24I). Both the predicted and test data consistently 
showed early and massive surge in the cytokine expression under I8R stimulation, and a delayed and 
diminished response under I24R stimulation, which support of the significance of the timing of PAMP 
treatments. This validated model was used next to perform a variety of in silico experiments. 
 
Sensitivity analysis identified key components and reactions controlling cytokine 
synergy 
To identify the components and reactions that are essential to inducing a synergistic cytokine 
production, we conducted an extensive sensitivity analysis, using logic-based statistical model 
checking (SMC) technique (Palaniappan et al, 2013).   
We first carried out control coefficients-based sensitivity analysis for initial concentrations of 
major species in the model. The model output was defined as the integrated Il12b and Il6 expression 
in response to the five conditions (R, I, IR, I8R, I24R). The computed normalized local sensitivities 
are summarized in Figure 4A.  
The results for single stimulation conditions show that TLR7 and directly downstream 
components along TLR7 pathway are more sensitive to R stimulation than TLR3 pathway, and its 
downstream components are more sensitive to I stimulation (lower portion). TLR3-mediated cytokine 
production is mainly regulated by I!B"-NF-!B (indicated by an arrow), which exhibits high 
sensitivities under all five conditions. In contrast, AP-1, another key transcription factor that regulates 
cytokine production, is sensitive only under conditions that involve TLR7 activation (R, IR, I8R, 
I24R). MKK1/2, MKK3/6, MKK/4/7, ERK, p38, and JNK display sensitivity patterns similar to the 
downstream AP-1, suggesting that the MAPK signaling cascades (Core box in Figure S1) play 
crucial roles in coupling the upstream TLR3 and TLR7 signaling modules to the downstream 
transcription module, especially under combinatorial stimulation conditions. Although the three 
MAPK cascades (involving JNK, ERK and p38) can activate AP-1 in parallel, the components on the 
JNK signaling cascade exhibit positive sensitivities, while those of the ERK and p38 cascades show 
negative sensitivities. This draws attention to the distinct roles of JNK, ERK and p38 in regulating 
cytokine synergy. The highly negative sensitivities displayed by MSK1/2 and STAT3 suggest the 
potential importance of IL-10 induced STAT3 activation in inhibiting cytokine production and 
maintaining homeostasis. Interestingly, TYK2-JAK1 and STAT1-STAT2 had very strong controls 
over the system response while the influences of proteins on the AKT and NIK pathways were low, 
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which implies the importance of JAK-STAT1/2 pathway among all the potential crosstalk 
mechanisms.   
 We next computed the global sensitivities of the model to kinetic parameters using a multi-
parametric sensitivity analysis (MPSA) method (see details in Materials and Methods) based on our 
SMC approach. The model output is defined as integrated Il12b and Il6 expression under I8R 
stimulation. The results are presented in Figure 4B. 32 kinetic parameters (rate constants) are 
distinguished by their strong effects on cytokine production (global sensitivities > 0.1, colored blue). 
The corresponding reactions are indicated by red arrows in Figure S1. These are classified into seven 
functional groups (Figure 4C): the production of Il12b, Il6 and type I IFN, JAK-STAT1/2 signaling 
cascade, IL-10-STAT3 signaling cascade, and the three MAPK signaling cascades (ERK, p38 and 
JNK) also noted above. The two rate constants (k72 and k73) that give rise to the highest sensitivities 
are associated with the transcription and degradation of Il12b and Il6 mRNA, respectively. This is not 
surprising as these two parameters directly determine the production and level of Il12b and Il6 
mRNAs. Seven rate constants associated with reactions along the JNK pathway, which leads to the 
activation of AP-1, also exert strong controls. This result is consistent with the local sensitivity 
analysis, which suggests the dominant role of JNK pathway in activating AP-1 over the ERK and p38 
pathways. In addition, the analysis highlights the important inhibitory role of the reactions associated 
with IL-10-STAT3 pathway, compared to other inhibitory interactions in the system, such as A20 
(Figure S1). Additionally, many critical reactions are involved in type I IFN transcription and the 
activation of JAK1-STAT1/2 pathway, which can be connected by our hypothesized pathway Type I 
IFN ! STAT1/2 ! cytokines.  Thus, a crucial insight that emerges from these findings is that the 
time-dependent cytokine synergy we observed experimentally may be induced by a STAT1/2-
mediated crosstalk mechanism, in addition to the regulatory feedback of MAPK signaling cascades. 
 
The time interval between TLR3- and TLR7-stimulations influences cytokine synergy 
but not type I IFN production 
 
In addition to the crucial components and reactions we identified in the previous section, the overall 
expressions of both Il6 and Il12b genes are also highly sensitive to the time interval, !t, between the 
two PAMP treatments, as illustrated in Figure 1C. Here we simulated the model behavior by varying 
!t between TLR3 and TLR7 activations from 0 h to 48 h in order to explore the dependency of the 
immune response in the timing of combined stimulations. The predicted effects in terms of Il6 and 
Il12b expression levels are shown in Figure 5A. We calculated the peak amplitudes and peak time 
(starting from R stimulation) of each response curve in Figure 5A and plotted them as functions of !t 
(Figure 5B). With increasing !t, the peak amplitudes of Il6 and Il12b first increased until maximal 
values were reached, and then dropped. Maximal amplitudes were reached around !t = 7 h for both 
Il6 and Il12b production. This is consistent with our experimental data shown in Figure 1C, which 
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indicated that the optimal !t was 8 h (among the measurements made at concrete intervals). On the 
other hand, the duration required to reach the response peaks was robustly found to be around 4 h for 
both Il12b and Il6.  
 We also simulated the time profiles of type I IFN for different values of !t under sequential 
treatments (Figure 5C): poly(I:C) followed by R848 (I!R) (left panel), and R848 followed by 
poly(I:C) (R!I) (right panel). The effects of !t on type I IFN production is negligible in the former 
case. In contrast, for R!I stimulation, the production curve significantly shifted along with the 
starting time point of I stimulation, and maintained a constant peak amplitude.  
 Taken together, these results imply that the type I IFN production is predominantly governed by 
the application time of the first stimulus (I), or by the activation of the TLR3 signaling pathway 
(Figure 5C), whereas cytokine production is regulated by both TLR3 and TLR7 pathways or their 
crosstalk. Importantly, although type I IFN is implicated in most of the putative crosstalk pathways 
between TLR3 and TLR7 pathways, it is not sufficient per se to account for the dependency of 
cytokine production (or synergy) on the time interval, !t, between the two consecutive stimuli.  
 
In silico knockdown of MAPKs revealed the distinct effects of JNK, ERK and p38 on 
cytokine production, confirmed by experiments 
 
The sensitivity analysis presented in Figure 4 drew attention to the significant role of MAPKs in 
modulating cytokine synergy.  As shown in Figure S1, TAK1 complex activated the ERK, JNK and 
p38 signaling cascades in parallel, and either of these cascades was capable of triggering the 
activation of AP-1 and promoting the production of Il12b and Il6 mRNA. At the same time, ERK and 
p38 also induced the production of anti-inflammatory cytokine IL-10, which led to the suppression of 
IL-12p40 and IL-6 production through STAT3-dependent pathway. This forms the incoherent type 1 
feed-forward loops (I1-FFL), a circuit in which a regulator X activates Z, and X also activates Y 
which in turn inhibits Z.  
To assess the effects of different MAPK pathways on cytokine synergy, we performed in silico 
knockout experiments, by eliminating the phosphorylation reactions along each of the three MAPK 
cascades. The predicted time profiles of Il12b and Il6 mRNA for !t in the range [0 - 48 h] are shown 
in Figure 6A-C. Knocking down 90% of activated JNK significantly decreased the cytokine 
production, indicating its dominant upregulating role amongst the three cascades. In contrast, the 
knockdown of activated ERK increased cytokine production under various conditions (e.g. IR, I8R, 
I24R), indicating that the inhibitory effect of ERK mediated by IL-10 and STAT3 are stronger than 
enhancing effect mediated by AP-1. Hence ERK acts as an overall negative modulator (or suppressor) 
of cytokine production. p38 also downregulated cytokine production under combinatorial treatment, 
although the effect was relatively small (if not negligible) compared to ERK. 
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To experimentally verify the model predictions, we perturbed the initial amount of JNK, ERK and 
p38 by incubating BMDM cells with the inhibitors SP600125 (JNK inhibitor), U0126 (ERK inhibitor) 
and SB203580 (p38 inhibitor) for 50 min. BMDMs were then treated first with poly(I:C) for 0, 8 or 
24 h followed by R848 for 8 h before RT-PCR. As can be seen in Figure 6D, for all the three 
conditions, JNK inhibition caused a decrease in the cytokine production, while low ERK levels 
increased cytokine production (consistent with its negative regulation that has been removed upon its 
inhibition). Finally, p38 inhibition slightly increased cytokine production in general.# $hese 
observations are consistent with the simulation results shown in Figure 6A-C, and confirm the 
distinctive effect of each MAPK signaling cascade on the (synergistic) production of cytokine. 
 
JAK-STAT1/2 pathway is the main mechanism responsible for induction of cytokine 
synergy 
 
The sensitivity analysis results (Figure 4) implied that JAK-STAT1/2 pathway is a major determinant 
of cytokine synergy. To confirm this, we carried out in silico knockout experiments where the four 
putative mechanisms discussed earlier were inactivated; namely (i) transcriptional activation of type 1 
IFNs and other target genes by IRF3 (downstream of TLR3), (ii) core reactions induced by Akt  
activation and (iii) those induced by NIK activation (both Akt and NIK being activated via secreted 
type 1 IFN), and (iv) JAK-STAT1/2 mechanism potentially establishing crosstalks relevant to 
cytokine synergy were turned off by knocking out IRF3, Akt, NIK or JAK-STAT1/2, and the time 
evolution of cytokine levels under each of the four knockout conditions were examined, subject to 
different combinatorial stimulation protocols. The results from simulations for Il12b mRNA levels are 
presented in Figure 7, and their counterparts for Il6 mRNA levels in the Figure S2. The data clearly 
show that the knockout of STAT1-STAT2 almost completely abrogates the synergistic production of 
cytokines, irrespective of the time interval between the two stimuli, whereas the other three have no 
detectable effect. We also performed in silico knockouts for different combinations of the putative 
mechanisms (Figure S3), which invariably confirmed the essential role of JAK-STAT1/2 pathway in 
mediating the cytokine synergy, consistent with the parameter sensitivity results.  
 
In silico and experimental knockdown of STAT1 highlighted the complex regulatory 
role of the incoherent feedforward loop 
 
Similar to the ERK and p38 signaling events, the JAK-STAT1/2 pathway mediates an I1-FFL since 
its target genes not only directly regulate the production of IL-12p40 and IL-6 but also enhance the 
production of IL-10 which inhibits IL-12p40 and IL-6. In the previous section, we showed that 
knockout of STAT1 would lead to a significant decrease in cytokine synergy (Figure 7D). However, 
the negative local sensitivity values associated with STAT1-STAT2 complex (Figure 4A) suggest 
that a mild decrease in STAT1 initial concentration might induce cytokine production. The opposing 
roles of STAT1 in cytokine synergy imply that the STAT1-mediated I1-FFL (Figure 8A) might lead 
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to the generation of non-monotonic input-output relation, i.e. biphasic response (Hart & Alon, 2013; 
Kim et al, 2008). To verify this, we evaluated the Il12b mRNA levels 8 h after the second PAMP 
challenge under IR, I8R and I24R conditions with the STAT1 initial concentration ranging from 0.01 
to 10 nM. The results summarized in Figure 8B show that a biphasic response occurred under I8R 
and I24R (but not IR) conditions. Reducing STAT1 concentration starting from physiological 
concentration (2.3 nM; indicated as ‘normal’) led to an increase and then a decrease in the cytokine 
production in both time-delayed combinatorial stimuli.  
To confirm the role of STAT1 predicted by our model, we performed in vitro STAT1 knockdown 
experiments with mouse macrophage cell line, J744 cells. Cells were transfected with Stat1 sequence-
specific siRNA or non-target control siRNA. Figure 8C shows substantial knockdown of STAT1 at 
24 h, after which the cells were stimulated with IR, I8R or I24R for 8 h. As shown in Figure 8D, 
STAT1 knockdown resulted in the enhancement of Il6 and Il12b mRNA expression in cells 
stimulated with IR, I8R and I24R. These observations agree well with the in silico model predictions, 





TLR signaling pathways protect the host against a broad range of microbial pathogens. Here, our 
empirical and computational analyses identified how two key TLR pathways coordinate an optimal 
innate immune response in macrophages. Specifically, when TLR3 is activated, it primarily leads to 
the production of type I IFNs via TRIF-dependent pathway. This initial response primes the host cell 
for a more effective immune response (in terms of the MyD88-mediated production of 
proinflammatory cytokines) to a subsequent TLR7-specific PAMP challenge, by creating a form of an 
immunological memory. This synergy effect is highly time-dependent, and an optimal immune 
response requires a proper synchronization of events downstream of TLR3 and TLR7 pathways. In 
the present study, we found that the time-dependent synergistic cytokine production predominantly 
controlled by the JAK-STAT1/2 pathway, triggered by the autocrine type I IFNs, upregulated by the 
TLR3 signaling cascade. Through a combination of efforts in experimental and computational 
approaches, we revealed the dual opposing roles of JAK-STAT pathway: knocking down STAT1 led 
to a decrease in cytokine gene expression via transcription factors such as IRF1 (unpublished data), as 
well as an increase of cytokine production via its target, anti-inflammatory cytokine, e.g. IL-10. The 
overall cytokine production depends on a subtle time-dependent coordination of those factors. Thus, 
STAT1 is not only an essential mediator for generating the cytokine synergy to boost immune 
response, but also a modulator for avoiding excessive immune responses.  The study further 
highlighted the effects of MAPK signaling cascades, revealing the opposite effects of JNK (an 
enhancer of cytokine production) and ERK (a suppressor of cytokine production), predicted by the 
model and simulations, and confirmed by experiments.  
 In the past two decades, intense research has identified and characterized hundreds of components 
and interactions implicated in TLR signaling. Various systems biology approaches have been used for 
improving our understanding of TLR-mediated innate immune responses (Vandenbon et al, 2012). 
However, an accurate and validated mathematical model of TLR signaling network, taking into 
account of the dynamic crosstalk between various TLR pathways has been hitherto lacking (Basak et 
al, 2007; Cheong et al, 2008; Covert et al, 2005; Hoffmann et al, 2002; Li et al, 2011; Longo et al, 
2013; O'Dea et al, 2007; Oda & Kitano, 2006; Shih et al, 2009; Shinohara et al, 2014; Tay et al, 2010; 
Werner et al, 2005). In the present study, we have developed a first calibrated ODE-based kinetic 
model for the time-dependent coupling between two specific TLR pathways and its complex 
implications. Furthermore, a novel JAK-STAT-mediated synergistic mechanism and the complex role 
of STAT1 is suggested by our study, which could guide future experimental investigations on 
discovering unidentified components and their interactions in the TLR signaling network. As new 
data become available our model can be refined and extended to help gain more insights.  
 The innate immune system must be tightly regulated so as to amplify the appropriate level of 
protective responses during infection, attenuate the damage inflicted by inflammation, as well as to 
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maintain or restore homeostasis. For example, complement pathways can crosstalk to enhance 
antibacterial activities under inflammatory conditions and simultaneously establish tight surveillance 
(Liu et al, 2011). In this context, ‘priming’ and ‘tolerance’ are important concepts that have emerged 
from accumulating evidence (Biswas & Lopez-Collazo, 2009; Shnyra et al, 1998). For example, it has 
been reported that a low dose of lipopolysaccharide (LPS), an inducer of TLR4 signaling, could prime 
macrophages and amplify cytokine production in response to a subsequent high dose-LPS stimulation; 
whereas, preconditioning macrophages with a high dose of LPS renders the cells much less 
responsive to a subsequent high dose-LPS stimulation (Fu et al, 2012a). Basic mechanisms underlying 
these priming and tolerance phenomena have been predicted in a recent work (Fu et al, 2012a), which 
computationally enumerated all possible topologies of an essential network with three abstract nodes. 
A follow-up study (Fu et al, 2012b) further hypothesized that IFNs and STAT1 might contribute to 
LPS-mediated priming in macrophages. Our study clearly demonstrates that IFN and STAT1 play a 
key role in priming the cell for subsequent challenges, and as such, it validates the hypothesis made 
by Xing and coworkers for TLR4, since TLR4 signaling itself is mediated by both MyD88 and TRIF. 
 The biphasic modulation of cytokine production through an incoherent type 1 feedforward loop 
(I1-FFL) deserves further attention. I1-FFL is one of the most frequently observed network motifs in 
biological networks. It appears hundreds of times in bacteria (Alon, 2007), yeast (Milo et al, 2002), 
and animals (Boyer et al, 2005; Milo et al, 2002). It has been reported (Hart & Alon, 2013) that the 
roles of I1-FFL include: (i) shortening of gene-circuit response time, (ii) generation of gene 
expression pulses (Hart & Alon, 2013), (iii) distinguishing time-varying inputs, (iv) filtering out noise, 
(v) detecting fold change of input signal, and (vi) generating non-monotonic input-output relations 
(Hart & Alon, 2013). There exist three I1-FFLs in our model, mediated by ERK, p38 and STAT1 
respectively. Among them, we found that the STAT1-dependent I1-FFL, inducing a biphasic response, 
is crucial to both amplifying the antiviral response and avoiding excessive inflammatory response. 
The I1-FFL mediated by p38 has minimal effect on cytokine production, but that of ERK is also 
shown to induce a strong (suppressive) effect. At the gene transcription level, Litvak et al (2009) 
identified a coherent type 1 feedforward loop (C1-FFL) formed by NF-!B, ATF3 and C/EBP", which 
discriminates between transient and persistent TLR4-induced signal. As a future direction, it might be 
interesting to explore the role of the gene transcription circuit downstream of TLR3-TLR7 signaling, 
and examine how different network motifs (e.g. I1-FFL, C1-FFL) cooperate to determine the immune 
response.  
A large number of previous modeling efforts have been focused on the NF-!B signaling module, 
which constitutes a core component downstream of all TLR pathways (Cheong et al, 2008; Covert et 
al, 2005; Hoffmann et al, 2002; Shinohara et al, 2014; Tay et al, 2010; Werner et al, 2005). An 
important finding indicates that a strong negative feedback loop mediated by I!B# can result in the 
oscillatory behavior of NF-!B level upon tumor necrosis factor-# (TNF#) stimulation (Hoffmann et al, 
2002; Werner et al, 2005). Interestingly, when cells are stimulated by LPS that initiates TLR4 
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signaling, activated NF-!B exhibits sustained behavior (Covert et al, 2005). It has been shown that the 
stability of LPS-induced NF-!B activation is achieved by two rounds of NF-!B activation: (i) an early 
NF-!B response via MyD88-dependent pathway, and (ii) a late NF-!B response via TRIF-dependent 
pathway, which first activates IRF3, leading to the expression of TNF", and then triggering the TNFR 
pathway with a time delay of 30 min (Covert et al, 2005). We have included the I!B"-mediated 
negative feedback loop in our model and observed a dampened oscillatory behavior of activated NF-
!B under single poly(I:C) stimulation (Figure S4). Upon combinatorial stimulation with poly(I:C) 
and R848, the NF-!B activity was significantly increased and the oscillation behavior disappeared 
(Figure S5). Thus, there is an analogy between the TLR4-dependent two-round NF-!B activation 
mechanism identified by Covert et al (Covert et al, 2005) and the TLR3-TLR7-dependent synergistic 
cytokine production mechanism identified here. Both mechanisms are controlled by MyD88-TRIF 
pathways and are mediated by IRF3-induced expression of autocrine signaling molecules. Since 
similar signaling network structures evolve to achieve modular dynamic functions (Purvis & Lahav, 
2013) it might be interesting to see if the MyD88-TRIF-IRF3 mediated crosstalk mechanisms are 
present in other TLR pathways.  
 Apart from TLRs, other pattern recognition receptors (PPRs) including retinoic acid-inducible 
gene 1 (RIG-I)-like receptors (RLRs), C-type lectin receptors, NOD-like receptors, also contribute to 
PAMP recognition and the regulation of innate immunity (Kawai & Akira, 2011). As pathogens often 
contain various PAMPs activating multiple PRRs, TLRs in crosstalk with other PRRs, orchestrate 
both host innate and adaptive immune responses to combat infections (Kawai & Akira, 2011). For 
instance, hepatitis C virus (HCV) is recognized by both TLR3 and RIG-I. The HCV RNA delivered 
from infected hepatocytes can also trigger the activation of the TLR7 pathway (Takahashi et al, 2010). 
PRR crosstalk can either positively or negatively regulate the eventual immune responses. Different 
types of collaborative responses have been reviewed by (Tan et al, 2014). Thus, it is important to 
understand how immune responses are coordinated and regulated by different PRRs. In this context, 
an important future direction will be the extension of the current model to non-TLR-PRR pathways as 
well as different cell types.   
 Turning to computational methods, our study demonstrated that statistical model checking 
(SMC)-based framework (Palaniappan et al, 2013) can be advantageously applied to noisy cell-
population data to obtain good estimates for hundreds of unknown parameters. Furthermore, we also 
showed that this framework enables the computation of global sensitivities of parameters for a large 
signaling network. To cope with even larger networks in the future, we plan to refine this method by 
exploiting the inherent massive parallelism in numerical simulation and develop a platform-aware 
GPU-based implementation using the strategy proposed recently (Hagiescu et al, 2013; Liu et al, 
2012).  
 In summary, our experimental and computational modeling analyses revealed how macrophages 
create ‘innate immune memory’ by activating TLR3 pathway and augmenting immune response to a 
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subsequent PAMP challenge. We have obtained novel insights regarding the crosstalk mechanisms 
between two major TLR pathways that help achieve this innate immune memory-based responses to 
time-dependent multiple infections. The model also provides a potential platform for designing and 
testing pharmaceutical strategies for immunotherapy.  
 
Material and Methods 
Mathematical modeling 
Our model consists of multiple modules (Figure S1) the time evolution of which is described by a 
system of ODEs corresponding to each reaction/interaction schematically shown in Figure S1. Each 
molecular species (or model component)  is associated with an equation of the form, 
, where the function  describes the kinetics of the reactions that produce or deplete 
,  is a vector that denotes the instantaneous concentration  of all components involved in 
this reaction, and the vector  denotes the rate constants governing this reaction. The reaction rates 
for assembly/binding, catalysis and transcription are described using mass action kinetics, Michaelis-
Menten kinetics, or the equations developed by Kuttykrishnan et al (Kuttykrishnan et al, 2010). We 
assume that  takes on values in the interval, , where  and  are non-negative 
rational numbers with . We address cell-to-cell variability explicitly by using probability 
distributions over the initial concentrations and rate constants (Table S2). The text files corresponding 
to the system of 97 ODEs are available in the supplementary information. 
 
Statistical model checking (SMC)  
SMC is a scalable computational technique for verifying whether a probabilistic dynamical system 
satisfies properties encoded as temporal logic formulas (Younes et al, 2004). We employed a recently 
developed SMC-based technique (Palaniappan et al, 2013) where we specified qualitative or 
quantitative properties of interest using a mildly strengthened bounded linear temporal logic (BLTL). 
Our BLTL is defined over a finite set of atomic propositions (APs), which is of the form  with 
Li!I<u!Ui, meaning “the current concentration level of  falls in the interval [l, u].”. The logic 
operators consist of  (and),  (or),  (negation), and time bounded  (until),  (global) and  
(future). We define the BLTL formulas as: (i) every AP and the constants true and false are BLTL 
formulas; (ii) if ,  are BLTL formulas then , and  are BLTL formulas; (iii) if 
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,  are BLTL formulas and  is a positive integer then , ,  and  
are BLTL formulas. 
Since experimental data were available at a finite number of time points, we applied the SMC 
method to the discrete time points, . A trajectory in our model is a solution (up to 
time, ) to the ODE system. The notion of a trajectory satisfying a BLTL specified property  at 
time point  is written as and is defined as follows: (i) !,t|=(i,l,u) iff , 
where  is the th component of vector ; (ii) , , and  are interpreted in the usual 
way; (iii)  iff there exists  such that , and . 
 for every ; (iv)  iff  and .  
for every . (v)  iff . (vi)  iff  . 
Let  represent the set of all trajectories of our ODE system, starting from an initial state, (the 
set of all initial concentrations defined in Table S1). We note that the set of trajectories satisfying a 
BLTL formula , denoted as  can be identified by the corresponding 
set of initial states, denoted as . Thus, we define probabilistic BLTL formulas in the form of 
, where , meaning the probability that a trajectory in belongs to  is at least 
. We then use  to denote that M, the systems of ODEs, meets the specification 
with a probability of at least . 
Using SMC, properties can be verified and/or assigned confidence levels and error bounds. 
Specifically, we verified each property using a sequential hypothesis test between the null hypothesis 
H0:  and the alternative hypothesis H1: , where  is the probability of M 
satisfying  and  specifies the indifference region. The strength of the test is determined by the 
parameter  and  which bound the type-I and type II errors, respectively. The test proceeds by 
generating a sequence of sample trajectories, !1,!2... A corresponding sequence of Bernoulli random 
variables  is assumed, where  = 1 if , and zero otherwise. For each generated 
sample, we update the score using the function  
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where is the number of generated samples. We accept hypothesis H0 if , and 
hypothesis H1 if ; otherwise, we draw another sample. Our implementation of this 
scheme is available at our website (http://www.comp.nus.edu.sg/~rpsysbio/smc). It is written in 
MATLAB and C++, and employs the SUNDIALS CVODE package (Hindmarsh et al, 2005) to solve 
the ODE system. 
  
Parameter estimation 
Unknown parameters were estimated using an SMC-based approach. We encoded the training data in 
terms of time series of experimental data as well as qualitative dynamic trends, defined by the 
respective BLTL formulas  and . For each estimate w of unknown parameters, we assumed 
a prior distribution as w ~ U(0.95w, 1.05w) so as to take into account the cellular stochasticity. We 
ran our SMC procedure to evaluate the goodness of w, in terms of fitting the training data, by 
verifying   with strength of statistical test (!=0.05, "=0.05). Specifically, we 
quantified the goodness of w using the following objective function: 
! 




where  is the number of conjuncts in ,  is the number of formulas of the form  
(a conjunct in  ) where  holds with the statistical strength of (!/J ,")(J being defined 
as ) and  is the number of conjuncts in  where 
! 
Pr"0.9 # l,qlty( )  
holds with the strength (!/J ,"). We implemented the stochastic ranking evolutionary strategy (SRES) 
(Runarsson & Yao, 2000) to evolve candidate parameters in order to search for the w values with 
global minimum objective value  in the parameter solution space. The resulting list of 
parameter is presented in Table S2.    
 
Sensitivity analysis 
Local sensitivity analysis was performed using the standard approach (Liu & Thiagarajan, 2012). 
Global sensitivity analysis was performed using an SMC-based multi-parametric sensitivity analysis 
(MPSA) method (Cho et al, 2003). We encoded the time profile of Il12b (the model output) as a 
BLTL formula, . The MPSA procedure involves drawing a representative set of samples from 
the parameter space. For each sampled combination of parameter values w, we compute the objective 
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value  with respect to the . The sampled parameter sets were classified into two classes 
using a threshold objective value. The sensitivities were then evaluated as Kolmogorov-Smirnov 
cumulative frequencies associated with the two classes. 
 
Preparation of bone marrow-derived macrophages (BMDMs)  
BMDMs were extracted from the tibia and femur of 8-week old female balb/c mice. Bone marrow 
cells were harvested and cultured in Dulbecco’s modified Eagle’s medium (DMEM) (Gibco, Life 
Technologies, Carlsbad, CA, USA), supplemented with 10% (v/v) fetal bovine serum (FBS) (Hyclone, 
Thermo Fischer Scientific, Waltham, MA, USA), 100 U/ml recombinant M-CSF (Ebioscience, San 
Diego, CA, USA), 100 U/ml penicillin and 100 µg/ml streptomycin (Gibco, Life Technologies, 
Carlsbad, CA, USA) at a density of 1.5x106 cells/ml. Additional complete medium with M-CSF was 
added three days after plating. Then cells were cultured for another four days before harvesting the 
adherent macrophages. Mouse work was under the guidance and regulation of Institutional Animal 
Care and Use Committee (IACUC protocol number: 049-11).  
 
Cell culture and PAMP treatments 
BMDMs and J774 cells were cultured in DMEM supplemented with 10% (v/v) FBS in 37°C 
incubator with 5% CO2 and 95% air supply. BMDM cells were plated at a density of 1x106/ml and 
J774 were plated at 0.4x106 cells/ml. The final concentration of PAMP treatment is 10 µg/ml and 25 
ng/ml for poly(I:C) and R848 (InvivoGen, SD, CA, USA). 
 
Western blot experiments 
Cells were lysed with Radioimmunoprecipitation assay (RIPA) buffer supplemented with proteinase- 
and phosphatase-inhibitor cocktail (Roche). 15 µg of total protein were resolved in a reducing SDS-
PAGE (10%) and electrotransferred to polyvinyldifluoride membranes. Blots were subsequently 
blocked with 5% dry, skimmed milk in TBST (50 mM Tris-base, 150 mM NaCl, 0.01% Tween-20, 
pH 7.6) and probed with specific antibodies: Rabbit polyclonal antibodies against STAT1 (#9172) 
were obtained from Cell Signaling Technologies (Boston, MA, USA). Mouse monoclonal anti-
GAPDH (sc-32233) was purchased from Santa Cruz Biotechnologies. Blots were then incubated with 
HRP-conjugated rabbit or mouse secondary antibodies (Sigma) and visualized with Western Bright 






For RNAi experiments, cells were transfected with a scramble control (Darmacon) or ON-
TARGETplus SMARTpool siRNA (Darmacon) against mouse Stat1 (50 nM) with X-tremeGENE HP 
DNA Transfection Reagent (Roche) for 24 h until subsequent PAMP stimulation. 
 
MAPK inhibitor treatment 
Inhibitors for JNK (SP600125), ERK (U0126) and p38 (SB203580) were purchased from Cell 
Signaling Technology (Boston, MA, USA). Cells were first treated with 10 µM inhibitors for 50 min, 
followed by corresponding PAMP stimulation. Media were not changed after inhibitor treatment. 
 
Real-time quantitative PCR 
Total RNA from cells was extracted with Trizol (Invitrogen). cDNAs were synthesized with 
Superscript III reverse transcriptase (Invitrogen). Lightcycler 480 master probes master (Roche) were 
used for the Taqman assays, and pre-designed TaqMan Gene Expression Assays (Life Technologies) 
Mm00446190_m1, Mm00434174_m1, Mm00446968_m1 were used for the detection of Il6, Il12b, 
and Hprt mRNA, respectively. Real-time PCR was carried out with Light cycler 480 system (Roche). 
The PCR cycles were: 1 cycle of 95°C for 10 min, 40 cycles of 95°C for 10 s, 60°C for 20 s. The 
mRNA levels of Il6 and Il12b were normalized with respect to the amount of Hprt.   
 
Calculation of “fold-synergy” for cytokine production 
To quantify the synergistic effect, the cytokine production under combinatorial stimulation was 
divided by the sum of the respective single stimulations. This ratio was termed “fold synergy”.  
Statistical analysis 
Data are represented as mean values and standard deviations based on at least three independent 
experiments. Statistically significant differences between treatments were analyzed with one-tailed 
Student’s t-test. A value of p < 0.05 was considered significant (*) and p < 0.01 very significant (**). 
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Figure 1. Characterization of Il6 and Il12b expression profiles after TLR3 and TLR7 co-
activation. A. Experimental design. Bone marrow-derived macrophages (BMDMs) were treated with 
1st PAMP for 0, 8, 24 h followed by 2nd PAMP for 4, 8, 16, 24 h. The control for the combinatorial 
stimulation is the single PAMP stimulation. Taking I8R16 as an example, the single control for it are 
poly (I:C) stimulation for 8 h or R848 stimulation for 16 h. B. Il6 and Il12b mRNA levels detected by 
real-time (RT)-PCR, under different treatment protocols. BMDMs were treated with 10 µg/ml 
poly(I:C) followed by 25 ng/ml R848 (left), or with R848 followed by poly(I:C) (middle), or single 
stimulation for 4, 8, 12, 16, 24, 28, 32, 40, 48 h as control (right; NT stands for no treatment). Time 
intervals between poly(I:C) and R848 treatments were 0 (!), 8 (!), 24 (") h. Results are normalized 
with respect to hypoxanthine guanine phosphoribosyl transferase (Hprt). Solid red curves refer to 
combinatorial stimulation, dashed blue curves indicate additive control for combinatorial stimulation 
as described in A. Data are representative of three independent experiments. C. Il6 and Il12b mRNA 
levels for BMDMs treated with 10 µg/ml poly(I:C) for 0, 4, 8, 12, 16, 24 h followed by 25 ng/ml 
R848 stimulation for 8 h. Data are presented as means ± SEM of three individual experiments.   
Figure 2. Schematic representation of TLR3 and TLR7 signaling network of interactions. TLR3 
recognizes dsRNA (and analogues such as poly(I:C)) derived from viruses or virus-infected cells and 
induces antiviral immune response by promoting the expression of type I IFNs and inflammatory 
cytokines (e.g. IL-6 and IL-12p40), via the TRIF-dependent pathway. TLR7 recognizes ssRNA (and 
analogues such as R848) and induces the production of type I IFNs and cytokines via the MyD88-
dependent pathway. IRF3 and IRF7 activated by TLR3 and TLR7 pathways respectively lead to the 
production of type I IFNs. NF-!B and AP-1 activated by both pathways lead to the production of 
inflammatory cytokines. The detailed reaction schema is shown in Figure S1.. 
Figure 3. Model predictions and experimental validation. A. Experimental and simulated protein 
dynamics of the TLR3-TLR7 pathway. The time profiles of activated ERK, p38, JNK, and IkB" 
under the following four conditions were simulated using estimated parameters and compared against 
the experimental data: R848 single stimulation, poly(I:C) single stimulation, poly(I:C) and R848 
combinatorial stimulation with 0 h time interval, poly(I:C) and R848 combinatorial stimulation with 8 
h time interval. Blue curves depict the model simulation results and red dots display experimental data. 
B. Model predictions and experimental validation of the synergistic cytokine production. The 
simulated time profiles of Il6 and Il12b expression levels under various conditions (right panels) 
reconcile the observed (left panel) time-dependent synergistic effect induced by the combinatorial 
TLR3-TLR7 activation. On the left panels, the experimental data are connected by lines to guide the 
eye. 
Figure 4. Sensitivity analysis. A. Local sensitivities (control coefficients) of the initial protein 
concentrations (listed along the ordinate) to the integrated response of the Il12b production under R, I, 
IR, I8R and I24R conditions. The heat map is color-coded from red (high positive sensitivity) to blue 
(high negative sensitivity). The former group refers to compounds whose increase in initial 
concentration would enhance cytokine production, and the latter to those whose decrease in initial 
concentration might enhance cytokine production. Components whose initial concentrations have 
little or no effect on the system dynamics are shown in light colors or white. B. Global sensitivities 
calculated according to the SMC-MPSA method. Sensitive parameters (that strongly influence the 
observed behavior) are shown by the peaks, colored dark blue. Robust parameters (the variations of 
!"##
which have little effect of the model dynamics) are colored purple. The highest peaks refer to Il6 and 
Il12b transcription or degradation rate constants. C. Functional classification of 33 kinetic parameters 
that led to the highest sensitivity peaks (above the dotted threshold line in panel B). The 
corresponding reactions are indicated by red arrows in Figure S1. 
Figure 5. Dependency of the immune response on the time interval !t between the two stimuli. 
A. Predicted time evolutions of the Il6 and Il12b mRNA expression levels in response to various 
combinatorial stimulations with a time interval !t (between the first (I) and second (R) stimulus) 
varying from 0 h to 48 h. The series of dotted curves represent results for successive !t values, the 
ordinate referring to the time elapsed with respect to the application of the first stimulus. Highest 
cytokine production occurs when the time interval between the two stimuli is !t ! 7 h. The results for 
!t = 0 (blue), 8 h (magenta), and 24 h (dark green) are shown by the thick colored curves. B. Peak 
amplitude and peak time derived from curves in (A). C. Predicted expression profiles for type I IFN 
produced in response to the combinatorial I!R (left panel) or R!I (right panel) stimuli with !t 
ranging from 0 h to 48 h.   
Figure 6. Effect of JNK, ERK and p38 inhibition on cytokine production. A-C Time evolution of 
Il12b mRNA (left) and Il6 mRNA (right) levels in the absence of JNK (A), ERK (B) and p38 (C) 
activation. The series of curves refer to different time intervals between the two stimuli (similar to 
Figure 5A).  JNK and ERK have opposite effects, i.e. upregulation and downregulation of cytokines, 
as can be seen from the comparison of the computationally predicted curves for !t = 0, 8 and 24 
(colored, thick) with those deduced from control simulations (thick, gray curves). The inhibition of 
p38 has relatively small effects, if any, on cytokine production. D. Experimental verification of 
computational predictions. BMDMs were treated with 10µM MAPK inhibitors for 50 min followed 
by IR, I8R or I24R stimulation. After 8 h of R848 stimulation, Il6 and Il12b mRNA were then 
measured with RT-PCR normalized with Hprt. Data are presented as mean values and SEMs obtained 
from three independent experiments. 
Figure 7. Knockout simulations highlight the significance of JAK-STAT pathway in triggering 
synergistic cytokine production. Simulation profiles of Il12b mRNA (A) in the absence of Akt 
activation reaction, (B) without crosstalk mechanism induced by IRF3, (C) in the absence of NIK 
activation, and (D) in the absence of STAT1-STAT2 activation.  
Figure 8. In silico and empirical knockdown of STAT1 revealed a complex regulatory role of an 
incoherent feedforward loop. A. A STAT1-mediated incoherent type 1 feedforward loop. B.  
Simulated STAT1 initial concentration-cytokine production response curves under IR, I8R, and I24R 
conditions. C. Knockdown efficiency of Stat1. J774 cells were transfected with either anti-Stat1 
siRNA or control scramble siRNA for 24. Cell lysates were collected for Western analysis. Data are 
representative of two independent experiments. D. Stat1 knockdown enhanced cytokine production. 
24 h after either anti-Stat1 siRNA or control siRNA transfection, cells were stimulated with IR, I8R, 
I24R for 8 h. Then expression of Il6 and Il12b mRNAs were analyzed by real-time PCR. Data are 
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k71, k72, k73, k74, k102, k105 Il6/Il12b transcription/degradation
k83, k84, k85, k87, k111, k128 JAK-STAT1/2 signaling cascade
k122, k126, k127, k129, k130, k131 IL-10-STAT3 signaling cascade
k81, k106, k109, k110 Type I IFN transcription/degradation
k31, k30, k31, k32, k33, k34, k79 JNK signaling cascade
k13, k23 p38 signaling cascade
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Figure S1: Reaction schema for the same signaling network organized by diﬀerent modules, designated
as TLR7-, TLR3-, and core-interactions, inhibition and transcription events, and TLR3-TLR7 cross-talk.
Complexes are denoted by the names of their components, separated by a “:”. Single-headed solid arrows
designate irreversible reactions and double-headed arrows, reversible reactions. Dotted arrows represent
enzymatic reactions. The corresponding kinetic equations are presented in the supplementary information.
The reactions with high global sensitivities, identified from sensitivity analysis, are labeled in red.
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Knockout AKT crosstalk Knockout IRF3 crosstalk 






















































Figure S2: Knockdown simulation results (the counterpart of these data for Il12b mRNA is presented in
Figure 7). A. Simulation profiles of Il6 mRNA without AKT activation reaction. B. Simulation profiles
of Il6 mRNA without crosstalk mechanism induced by IRF3. C. Simulation profiles of Il6 mRNA without
NIK activation reaction. D. Simulation profiles of Il6 mRNA without STAT1-STAT2 activation reaction.
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Figure S3: Combinational knockdown simulation results. A. Simulation profiles of IL6 mRNA without AKT
activation reaction and crosstalk mechanism induced by IRF3. B. Simulation profiles of IL6 mRNA without
AKT activation reaction and NIK activation reaction. C. Simulation profiles of IL6 mRNA without AKT
activation reaction and STAT1-STAT2 activation reaction. D. Simulation profiles of IL6 mRNA without
crosstalk mechanism induced by IRF3 and NIK activation reaction. E. Simulation profiles of IL6 mRNA
without crosstalk mechanism induced by IRF3 and STAT1-STAT2 activation reaction. F. Simulation profiles
of IL6 mRNA without STAT1-STAT2 activation reaction and NIK activation reaction.
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Figure S4: Nuclear NFκB profile under no-stimulation condition.












































Figure S5: Nuclear NFκB profile under IR-stimulation condition.
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Text S1: Incoherent Type 1 Feed-Forward Loop (I1-FFL)
Feed-forward loop (FFL) is one of the most common network motifs in biomolecular regulatory networks [9, 1]. For
instance, transcription factor X regulates transcription factor Y, and both X and Y regulate target gene Z. Thus, the
X, Y and Z form a FFL. Since each of the three transcriptional interactions in a FFL can be either positive (activation)
or negative (inhibition), there are eight possible combinations of positive or negative interactions, which have been
named as coherent/incoherent type 1-4 FFLs (see below). The abundance and functionality of diﬀerent FFLs have
been studied and discussed in [7]. Of particular interest in our context is the inherent type 1 FFL (I1-FFL), a circuit in
which X activates Z and Y, and Y inhibit Z. It has been reviewed in [4] that the roles of I1-FFL include: (i) shortening
of gene-circuit response time [8], (ii) generation of gene expression pulses [2], (iii) distinguishing time-varying inputs,
(iv) filtering out noise [10], (v) detecting fold change of input signal [3], and (vi) generating nonmonotonic input-
output relations [5]. The behavior resulted from (vi) is also called biphasic response, which can be time-dependent:
as time evolves the output response initially increases but subsequently decreases, even if the input is sustained; or
dose-dependent: over a certain range of input dose, the output response increases but subsequent decreases. It has
been shown that the parameters inducing biphasic responses are highly limited [6]. In the signaling network studied
in this work, we showed that the I1-FFLs mediated by STAT1 induces a dose-dependent biphasic response, which is
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Table S1: List of species and their initial concentrations1
Name Initial State (nM) Description
TLR7 0.53 ± 0.027 Toll-like receptor 7
MyD88 0.87 ± 0.044 Myeloid diﬀerentiation primary response 88
IRAK1/4 0.13 ± 0.0064 Interleukin-1 receptor-associated kinase 1/4
TRAF6 1.0 ± 0.05 TNF receptor-associated factor 6
A20 0.0048 ± 0.00024 Zinc finger protein A20
TRAF3 0.2 ± 0.01 TNF receptor-associated factor 3
Mkk1/2 0.99 ± 0.05 Mitogen-activated protein kinase kinase 1/2
Mkk3/6 0.00018 ± 8.86e-06 Mitogen-activated protein kinase kinase 3/6
ERK 0.076 ± 0.0038 Extracellular signal-regulated kinase
p38 0.46 ± 0.023 p38 mitogen-activated protein kinase
AP1 0.2 ± 0.01 AP-1 transcription factor
NEMO:IKKb:IKKa 0.2 ± 0.01 A complex of NF-kappa-B essential modulator, inhibitor of nuclear factor
kappa-B kinase subunit beta, and inhibitor of nuclear factor kappa-B kinase
subunit alpha
IκBα 0.0025 ± 0.00013 Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor,
alpha
NFκB 0.003 ± 0.00015 Nuclear factor kappa-light-chain-enhancer of activated B cells
IκBα:NFkB 0.06 ± 0.003 A complex of NFkB and IκBα
IRF7 0.2 ± 0.01 Interferon regulatory factor 7
JNK 0.32 ± 0.016 c-Jun N-terminal kinases
Mkk4/7 0.0064 ± 0.00032 Mitogen-activated protein kinase kinase 4/7
TLR3 0.22 ± 0.011 Toll-like receptor 3
TRIF 0.2 ± 0.01 TIR-domain-containing adapter-inducing interferon-beta
TRADD:FADD:RIP1 0.2 ± 0.01 A complex of TNFRSF1A-associated via death domain protien, Fas-
Associated protein with death domain protien, and Receptor-interacting
serine/threonine-protein kinase 1
IKKi 0.2 ± 0.01 Inhibitor of nuclear factor kappa-B kinase subunit epsilon
TBK1 0.18 ± 0.0088 TANK-binding kinase 1
IRF3 0.18 ± 0.0092 Interferon regulatory factor 3
Tak1:Tab2:Tab3 1.0 ± 0.05 A complex of Transforming growth factor beta activated kinase-1, Tak1 bind-
ing protien 2, and Tak1 binding protien 3
Tyk2:Jak1 0.26 ± 0.013 A complex of Tyrosine kinase 2 and Janus kinase 1
Stat1:Stat2 1 ± 0.05 A complex of Signal transducer and activator of transcription 1 and 2
PI3K 0.62 ± 0.031 Phosphoinositide 3-kinase
Akt 0.25 ± 0.012 Protein kinase B
NIK 0.01 ± 0.0005 NF-kappa-B-inducing kinase
RelBp52 0.01 ± 0.0005 NF-kappaB Rel-like domain-containing protein/p52 heterodimer
Continued on next page
6
Table S1 – continued from previous page
Name Initial State Description
RelBp100 0.01 ± 0.0005 NF-kappaB Rel-like domain-containing protein/p100 heterodimer
MSK1/2 1 ± 0.05 Mitogen- and stress-activated protein kinase 1/2
STAT3 10 ± 0.5 Signal transducer and activator of transcription 3
FacY 1 ± 0.05 Stat1:Stat2 target factors (e.g. IRF1)
IκBαn 0.0034 ± 0.00017 nuclear IκBα
IκBα:NFkBn 0.0001 ± 0.000005 nuclear IκBα-NFkB complex
NFκBn 0.0023 ± 0.00012 nuclear NFκB
R848 0.08 ± 0.004 Resiquimod
Poly(I:C) 0.015 ± 0.00074 Polyinosinic:polycytidylic acid
IFN 0 ± 0 Type 1 interferon
1Species with prefix “b” denotes its binding form. Species with suﬃx “*” denotes its activated form. Species with suﬃx “n”
denotes its localization is nucleus.
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Text S1: The ODE Model
d ([TLR7])
dt
= − (k1 · [R848] · [TLR7])
d ([bTLR7])
dt
= − (k2 · [bTLR7])
+ (k1 · [R848] · [TLR7])
d ([MyD88∗])
dt
= + (k3 · [bTLR7] · [MyD88])
− (k4 · [MyD88∗] · [IRAK1/4] · [TRAF6])
d ([MyD88])
dt
= − (k3 · [bTLR7] · [MyD88])
+ (k7 · [MyD88∗ : IRAK1/4 : TRAF6])
d ([IRAK1/4])
dt
= − (k4 · [MyD88∗] · [IRAK1/4] · [TRAF6])
+ (k19 · [IRAK1/4∗ : TRAF6])
d ([TRAF6])
dt
= − (k60 · [TRIF∗] · [TRADD : FADD : RIP1] · [TRAF6])
+ (k70 · [TRIF∗ : TRADD : FADD : RIP1 : TRAF6])
− (k4 · [MyD88∗] · [IRAK1/4] · [TRAF6])
− ((k26 · [TRAF6] · [A20] − k27 · [TRAF6 : A20]))
+ (k19 · [IRAK1/4∗ : TRAF6])
d ([MyD88∗ : IRAK1/4 : TRAF6])
dt
= + (k4 · [MyD88∗] · [IRAK1/4] · [TRAF6])
− (k7 · [MyD88∗ : IRAK1/4 : TRAF6])
d ([A20])
dt
= + (k35 · [A20mRNA])
− (k37 · [A20])
− ((k26 · [TRAF6] · [A20] − k27 · [TRAF6 : A20]))
d ([TRAF6 : A20])
dt
= + ((k26 · [TRAF6] · [A20] − k27 · [TRAF6 : A20]))
d ([IRAK1/4∗ : TRAF6])
dt
= + (k7 · [MyD88∗ : IRAK1/4 : TRAF6])
− ((k9 · [IRAK1/4∗ : TRAF6] · [TRAF3] − k28 · [IRAK1/4∗ : TRAF6 : TRAF3]))
− (k19 · [IRAK1/4∗ : TRAF6])
d ([TRAF3])
dt
= − ((k58 · [TRIF∗] · [TRAF3] − k59 · [TRIF∗ : TRAF3]))
+ (k69 · [TRIF∗ : TRAF3])





k10 · [Tak1 : Tab2 : Tab3∗] · [Mkk1/2]
k77 + [Mkk1/2]
￿





k11 · [Tak1 : Tab2 : Tab3∗] · [Mkk3/6]
k78 + [Mkk3/6]
￿
+ (k25 · [Mkk3/6∗])
d ([ERK])
dt
= − (k12 · [ERK] · [Mkk1/2∗])
+ (k18 · [ERK∗])
d ([ERK∗])
dt
= + (k12 · [ERK] · [Mkk1/2∗])





k10 · [Tak1 : Tab2 : Tab3∗] · [Mkk1/2]
k77 + [Mkk1/2]
￿





k11 · [Tak1 : Tab2 : Tab3∗] · [Mkk3/6]
k78 + [Mkk3/6]
￿
− (k25 · [Mkk3/6∗])
d ([p38∗])
dt
= + (k13 · [p38] · [Mkk3/6∗])




= − (k13 · [p38] · [Mkk3/6∗])
+ (k23 · [p38∗])
d ([AP1])
dt
= − (k32 · [JNK∗] · [AP1])
− (k20 · [ERK∗] · [AP1])
− (k14 · [p38∗] · [AP1])
+ (k29 · [AP1∗])
d ([NEMO : IKKb : IKKa])
dt
= + (k21)
− (k49 · [NEMO : IKKb : IKKa])
− (k94 · [Akt∗] · [NEMO : IKKb : IKKa])
− (k75 · [NEMO : IKKb : IKKa] · [Tak1 : Tab2 : Tab3∗])
d ([NEMO : IKKb∗ : IKKa])
dt
= + (k54 · [NEMO : IKKb∗ : IKKa : NFκB : IκBα])
− (k39 · [NEMO : IKKb∗ : IKKa] · [IκBα])
+ (k40 · [NEMO : IKKb∗ : IKKa : IκBα])
− (k41 · [NEMO : IKKb∗ : IKKa])
− (k50 · [NEMO : IKKb∗ : IKKa])
− (k53 · [NEMO : IKKb∗ : IKKa] · [A20])
+ (k76 · [NEMO : IKKb : IKK : Tak1 : Tab2 : Tab3∗])
+ (k94 · [Akt∗] · [NEMO : IKKb : IKKa])
− (k15 · [NEMO : IKKb∗ : IKKa] · [NFκB : IκBα])
d ([IκBα])
dt
= + (k47 · [IκBαmRNA])
− (k48 · [IκBα])
− (k39 · [NEMO : IKKb∗ : IKKa] · [IκBα])
− ((k44 · [IκBα] − k45 · [IκBαn]))
− (k17 · [NFκB] · [IκBα])
d ([NFκB : IκBα])
dt
= − (k38 · [NFκB : IκBα])
+ (k43 · [IκBαn : NFκBn])
− (k15 · [NEMO : IKKb∗ : IKKa] · [NFκB : IκBα])
+ (k17 · [NFκB] · [IκBα])
d ([NFκB])
dt
= + (k38 · [NFκB : IκBα])
+ (k54 · [NEMO : IKKb∗ : IKKa : NFκB : IκBα])
− (k17 · [NFκB] · [IκBα])
− (k16 · [NFκB])
d ([A20mRNA])
dt
= − (k36 · [A20mRNA])
+ (k52 · [NFκBn])
d ([IκBαmRNA])
dt
= − (k46 · [IκBαmRNA])
+ (k55 · [NFκBn])
d ([IRF7])
dt
= − (k5 · [IRAK1/4∗ : TRAF6 : TRAF3] · [IRF7])
+ (k6 · [IRF7∗])
d ([JNK])
dt
= + (k33 · [JNK∗])
− (k30 · [JNK] · [Mkk4/7∗])
d ([Mkk4/7∗])
dt
= − (k34 · [Mkk4/7∗])
+
￿





= − (k33 · [JNK∗])
+ (k30 · [JNK] · [Mkk4/7∗])
d ([Mkk4/7])
dt
= + (k34 · [Mkk4/7∗])
−
￿




d ([IRAK1/4∗ : TRAF6 : TRAF3])
dt
= + ((k9 · [IRAK1/4∗ : TRAF6] · [TRAF3] − k28 · [IRAK1/4∗ : TRAF6 : TRAF3]))
d ([IκBα∗])
dt
= − (k144 · [IκBα∗])
+ (k38 · [NFκB : IκBα])
+ (k54 · [NEMO : IKKb∗ : IKKa : NFκB : IκBα])
+ (k40 · [NEMO : IKKb∗ : IKKa : IκBα])
d ([NEMO : IKKb∗ : IKKa : NFκB : IκBα])
dt
= − (k54 · [NEMO : IKKb∗ : IKKa : NFκB : IκBα])
+ (k15 · [NEMO : IKKb∗ : IKKa] · [NFκB : IkBa])
d ([NEMO : IKKb∗ : IKKa : IκBα])
dt
= + (k39 · [NEMO : IKKb∗ : IKKa] · [IκBα])
− (k40 · [NEMO : IKKb∗ : IKKa : IκBα])
d ([inactiveIKK])
dt
= + (k41 · [NEMO : IKKb∗ : IKKa])
− (k51 · [inactiveIKK])
+ (k53 · [NEMO : IKKb∗ : IKKa] · [A20])
d ([TLR3])
dt
= − (k56 · [Poly(I : C)] · [TLR3])
d ([bTLR3])
dt
= + (k56 · [Poly(I : C)] · [TLR3])
− (k67 · [bTLR3])
d ([TRIF])
dt
= − (k57 · [bTLR3] · [TRIF])
+ (k69 · [TRIF∗ : TRAF3])
+ (k70 · [TRIF∗ : TRADD : FADD : RIP1 : TRAF6])
d ([TRIF∗])
dt
= + (k57 · [bTLR3] · [TRIF])
− ((k58 · [TRIF∗] · [TRAF3] − k59 · [TRIF∗ : TRAF3]))
− (k60 · [TRIF∗] · [TRADD : FADD : RIP1] · [TRAF6])
d ([TRIF∗ : TRAF3])
dt
= + ((k58 · [TRIF∗] · [TRAF3] − k59 · [TRIF∗ : TRAF3]))
− (k69 · [TRIF∗ : TRAF3])
d ([TRADD : FADD : RIP1])
dt
= − (k60 · [TRIF∗] · [TRADD : FADD : RIP1] · [TRAF6])
+ (k70 · [TRIF∗ : TRADD : FADD : RIP1 : TRAF6])
d ([TRIF∗ : TRADD : FADD : RIP1 : TRAF6])
dt
= + (k60 · [TRIF∗] · [TRADD : FADD : RIP1] · [TRAF6])
− (k70 · [TRIF∗ : TRADD : FADD : RIP1 : TRAF6])
d ([IKKi])
dt
= − (k62 · [TRIF∗ : TRAF3] · [IKKi])
+ (k66 · [IKKi : TBK1∗])
d ([IKKi∗])
dt
= + (k62 · [TRIF∗ : TRAF3] · [IKKi])
− (k64 · [TBK1∗] · [IKKi∗])
d ([TBK1])
dt
= − (k63 · [TRIF∗ : TRAF3] · [TBK1])
+ (k66 · [IKKi : TBK1∗])
d ([TBK1∗])
dt
= + (k63 · [TRIF∗ : TRAF3] · [TBK1])
− (k64 · [TBK1∗] · [IKKi∗])
d ([IKKi : TBK1∗])
dt
= + (k64 · [TBK1∗] · [IKKi∗])
− (k66 · [IKKi : TBK1∗])
d ([IRF3])
dt
= − (k65 · [IKKi : TBK1∗] · [IRF3])




= − (k105 · [A])





0.0001 + 0.9999 ·
￿
1 − 1







1 + k98 · [NFκBn]
· 1
1 + k97 · [NFκBn] · [AP1∗] · [FacY∗]1.5
· 1
1 + k100 · [AP1∗]
· 1




= + (k71 · [A])
− (k72 · [A2])
d ([A3])
dt
= + (k72 · [A2])
− (k73 · [A3])
d ([IL6mRNA])
dt
= + (k73 · [A3])
− (k74 · [IL6mRNA])
− (k123 · [IL6mRNA] · [STAT3∗])
d ([Tak1 : Tab2 : Tab3])
dt
= − (k61 · [TRIF∗ : TRADD : FADD : RIP1 : TRAF6] · [Tak1 : Tab2 : Tab3])
+ (k22 · [Tak1 : Tab2 : Tab3∗])
− (k8 · [IRAK1/4∗ : TRAF6] · [Tak1 : Tab2 : Tab3])
d ([NEMO : IKKb : IKK : Tak1 : Tab2 : Tab3∗])
dt
= − (k76 · [NEMO : IKKb : IKK : Tak1 : Tab2 : Tab3∗])
+ (k75 · [NEMO : IKKb : IKKa] · [Tak1 : Tab2 : Tab3∗])
d ([Tak1 : Tab2 : Tab3∗])
dt
= + (k61 · [TRIF∗ : TRADD : FADD : RIP1 : TRAF6] · [Tak1 : Tab2 : Tab3])
− (k22 · [Tak1 : Tab2 : Tab3∗])
+ (k76 · [NEMO : IKKb : IKK : Tak1 : Tab2 : Tab3∗])
+ (k8 · [IRAK1/4∗ : TRAF6] · [Tak1 : Tab2 : Tab3])
− (k75 · [NEMO : IKKb : IKKa] · [Tak1 : Tab2 : Tab3∗])
d ([B])
dt






1 + k98 · [NFκBn]
· 1
1 + k99 · [NFκBn] · [AP1∗] · [FacY∗]1.5
· 1
1 + k100 · [AP1∗]
· 1
1 + k101 · [factX] · [NFκBn] · [AP1∗]
￿￿





0.0001 + 0.9999 ·
￿
1 − 1




= + (k71 · [B])
− (k72 · [B2])
d ([B3])
dt
= + (k72 · [B2])
− (k73 · [B3])
d ([IL12mRNA])
dt
= + (k73 · [B3])
− (k74 · [IL12mRNA])







0.0001 + 0.9999 ·
￿
1 − 1
1 + k82 · [IRF3∗]
· 1
1 + k133 · [AP1∗] · [IRF3∗] · [NFκBn]
￿￿￿
− (k106 · [C])





0.0001 + 0.9999 ·
￿
1 − 1




= + (k106 · [C])
− (k107 · [C2])
d ([C3])
dt
= + (k107 · [C2])
− (k108 · [C3])
d ([Type1IFN])
dt
= + (k108 · [C3])





0.0001 + 0.9999 ·
￿
1 − 1
1 + k90 · [Stat1 : Stat2 ∗ n]
￿￿￿
d ([Tyk2 : Jak1])
dt
= − (k83 · [Type1IFN] · [Tyk2 : Jak1])
+ (k85 · [Tyk2 : Jak1∗])
− (k135 · [IL10] · [Tyk2 : Jak1])
d ([Tyk2 : Jak1∗])
dt
= + (k83 · [Type1IFN] · [Tyk2 : Jak1])
− (k85 · [Tyk2 : Jak1∗])
+ (k135 · [IL10] · [Tyk2 : Jak1])
d ([Stat1 : Stat2])
dt
= − (k84 · [Tyk2 : Jak1∗] · [Stat1 : Stat2])
+ (k86 · [Stat1 : Stat2∗])
d ([Stat1 : Stat2∗])
dt
= + (k84 · [Tyk2 : Jak1∗] · [Stat1 : Stat2])
− (k86 · [Stat1 : Stat2∗])
− ((k87 · [Stat1 : Stat2∗] − k88 · [Stat1 : Stat2 ∗ n]))
d ([PI3k])
dt
= − (k91 · [Type1IFN] · [PI3k])
+ (k93 · [PI3K∗])
d ([PI3K∗])
dt
= + (k91 · [Type1IFN] · [PI3k])
− (k93 · [PI3K∗])
d ([Akt])
dt
= − (k92 · [PI3K∗] · [Akt])
+ (k95 · [Akt∗])
d ([Akt∗])
dt
= + (k92 · [PI3K∗] · [Akt])
− (k95 · [Akt∗])
d ([NIK])
dt
= − (k112 · [Type1IFN] · [NIK])
+ (k113 · [NIK∗])
d ([NIK∗])
dt
= + (k112 · [Type1IFN] · [NIK])
− (k113 · [NIK∗])
d ([RelBp52])
dt
= − (k116 · [RelBp100∗] · [RelBp52])
+ (k117 · [RelBp52∗])
d ([RelBp100])
dt
= − (k114 · [NIK∗] · [RelBp100])
+ (k115 · [RelBp100∗])
d ([RelBp100∗])
dt
= + (k114 · [NIK∗] · [RelBp100])




= + (k116 · [RelBp100∗] · [RelBp52])
− (k117 · [RelBp52∗])
d ([IL10])
dt
= + (k136 · [MSK1/2∗])
− (k127 · [IL10])
+ (k137 · [Stat1 : Stat2 ∗ n])
+ (k130 · [MSK1/2∗] · [Stat1 : Stat2 ∗ n])
d ([MSK1/2])
dt
= − (k143 · [MSK1/2] · [ERK∗])
− (k138 · [MSK1/2] · [p38∗])
+ (k139 · [MSK1/2∗])
− (k140 · [MSK1/2] · [ERK∗] · [p38∗])
d ([MSK1/2∗])
dt
= + (k143 · [MSK1/2] · [ERK∗])
+ (k138 · [MSK1/2] · [p38∗])
− (k139 · [MSK1/2∗])
+ (k140 · [MSK1/2] · [ERK∗] · [p38∗])
d ([STAT3])
dt
= − (k141 · [STAT3] · [Tyk2 : Jak1∗])
+ (k142 · [STAT3∗])
− (k129 · [STAT3] · [IL10])
d ([STAT3∗])
dt
= + (k141 · [STAT3] · [Tyk2 : Jak1∗])
− (k142 · [STAT3∗])










= −VNuclues · (k42 · [NFκBn] · [IκBαn])
+ ((k44 · [IκBα] − k45 · [IκBαn]))
d ([IκBαn : NFκBn])
dt
= +VNuclues · (k42 · [NFκBn] · [IκBαn])
− (k43 · [IκBαn : NFκBn])
d ([NFκBn])
dt
= −VNuclues · (k42 · [NFκBn] · [IκBαn])
+ (k16 · [NFκB])
d ([AP1∗])
dt
= + (k32 · [JNK∗] · [AP1])
+ (k20 · [ERK∗] · [AP1])
+ (k14 · [p38∗] · [AP1])
− (k29 · [AP1∗])
d ([Stat1 : Stat2 ∗ n])
dt
= + ((k87 · [Stat1 : Stat2∗] − k88 · [Stat1 : Stat2 ∗ n]))
−VNuclues · (k128 · [Stat1 : Stat2 ∗ n])
d ([factX])
dt
= +VNuclues · (k103 · [IRF3∗])





k124 · [Stat1 : Stat2 ∗ n] · [FacY]
k125 + [FacY]
￿
−VNuclues · (k111 · [FacY∗])
d ([IRF3∗])
dt
= + (k65 · [IKKi : TBK1∗] · [IRF3])
− (k68 · [IRF3∗])
d ([IRF7∗])
dt
= + (k5 · [IRAK1/4∗ : TRAF6 : TRAF3] · [IRF7])
− (k6 · [IRF7∗])
18
References
[1] U. Alon. Network motifs: theory and experimental approaches. Nat Rev Genet, 8(6):450–461, 2007.
[2] S. Basu, R. Mehreja, S. Thiberge, M.-T. Chen, and R. Weiss. Spatiotemporal control of gene expression with pulse-generating
networks. Proc Natl Acad Sci, 101(17):6355–6360, 2004.
[3] L. Goentoro, O. Shoval, M. W. Kirschner, and U. Alon. The incoherent feedforward loop can provide fold-change detection in
gene regulation. Mol Cell, 36(5):894–899, 2009.
[4] Y. Hart and U. Alon. The utility of paradoxical components in biological circuits. Mol Cell, 49(2):213–221, 2013.
[5] S. Kaplan, A. Bren, E. Dekel, and U. Alon. The incoherent feed-forward loop can generate non-monotonic input functions for
genes. Mol Syst Biol, 4(1), 2008.
[6] D. Kim, Y.-K. Kwon, and K.-H. Cho. The biphasic behavior of incoherent feed-forward loops in biomolecular regulatory networks.
Bioessays, 30(11-12):1204–1211, 2008.
[7] S. Mangan and U. Alon. Structure and function of the feed-forward loop network motif. Proc Natl Acad Sci, 100(21):11980–11985,
2003.
[8] S. Mangan, S. Itzkovitz, A. Zaslaver, and U. Alon. The incoherent feed-forward loop accelerates the response-time of the gal
system of escherichia coli. J Mol Biol, 356(5):1073–1081, 2006.
[9] R. Milo, S. Shen-Orr, S. Itzkovitz, N. Kashtan, D. Chklovskii, and U. Alon. Network motifs: simple building blocks of complex
networks. Science, 298(5594):824–827, 2002.
[10] M. Osella, C. Bosia, D. Cora´, and M. Caselle. The role of incoherent microrna-mediated feedforward loops in noise buﬀering.
PLoS Comput Biol, 7(3):e1001101, 2011.
19
           


























































































































15-1-4 4:10Copyright Clearance Center










This is not an invoice
Order Details
Permission type: Republish or display content
Type of use: Republish in a thesis/dissertation
3541781285774Order License Id:















Title of the article or
chapter the portion is
from
Cooperation of Toll-like
receptor signals in innate
immune defence
Editor of portion(s) N/A
Author of portion(s) Giorgio Trinchieri and AlanSher
Volume of serial or
monograph
7




Rights for Main product
Duration of use Life of current edition




















Publisher: NATURE PUBLISHING GROUP
Nature Reviews Immunology
Permission Status:  Granted
Billing Status:
N/A
15-1-4 4:10Copyright Clearance Center
 2  2 https://www.copyright.com/printOrder.do?id=11287560
Total order items:  1 Order Total: $0.00
Get Permission | Products And Solutions | Partners | Education | About Us | Engineering Copyright & Content 
Privacy Policy | Terms & Conditions














The standard identifier NUS thesis database
Title The mechanism ofcytokine synergy




Estimated size (pages) 150
Note: This item was invoiced separately through our RightsLink service. More info $ 0.00
